Etude du repliement des protéines par RMN temps réel et autres méthodes biophysiques : l'exemple de la Beta-2-microglobuline by Cutuil, Thomas
Etude du repliement des prote´ines par RMN temps re´el
et autres me´thodes biophysiques : l’exemple de la
Beta-2-microglobuline
Thomas Cutuil
To cite this version:
Thomas Cutuil. Etude du repliement des prote´ines par RMN temps re´el et autres me´thodes
biophysiques : l’exemple de la Beta-2-microglobuline. Autre [cond-mat.other]. Universite´ de
Grenoble, 2012. Franc¸ais. <NNT : 2012GRENY097>. <tel-00849137>
HAL Id: tel-00849137
https://tel.archives-ouvertes.fr/tel-00849137
Submitted on 30 Jul 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
THÈSE
Pour obtenir le grade de
DOCTEUR DE L’UNIVERSITÉ DE GRENOBLE
Spécialité : Physics for life sciences
Arrêté ministérial : 7 août 2006
Présentée par
Thomas Cutuil
Thèse dirigée par Bernhard Brutscher
préparée au sein du Biomolecular NMR group, Institut de Biologie
Structurale
et de l’ Ecole Doctorale de Physique
Folding of proteins studied by real time
NMR and other biophysical methods: the
example of β2-microglobulin
Thèse soutenue publiquement le 14 Décembre 2012,
devant le jury composé de :
Dr. Sophie Zinn-Justin
DR-CEA (CEA Saclay, France), Rapporteur
Pr. Jochen Balbach
Professeur (Université de Halle, Allemagne), Rapporteur
Pr. Alessandra Corazza
Professeur (Université d’Udine, Italie), Examinatrice
Dr. Vincent Forge
DR-CEA (IRTSV, CEA Grenoble, France), Examinateur
Dr. Dominique Housset
DR-CEA (IBS Grenoble, France), Examinateur
Dr. Bernhard Brutscher
DR-CEA (IBS Grenoble, France), Directeur de thèse

Contents
I The protein folding problem 9
1 General principles 10
2 Amyloidoses as misfolding diseases 13
2.1 Amyloidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.2 Amyloid ﬁbrils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.3 Amyloid ﬁbril formation mechanism . . . . . . . . . . . . . . . . . . . 19
2.4 Amyloids and oligomers: paradigm shift for toxicity . . . . . . . . . . 20
3 Experimental techniques 21
3.1 UV-visible absorption spectroscopy . . . . . . . . . . . . . . . . . . . 21
3.2 Spectroﬂuorimetry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.3 Circular dichroism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.4 Infrared spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.5 Small angle X-Ray Scattering (SAXS) . . . . . . . . . . . . . . . . . . 26
3.6 Transmission Electron microscopy . . . . . . . . . . . . . . . . . . . . 28
3.7 NMR spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
II β2-microglobulin: a model protein for amyloid formation
and protein folding 32
4 B2M: general introduction 33
4.1 Isolation, structure, function . . . . . . . . . . . . . . . . . . . . . . . . 33
4.2 B2M and Dialysis Related Amyloidosis . . . . . . . . . . . . . . . . . . 37
4.3 B2M as a marker for other diseases . . . . . . . . . . . . . . . . . . . . 38
3
5 B2M: amyloidogenesis 40
5.1 B2M discovered as an amyloidogenic protein . . . . . . . . . . . . . . . 40
5.2 B2M ﬁbril formation mechanism . . . . . . . . . . . . . . . . . . . . . 40
5.3 B2M and oligomers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
5.4 B2M native oligomers . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
6 B2M folding 50
6.1 A central disulphide bridge . . . . . . . . . . . . . . . . . . . . . . . . 50
6.2 B2M folding studied in real time . . . . . . . . . . . . . . . . . . . . . 50
6.3 B2M folding followed using NMR . . . . . . . . . . . . . . . . . . . . . 53
6.4 Folding and amyloid formation/aggregation . . . . . . . . . . . . . . . 54
III The folding of B2M: from kinetics to a folding model 56
7 Real time NMR: theory and methods 58
7.1 NMR theory crash course . . . . . . . . . . . . . . . . . . . . . . . . . 58
7.2 Longitudinal relaxation optimized NMR . . . . . . . . . . . . . . . . . 64
7.3 Projection NMR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
7.4 B2M folding experiments: standard procedures . . . . . . . . . . . . . 69
7.5 Fast Mixing Device . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
7.6 Labeled B2M protein production . . . . . . . . . . . . . . . . . . . . . 73
8 Folding of B2M followed using real time 2D SOFAST NMR 76
8.1 Standard experiment: . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
8.2 Following the folding with methyl protons as probes . . . . . . . . . . 82
8.3 Folding of the W60G-B2M mutant . . . . . . . . . . . . . . . . . . . . 83
8.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
9 Exploring B2M folding 88
9.1 B2M folding: solvent dependence . . . . . . . . . . . . . . . . . . . . 88
9.2 B2M folding: temperature dependence . . . . . . . . . . . . . . . . . . 91
9.3 Fitting the folding signals: mono or bi-exponential functions? . . . . 94
9.4 B2M folding: Simpliﬁed model . . . . . . . . . . . . . . . . . . . . . . 94
4
IV Probing the NMR invisible state 97
10 Detecting a transient, invisible oligomer using real time NMR 99
10.1 The inﬂuence of concentration on the folding of B2M . . . . . . . . . . 99
10.2 B2M folding: discussion on both temperature and concentration inﬂuence103
10.3 The oligomeric intermediate state is in equilibrium with the monomeric
intermediate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
11 Expanding the scope: Biophysical methods for a further character-
ization of the oligomeric intermediate 107
11.1 SAXS: characterizing the stoichiometry of the oligomeric intermediate 107
11.2 Infrared Spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
11.3 UV-ﬂuorescence spectroscopy with the use of Thioﬂavin-T . . . . . . . 117
11.4 Back to NMR, detection of a short lived intermediate state . . . . . . 118
11.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
12 Single point mutants as in-equilibrium models? 124
12.1 Evaluating the average molecular weight using SAXS . . . . . . . . . . 126
12.2 NMR 15N relaxation experiments . . . . . . . . . . . . . . . . . . . . . 130
12.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
V Toward NMR structural characterization of short-lived
folding intermediates 134
13 B2M W60G as a test case 136
13.1 Cumulative discrete data acquisition vs continuous data acquisition . . 136
13.2 Assigning a transient state . . . . . . . . . . . . . . . . . . . . . . . . . 140
13.3 Chemical shift analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
13.4 Relaxation measurements in the I state . . . . . . . . . . . . . . . . . 147
13.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152






AFM Atomic force microscopy
ANS 8-Anilinonaphthalene-1-sulfonic acid, a ﬂuorescent molec-
ular probe that binds to hydrophobic patches of proteins




DRA Dialysis Related Amyloidosis
DTT Dithiothréitol
ESI-MS Electrospray ionization mass spectrometry
FT-IR Fourier Transform Infrared Spectroscopy
HLA Human Leukocyte Antigens
HMQC Heteronuclear multiple quantum coherence
HSQC Heteronuclear single quantum coherence
I* NMR-invisible folding intermediate state of B2M
I1 Monomeric folding intermediate state of B2M
I2 Low molecular weight oligomeric folding intermediate state
of B2M, likely to be a dimer
I3 Short-lived, heavy molecular weight oligomeric folding in-
termediate state of B2M
IAPP Islet amyloid polypeptide or amylin
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It Folding intermediate state of B2M, with a trans peptide
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Protein folding is the process through which a protein reaches its stable, functional,
conformation. In his Nobel Prize winning work, Anﬁnsen states that this stable con-
formation is unique, and determined only by the amino-acid sequence of the protein,
at least for small proteins. This links the genetic coding of a function as a sequence
in DNA to its material mode of action which is the lock-key interaction, through a
unique 3D protein structure. This of course should be moderated, as the structure of
proteins, even in their native functional state, should be considered as an ensemble of
highly similar states, rather than as a unique, static structure. Moreover, more and
more intrinsically disordered proteins are being discovered, which are proteins that
are functional despite their lack of well deﬁned structure. Some of them will even
acquire a deﬁned tertiary structure upon binding with another protein or substrate.
The traditional view of protein folding, the acquisition of this stable, functional struc-
ture, derives from the Levinthal paradox, which states that if a polypeptide chain
should sequentially experience every conformation possible before reaching the func-
tional tertiary structure, implies a folding time that is longer than the age of the
universe. Yet, most small proteins are folding within milliseconds. This paradox sug-
gests that proteins do not sample all possible conformations when folding, but rather
follow a preferential folding pathway. This can be illustrated using the folding fun-
nel model, meaning that the energy landscape of accessible protein conformations is
funnel-shaped, with the native folded structure being a deep, steep-walled minimum.
The funnel energy landscape model doesn't mean that the folding is straightforward,
limited to a two-state transition between the unfolded and folded structures. The
protein can be kinetically trapped in many local energy minima along the folding
pathway, and sometimes needs the intervention of chaperone proteins to go on with
its folding. An illustration of such a rough folding funnel is shown on ﬁgure 1.1.
Protein folding is thought to be mainly driven by the hydrophobic eﬀect, correspond-
ing to the burying of hydrophobic lateral chain amino-acids inside a hydrophobic
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Figure 1.1: Model of the folding landscape of lyzozyme. Unfolded conformations
are shown with a higher free energy, on the z axis. The native conformation is at
the bottom of the funnel, while two local minima can be seen, corresponding to two
folding intermediate states. Three folding pathways are shown, sampling either or
both intermediate conformations. Reproduced from [48]
core of the protein. The hydrophobic eﬀect is not due to the interaction between
these hydrophobic lateral chains, but is entropy-driven. When exposed to water, in
the unfolded conformation, a hydrophobic lateral chain disrupts the highly dynamic
hydrogen bond network between water molecules. This hydrogen bond network is re-
stored through the formation of a hydration shell around the hydrophobic chain, but
water molecules in this shell have a reduced mobility, equivalent to strongly reduced
entropy. The burying of the hydrophobic lateral chain inside the core of the protein
releases these water molecules, leading to an increase in entropy of the whole system,
and thus a reduced free energy. Of course other interactions are involved in folding,
such as hydrogen bonds between amino-acids, salt bridges or hydrophobic, especially
aromatic, interactions and disulﬁde bridges.
The major limitation to the study of protein folding is its timescale: micro- to mil-
liseconds for most small (∼5-50kDa) proteins. Traditional physical methods that are
used to study the structure of proteins have time resolutions that are at best of the
order of seconds, if at all adapted to the detection of transient species. One solution
to this problem is the modiﬁcation of the folding conditions, at the expense of phys-
iological relevance: a lower temperature slows down the folding often several orders
of magnitude, a change of the solvent can also have an eﬀect on the folding speed.
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Another solution is reducing the experimental time needed to acquire signals with the
diﬀerent methods, and the development of stopped-ﬂow systems in UV spectroscopy
and circular dichroism and high speed pulse sequences in NMR is a way of tackling
this diﬃculty. Finally biochemical modiﬁcations of the protein, such as mutation of
one or several amino-acids, can trap it in non native conformations, producing equi-
librium models of transient species. Yet most studies focusing on protein folding are
using proteins that naturally fold at much lower timescales, of the order of minutes.
Luckily, some of them are also linked to misfolding diseases.
Misfolded proteins are usually detected by the cell and degraded through proteolysis,
but some diseases are due to mutated proteins that cannot reach their native folded
state, or to the adoption by wild-type proteins of non-native conformations in speciﬁc
conditions. Disfunctioning in the proteolytic system can also lead to the accumulation
of misfolded protein, which can be pathogenic. Misfolding diseases can be either due
to the loss of function of a misfolded protein, or to the accumulation of misfolded
protein aggregates [41]. For example, the misfolding of a tumor suppressing protein,
such as p53, can cause cancers, while the accumulation of beta and tau aggregates,
in the form of amyloids, is characteristic of Alzheimer's disease. This involvement







Amyloidosis is deﬁned as a group of medical conditions in which normally innocuous
soluble proteins polymerize to form insoluble ﬁbrils [156], making of amyloidosis a
class of misfolding diseases. Amyloid ﬁbrils grow and associate with constituents of
extracellular medium such as plasma, matrix proteins, proteoglycans, to form amyloid
deposits in tissues, destroying their normal architecture and function. Amyloid de-
posits are involved in a lot of very diﬀerent medical conditions such as some cancers,
Alzheimer's disease, rheumatoid arthritis, and Parkinson's disease [69]. Amyloidoses
can be systemic, like the Dialysis Related Amyloidosis (DRA), or localized in a sin-
gle organ, such as brain for Alzheimer's disease. Systemic amyloidoses are based on
plasma circulating precursors, such as β2-microglobulin (B2M) or Serum amyloid A
(SAA). Most amyloidoses are linked to aging, and imply extracellular accumulation of
precursor proteins, many involve a defective proteolytic process while some are based
on intact precursor proteins. Precursor proteins are usually of small size (3-30kDa),
are polyanionic, and often rich in aspartic and glutamic acids.
The ﬁrst step in the formation of amyloid ﬁbrils is the association of precursor proteins
into ﬁlaments with a beta-pleated structure. In a dynamic process, ﬁlaments are
assembled into ﬁbrils, which later on form bundles in association with extracellular
medium components, and ﬁnally ﬁbrous deposits in tissues. It is of importance that all
amyloid deposits collected in tissues are not only composed of protein amyloid ﬁbrils,
but also of diﬀerent extracellular components, such as serum amyloid P component
or heparan proteoglycans. The study of amyloids in vitro is mainly focused on the
ﬁbrillar part of the deposits [157]. A brief description of a few examples of amyloidoses
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can help grasping the major characteristics of this class of misfolding diseases.
2.1.1 Alzheimer's Disease
Alzheimer's Disease is a neuro-degenerative disease, often associated to aging, as it
is the most common form of senile dementia. It was named after Dr. Alzheimer,
who described this disease in 1906 [12]. Symptoms at early stages include inability to
acquire new memories, while at later stages, symptoms evolve to mood swings, long
term memory loss, confusion, language breakdown. Failure to recognize close relatives,
motor diﬃculties, delusion and resistance to caregiving often imply a lot of stress for
the relatives of Alzheimer's disease patients, that are also often the caregivers [166].
The need of healthcare professionals for long-term care of these patients, combined
with the high prevalence of the disease (5-8% of population above 65 years, up to 30%
above 85), makes of Alzheimer's disease the most costly aging disease for health care
systems in developed countries [23], with costs increasing with the age average of the
population and age expectancy.
Causes of Alzheimer's disease are still widely debated. While from the 19th century
until into the 1960s a vascular cause was accepted for the cerebral atrophy evidence
of which was obtained during autopsies of patients with senile dementia, this hypoth-
esis has lost support since then. As soon as 1907 was shown that ﬁbrillar deposits
were present in the brain of deceased patients, either inside or outside of neurons
[4]. The amyloid cascade hypothesis was formulated in 1991 that states that these
amyloid deposits were the primary event of the molecular pathogenesis [80], when
a pathogenic mutation of the beta-amyloid precursor protein was discovered. This
mutation leads to an irregular cleavage of the precursor protein into beta amyloid
peptides, that can form amyloid ﬁbrils. This was supported by the fact that Down
syndrome patients, who have a third copy of the beta-amyloid precursor protein gene,
almost all display Alzheimer's disease by the age of 40 [82]. Another hypothesis is the
tau and tangles hypothesis, that states that the primacy leans toward the formation
of neuroﬁbrillary tangles by the tau protein [119], and that amyloid deposits would
only be a consequence. The involvement of amyloid ﬁbrils in this disease, either as a
cause or a symptom, caused a boost to amyloid ﬁbril formation research, along with
the idea that it may lead to the discovery of a treatment. A vaccine was developed,
and was successful in preventing the formation of ﬁbrils, but not the development of
the dementia, which lead to another toxicity theory for the Abeta peptides, involving
protein oligomers (see 2.4).
2.1.2 Creutzfeld Jacob disease and prion protein diseases
Creutzfeld Jacob disease is a transmissible spongiform encephalopathy, a neurodegen-
erative disease. It was brought to common knowledge during the mad cow epizootic,
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when it was thought that it could be transmitted via beef infected by the mad cow
disease (bovine spongiform encephalopathy BSE). This information led to political
decisions like the ban of beef products from the United Kingdom inside the rest of
the European union from 1996 to 2006, while the british too permissive regulations
on cattle feed were blamed for the development of the epizootic. Another possible
transmission (which led to another political scandal), was through the injection of
Human Growth Hormone obtained from the pituitary gland of CJD dead patients.
In both cases, a prion is involved. Prion is a word coined from protein and infection
by the 1997 Nobel prize Stanley Prusiner [131]. A prion is an infectious agent made
of a protein in a misfolded form, the ﬁrst identiﬁed that doesn't imply a nucleic acid
genome. Its key ability is to transmit its misfolded state to its well-folded counter-
parts that are expressed by the infected patient (or animal) [40]. This misfolded state
being stable, its propagation is exponential [115]. This prion has a strong propensity
to form amyloid ﬁbrils, that leads to the formation of deposits inside the brain and
to neuronal death [47]. Other diseases are linked to prions, such as Scrapie in sheeps,




Parkinson's disease is also a neurodegenerative disease. It was ﬁrst described by doctor
Parkinson in 1817 [125]. It involves in early stages movement-related symptoms, such
as shaking, rigidity, diﬃculties with walking, while later stages imply cognitive and
behavioral symptoms, often leading to dementia. Parkinson's disease is linked to the
formation of Lewy bodies inside neurons, that lead to neuronal death. Lewy bodies
are aggregates formed around alpha-synuclein amyloid ﬁbrils [158].
 Type II diabetes
Type II diabetes is a metabolic disorder, characterized by insulin resistance which
can be combined with lower insulin production. This disease has mainly lifestyle
factors, although genetic factors are also known. Insulin-producing islet beta cells
are located in the pancreas, and in type II diabetes patients, amyloid ﬁbrils made of
the islet amyloid polypeptide (IAPP or amylin) are found in these tissues. IAPP is
a small (37 residues) hormone, produced at the same time as insulin. IAPP amyloid
ﬁbrils have been proved to be toxic for pancreatic islet beta cells [110]. It has been




Prolactinoma is an adenoma (benign tumor) of the pituitary gland, that implies in-
creased production of prolactin, an hormone similar in structure to growth hormones,
which is primarily associated with lactation. Prolactinomas display the formation of
prolactin-derived amyloid ﬁbrils, especially linked to aging ([15], [177]).
In conclusion, the study of these various amyloidoses shows us the variety of proteins
involved, and the large number of patients that can be aﬀected by these diseases. Es-
pecially linked to aging, amyloidoses will see the number of aﬀected patients rise along
the increase of life expectancy, making of the study of amyloid ﬁbril formation a more
and more important topic of research.
2.2 Amyloid ﬁbrils
The amyloid term was coined in 1838 by Schleiden to describe the amylaceous (starchy)
constituent of plants. It was ﬁrst used in a medicinal context by Virchow in 1851,
to describe deposits he discovered in the extracellular medium inside the liver during
autopsies, that he thought were made of cellulose. The methods he used to char-
acterize the deposits, based on sulfuric acid and iodine, were indeed used at that
time to detect starch. Friedrich showed in 1859 that the main content of amyloids
is protein. Congo Red staining was introduced in 1922 by Bennhold, and the use
of polarization microscopy in 1927 by Divry, showing that amyloids have a highly
ordered structure. Viewed with polarized optics, congo red stained amyloid deposits
display a strongly increased birefringence, which is still today the standard charac-
terization test of amyloids. This strong increase in birefringence, that is not seen in
other ﬁbrillar structures such as collagen or ﬁbrin, shows that the dye molecules are
aligned in parallel along the axis of the amyloid structure ([136], [73],[70]). In 1959,
electron microscopy studies showed that amyloid deposits were composed of ﬁbrillar
material [39].
Amyloid ﬁbrils are resistant to proteolytic digestion [160] and insoluble in physiolog-
ical conditions [53]. Amyloid ﬁbrils share a common structure: each ﬁbril (∼7-10 nm
wide) contains at least two ﬁlamentous sub-units (∼3nm wide) called proto-ﬁlaments
or ﬁlaments, twisting around each other along the ﬁbril axis. The ﬁlamentous sub-
units are formed from protein polymerized in a cross beta sheet conformation ([22],
[53], [71]). These ﬁbrils can also associate with other ﬁbrils, twisting around each
other just as the ﬁlamentous sub-units they are made of, to form even larger ﬁb-
rils ([152],[171]), bundles and aggregates [130], or highly organized species known as
spherulites [96]. The beta sheets are directed perpendicular to the axis of the ﬁlament
[53], as shown by Xray diﬀraction patterns, and infrared spectroscopy showed that
these beta sheets are anti-parallel [165].
Amyloid ﬁbrils can be obtained by isolation from tissues, or by in-vitro synthesis. The
commonly used protocol to isolate amyloid ﬁbrils from tissues [130] implies treatments
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to wash the tissue from soluble proteins and salts, before re-suspension in distilled
water to separate the ﬁbrils from other insoluble proteins. Because some amyloidoses
are systemic, ﬁbrils can be found in a lot of diﬀerent tissues, but brain, liver and
joints are the most used in the isolation of amyloid ﬁbrils.
2.2.1 Amyloid ﬁbril synthesis in vitro
Amyloid ﬁbrils were ﬁrst obtained in vitro in 1971 [72], using Bence-Jones pro-
teins. Bence-Jones proteins are immunoglobulin light chain proteins, associated with
amyloid light chain (AL) amyloidosis, which is the most common form of systemic
amyloidoses [66]. In-vitro ﬁbrils were obtained after 2- to 5-hour incubation in a
50mM guanidine-HCl buﬀer with acidic pH (pH=3.5), at 37°C, at a concentration of
10mg/mL, in presence of pepsin, which is a proteolytic enzyme that degrades proteins
into small peptides. One can already ﬁnd in this paper major conditions that have
been used since then to produce amyloid ﬁbrils: acidic pH, denaturing buﬀer (even
if here the concentration of guanidine-HCl is too low to induce a real denaturation),
high protein concentration. It was later shown that the use of guanidine-HCl was not
necessary with digested Bence-Jones proteins, as 100mM sodium-acetate buﬀer could
be used just as eﬀectively[107]. On the contrary, a too acidic pH, below 3.6, has been
shown to greatly reduce the rate of formation of the ﬁbrils, this being explained by
the loss of tertiary structure that occurs at such pH [42].
Insulin can form ﬁbrils in aqueous solution with or without acidic conditions (50mMHCl),
at 20 or 85°C, even though the heat treatment largely increases the rate of formation
of the ﬁbrils ([126], [99]), proving that intact proteins can form amyloid ﬁbrils, and
not only proteolytic fragments. Islet amyloid polypeptide, or amylin, a pancreatic
hormone, forms amyloid ﬁbrils both at acidic and neutral pH, a formation that is
increased in presence of insulin, which is of relevance as both are involved in type
II diabetes and produced in pancreatic beta cells [32]. Fibril in vitro formation pro-
tocols can be as simple as incubation in water at 37°C for 30 minutes, as shown
for peptides homologous to Alzheimer's disease beta-protein [30], or a saline solution
(100mM NaCl), as shown for fragments of the same beta-protein [74]. Amyloid ﬁbrils
of B2M were also obtained in an in-vitro cell culture, showing that ﬁbrillation inside
a culture of a cell-line coming from patients was possible spontaneously even in-vitro
[28]. Polymerization can also be started by the addition of seeds, made of fragments
of amyloid ﬁbrils, that act as nucleation center [132]. Fibril formation can be induced
by the addition of an enzyme (such as a protease, see Bence Jones protein ﬁbrils) or
another biological molecule found in vivo such as a phospholipid, as Lysophosphatidic
acid (LPA) was shown to induce in-physiological conditions ﬁbril formation of B2M
[129], by destabilizing the tertiary structure of the protein.
To sum up, in a more general perspective, amyloid ﬁbrils are generally obtained in
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vitro using slightly destabilizing buﬀer conditions, like enzymatic, acidic, or organic
perturbations. Agitation can be employed, but it has been suggested that the eﬀect of
agitation is mainly kinetic, hypothetically creating nucleation seeds from the shearing
of the early-formed ﬁbrils that would accelerate the polymerization ([132], [2]).
2.2.2 Amyloid ﬁbril formation by non disease related proteins
Amyloid ﬁbril formation was ﬁrst studied in vitro by isolation from tissues, coming
from patients, and therefore linked to a pathology. After isolation, amyloid ﬁbrils
could be studied chemically and later physically. Once their constituent was identiﬁed,
in vitro studies of the process of formation of these ﬁbrils could be done. As shown
during the listing of diﬀerent pathologies linked to amyloid ﬁbrils, the constitutive
proteins or peptides are structurally rather diﬀerent, some having a alpha-helix-rich
structure while others display a beta-sheet-rich one, even though the structure of
ﬁbrils being a beta-sheet stacking, all share a beta-sheet conformation propensity.
In 1998, amyloid ﬁbrils were obtained, which were constituted of a protein (SH3)
not related to a pathology. Conditions were similar to what was previously used to
obtain amyloid ﬁbrils in vitro, meaning incubation in a phosphate buﬀer at 4°C or
room temperature for a few days, at pH=2. Amyloid ﬁbrils were totally identical
in structure to pathology-related ﬁbrils, showed a birefringence increase under Congo
red staining, ﬁbrillar aspect in electron microscopy, and a cross-beta structure in Xray
diﬀraction. This study showed that the amyloid ﬁbril formation could be accessible
to proteins that were not linked to a pathology, and that the key element was to
have access to destabilized states of the protein [79]. Since then, many other proteins,
not related to amyloidoses, have been shown to be able to form amyloid ﬁbrils, such
as muscle myoglobin [62], a cold shock protein [78] or a helical cytochrome [127] for
example.
2.2.3 Amyloids' functional role
Just as was seen in vitro, amyloid ﬁbrils not linked to diseases were found in vivo [38].
So-called functional amyloids have been used by living organisms with diﬀerent roles,
at one point or another of their life-cycle. For example, E. coli uses amyloid ﬁbrils,
made of the protein curlin, to colonize inert surfaces, and to bind to diﬀerent host
proteins [31]. These functional amyloids can also be found in mammalian systems,
as it was observed that ﬁbrous striations involved in the production of melanin are
composed of amyloid ﬁbrils [14]. Functional amyloids are exactly similar in structure
to disease related amyloids, as they show birefringence upon Congo red staining,
have the same diameter as seen in electron microscopy, show an extensive beta sheet
structure as seen in Circular Dichroism (CD) [63]. In a similar manner, the heritable
conformational changes of prion proteins have in some cases been proved beneﬁcial,
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and inheritable as a non-Mendelian non-chromosomal genetic trait. For example the
polymerization of Ure2p protein into amyloid ﬁbrils results in the activation of genes
involved in the uptake of poor nitrogen sources [35]. The polymerization of the CPEB
(cytoplasmic polyadenylation element-binding) protein from a marine snail has been
suggested to be essential for the long-term maintenance of synaptic changes associated
with memory storage [153]
2.3 Amyloid ﬁbril formation mechanism
The formation of amyloid ﬁbrils through a nucleated growth mechanism is widely
accepted [151]. The mechanism starts with a lag phase, during which the formation
of ﬁbrils is not signiﬁcant, as established using Thioﬂavin-T (ThT) ﬂuorescence or
light scattering, among other techniques. During this lag phase, diﬀerent oligomeric
constructs form, some of which have a beta-sheet-rich structure and will serve as
polymerization nuclei. The use of polymerization seeds, made from the shearing of
regular ﬁbrils, induce the disappearing of this lag-phase, because the polymerization
nuclei are provided. The lag phase is then followed by an exponential growth of the
ﬁbrils[121]. Many studies have been focusing, in the past decade, on these oligomeric,
pre-ﬁbrillar constructs, both for the fact that they may be the toxic agent in amy-
loidoses, and that to understand completely the mechanism of formation of amyloid
ﬁbrils, the formation of the polymerization nuclei can't be avoided.
For many proteins (including B2M and Abeta, responsible for Alzheimer's), these
oligomers have been identiﬁed, using either atomic force microscopy (AFM) or Trans-
mission electron microscopy (TEM) . Some of them appear as spherical beads (2-5nm
in diameter), or linear chains made of these beads, and even annular structure, that
could be formed by the circularization of these beaded chains [81]. They have also
been recently characterized by Small Angle Xray Scattering (SAXS), showing beaded-
chains of insulin, on-pathway of the formation of ﬁbrils [171]. These structures were
termed protoﬁbrils by their ﬁrst descriptors, and are not to be confused with proto-
ﬁlaments. Protoﬁbrils can bind ThT and show birefringence dyed with Congo Red,
and have a beta-sheet-rich structure [173]. Protoﬁbrils made from diﬀerent proteins
share structural elements, as a protoﬁbril-speciﬁc antibody can bind all of them but
not the corresponding monomers or mature ﬁbrils [98]. Protoﬁbrils themselves are
preceded by low molecular weight oligomers, dimers to hexamers for Abeta, that from
CD experiments seem to be rather disorganized [16]. Interestingly, these low molecu-
lar weight oligomers are found in the brain of Alzheimer's disease patients [17]. These
low molecular weight oligomers have been identiﬁed for Sup35p yeast prion [151],
insulin [171] and the SH3 domain from a bovine kinase [7], among others.
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2.4 Amyloids and oligomers: paradigm shift for tox-
icity
The discovery of ﬁbrillar deposits in the organs of patients suﬀering from certain
diseases made reasonable the assumption that amyloid ﬁbril deposits were the cause
of these diseases. Moreover, the injection of amyloid ﬁbrils into the cerebral cor-
tex of aged monkeys provoked neuronal loss [67]. But recent ﬁndings have shown
that amyloid ﬁbrils may be a symptom, and not the cause of the diseases, while
ﬁbril-precursors, such as oligomers or proto-ﬁbrils, would be the pathogenic agent,
at least in neuropathic diseases. To limit evidence to Alzheimer's disease, it has
been shown that the severity of the cognitive impairment correlates with the levels
of oligomers, but not that of ﬁbrils [111]. In transgenic mice, the same symptom
appears well before the accumulation of amyloid deposits in the brain [117]. And at
last, a mutation responsible for a heritable early onset manifestation of the disease
is proved to provoke oligomerization but no amyloid ﬁbril formation [122]. These
ﬁndings are corroborated by the toxicity of preﬁbrillar forms of non disease-related
proteins, while their native or ﬁbrillar form are not toxic [38]. The enhanced toxicity
of low molecular-weight oligomers compared to amyloid ﬁbrils may be explained by
the fact that smaller aggregates have a higher proportion of residues on their sur-
face, residues that in properly folded proteins would not be exposed. These exposed





Most biophysical techniques have been used to study folding or amyloid ﬁbril for-
mation, with either structural or kinetic focuses, and those that are mainly used
are brieﬂy described in this part. The study of these phenomenons is the study of
complex samples, involving the existence of transient species, polydispersity, aggre-
gation propensity, diﬀerent time and size scales, and fast kinetics, making the use of
complementary techniques a method of choice.
3.1 UV-visible absorption spectroscopy
UV-visible (UV-vis) spectroscopy is probably the most widely used technique for
routine analytical work, such as protein detection and concentration measurement,
along with rough protein characterization [154]. The method is based on the interac-
tion of light, inside visible (400-700nm) and UV (200-400nm) wavelength ranges, and
electrons of for example delocalized pi-systems. Protein concentration can be mea-
sured with absorption at 280nm, using Beer's law and calculated (or measured) molar
extinction coeﬃcients. UV-vis spectroscopy can also be used to follow molecular in-
teractions or changes in the structure of proteins. Aromatic amino-acids are powerful
probes in the ultraviolet spectral absorption range. The spectrum of a chromophore
is highly dependent on the polarity of its microenvironment. An aromatic residue
will have a diﬀerent spectrum depending on whether it is exposed to solvent or buried
inside the protein for example.
Using such a property, folding and unfolding (denaturation) of proteins can be fol-
lowed. Denaturation can be caused by successive adjuncts of urea or guanidinium, or
pH, ionic strenght and temperature changes. Folding kinetics can be followed using
denaturant dilution or pH jumps. If aromatic residues, such as tyrosine or trypto-
phan for example, are involved, interactions can be detected, such as protein-protein
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or enzyme-substrate binding or protein-metal interactions. Artiﬁcial chromophores
can also be attached to speciﬁc parts of the protein, through mutation of a residue
to an aromatic one or through disulﬁde linkeage to a cysteine, providing probes in
regions that can't be detected with this technique due to the absence of natural chro-
mophores.
Figure 3.1: Evolution of the human serum albumin (HSA) UV-vis spectrum in pres-
ence of growing concentrations of a drug. At high concentration, HSA is denatured
by the drug. [164]
3.2 Spectroﬂuorimetry
Fluorescence is a light emission phenomenon, implying a transition from a higher
to a lower energy state measured by the detection of the emitted radiation rather
than the absorption as seen in spectro UV-vis. In order for this transition to occur,
the molecule must have been excited, for example through the absorption of light.
Diﬀerent wavelengths in absorption and emission are due to energy losses as heat,
during collisions with other molecules, called the Stokes shift (see ﬁgure 3.2). Most
molecules that absorb in the ultraviolet/visible region of the spectrum do not ﬂuoresce,
as their excited electrons go back to ground energy state through heat emission, but
many ﬂuorescent compounds are of biological interest.
The technique of spectroﬂuorimetry is most accurate at very low concentrations,
whereas absorption spectrophotometry is least accurate under those conditions. Flu-
orescence is highly dependent on pH, solvent composition, and temperature [87]. This
technique can also be used for quantitative determination of low-concentration com-
pounds, for example vitamin B1 in foodstuﬀs [77]. Fluorescent probes can be used to






Figure 3.2: The Stokes shift explains the diﬀerence between the wavelengths of ab-
sorption and emission
Redox reactions involving NADH and NADPH can be followed kinetically in vitro
at in-vivo similar concentrations, or even in intact cells or mitochondria. Changes in
protein structure, using either FAD as tryptophan cofactor or a chimera with GFP,
can induce ﬂuorescence changes as conformation or microenvironment around the
probe changes. Thioﬂavin T is a widely used probe, as it is speciﬁc to amyloid ﬁbrils
(Figure 3.3).
Figure 3.3: Formation of amyloid ﬁbrils of B2M in presence of several co-factors,
followed using Thioﬂavin-T ﬂuorescence.
3.3 Circular dichroism
Electromagnetic radiation (light) oscillates in all possible directions, but it is possible
to select preferentially waves oscillating in a single plane using polarising material.
Polarimetry is essentially the measure of the angle through which the polarisation
plane is changed after passing through a solution containing a chiral substance. In
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circular dichroism, incident light is circularly polarized (composed of two 90° phase-
shifted perpendicularly polarized waves with identical intensities), and undergoes a
diﬀerent interaction with chiral compounds on diﬀerent polarization planes, inducing
an elliptically polarized resultant beam. This ellipticity is measured in CD experi-
ments and is plotted against wavelength, giving information on secondary and tertiary
structure. The CD spectrum of a protein is compared, through curve-ﬁtting, to those
of poly-L-amino acids, that have known alpha helix, beta sheet, and random coil con-
tents, and a percentage of the content in these secondary structures in the protein
can be estimated (ﬁgure 3.4 [86]). Using this estimation, the acquisition of secondary
structure during folding or unfolding can be easily followed, giving access to ther-
modynamic and kinetics parameters [101]. Another example is the determination of
binding constants in protein-protein or protein-substrate interactions[114]. Tertiary
structure changes can also be followed, through the burying or exposition of tyrosine
and tryptophan residues, using far UV wavelength.
Figure 3.4: Near (A) and far (B) circular dichroism spectra of alpha A crystallin and
its mutant Y118D. Diﬀerences are consistent with an increased alpha helix content in
the mutant protein.
3.4 Infrared spectroscopy
Below the UV-vis energy range in the electromagnetic spectrum is the infrared re-
gion (700nm to 25µm). The absorption energy corresponding to this level is that of
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vibrational states transitions. Bond between atoms can be considered here as ﬂexible
springs, allowing the molecule to adopt several vibrational modes, including stretch-
ing or bending. A molecule can absorb incident light by switching to the speciﬁcally
higher energy vibrational mode. An infrared spectrum is thus an absorption spec-
trum. As the number of functional groups increases, the molecules becoming more
complex, infrared absorption bands become more diﬃcult to assign, due to the overlay
of bands close in frequency, but also due to the inﬂuence of the molecular environ-
ment on the frequency itself. For example it is possible to distinguish between the
C-H vibrations of CH2 and CH3.
Figure 3.5: Typical protein infrared spectrum with assignment of the amide bands
[90]
While infrared spectroscopy is mainly used in chemical and biochemical research of
small compounds such as drugs or substrates, and can be coupled to a separating
method such as gas chromatography, it can be part of protein analysis. Especially, the
peptide bonds gives rise to nine absorption bands, named amide A, B and I through
VII, amide I and II being the major contributors. Both bands being related to the
backbone conformation, they are characteristic of secondary structure [9]. Secondary
structure changes can be followed using time-resolved infrared spectroscopy, speciﬁc
evolutions of the bands being linked to transitions in the alpha helix, beta sheet
or random coil content. In practical terms, transmission fourier transform infrared
spectroscopy (FT-IR) is highly contaminated by the strong absorption of the O-H
bond vibration, so liquid-state experiments on proteins have to be conducted in D2O,
with questions arising on the biological relevance of the solvent, and on the fact that
folding processes can be diﬀerent inD2O andH2O. To tackle this problem, attenuated
total reﬂectance (ATR) spectrometers can be used. ATR uses evanescent waves to
measure the spectrum of a sample deposited on a measurement crystal. Evanescent
waves are absorbed inside the sample in a layer which thickness is of the order of
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the wavelength, circa 1-10µm. This means that the optical thickness of the sample is
compatible with measurements in H2O.
Fourier transform infrared spectroscopy (either transmission or ATR) allows, through
the use of interferograms, measurement times of the order of seconds, instead of tens
of minutes for the classical dispersive infrared spectroscopy.
3.5 Small angle X-Ray Scattering (SAXS)
SAXS (and Small angle Neutron scattering where neutron beams replace X-rays, with
very similar principles) is a technique that allows the determination of size and shape
parameters of large molecules such as proteins. X-rays are diﬀracted by electrons, and
as such analysis of X-ray crystallography diﬀraction data sets produces an electron
density map of the crystal. But contrary to X-Ray crystallography, where a bias is
introduced as molecules are trapped in a crystal, in SAXS the proteins are in aqueous
solution. Due to the random positions and orientations of molecules in the liquid state,
the intensity distribution is isotropic, and proportional to the scattering intensity of
one molecule averaged over all orientations. Experimentally, the scattered intensity
is recorded as a function of momentum transfer q (q = 4pisinθλ ), where 2θ is the angle
between the incident and scattered radiation. At small angles, the scattering curve is
a rapidly decaying function of q, essentially determined by the shape of the molecules
in the sample. Guinier analysis (equation (3.2)) provides estimations of the radius of
gyration of the molecule and the extrapolated forward intensity, which is proportional
to the molecular weight of the molecule, which can be obtained by comparison to a
standard (equation (3.3) where C is the massic concentration). Fourier transform of
the scattering intensity curve provides the pair distribution of the molecule, which is
a histogram of interatomic distances. Comparison to the pair distribution of standard
shapes provides hints of the shape of the molecules in solution. Using simulation of
scattering curves and ﬁtting them to the experimental curves, softwares can calculate
a rough three dimensional structure, or an ensemble of structures of the molecule,
with a resolution up to 10Å. For a detailed theoretical approach of SAXS, see [162].

















Figure 3.6: Typical scattering curves of BSA before and after subtraction of the
solvent scattering curve.
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Standard conditions for successful SAXS experiments imply a monodisperse macro-
molecule solution. Indeed as soon as the sample is not monodisperse, scattering curves
measured are the sum of scattering curves of the diﬀerent compounds in the solution.
Of course calculating the average-shape of a mix of proteins makes no sense. But
one can follow the formation of a dimer, or a protein complex, by recording the in-
crease of the average gyration ratio or average molecular weight inside the sample.
The presence of oligomers can be proven, and the evolution of the oligomerization
state of a protein can be followed. Several tools have been recently developed, such
as singular value decomposition, to help in the analysis of polydisperse samples. Sin-
gular Value Decomposition is a mathematical data analysis that derives from the
scattering curves the singular vectors and values that compose the signal. It can be
an indication of the number of compounds present or of states that are populated, or
even the mechanism of formation of amyloid ﬁbrils [171].
3.6 Transmission Electron microscopy
While light microscopy is limited to a routine resolution of 0.5µm, electron microscopy
can provide a resolution up to 1nm. In electron microscopy, the light source is replaced
with an electron gun, consisting of a high voltage passed between the cathode (a
tungsten ﬁlament) and the anode in which a hole allows the formation of the electron
beam. While passing through the sample, some of the electrons of the beam are
scattered, while others are then focused on a digital camera. When the technique
was developed, samples had to be stained with high atomic number compounds, like
heavy metals such as uranium, lead or osmium, making labelled structures appear
dark or electron dense.
Negative staining techniques on the contrary oﬀer the possibility of contrast enhance-
ment, with faster and simpler protocols. The idea of negative staining is to surround
or embed the object of interest with an electron dense material that provides high
contrast. Instead of appearing dark on a light background, the biological object will
appear light on a dark background. These techniques have been used, with diﬀerent
stains, since the 1950s, and allowed the collection of information on the structure
of ribosomes, viruses, bacteriophages, microtubules, and amyloid ﬁbrils and other
biological ﬁlaments.
3.7 NMR spectroscopy
Similar to other spectroscopic techniques, NMR implies an energy input to promote
the transition from a ground state to a higher energy state, speciﬁcally here nuclear
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Figure 3.7: Amyloid ﬁbrils shown using negative staining electron microscopy, from
[142]
magnetic spins. Nuclear magnetic spins are intrinsic properties of nuclei which pop-
ulate energy levels according to quantum theory. After a certain time span, spins
excited by an electromagnetic radiation relax to the ground state, ﬁxed by exposition
to a high intensity magnetic ﬁeld. The spins resonate at a frequency linked to the
value of the magnetic ﬁeld produced by the coil of the superconductive magnet, but
shifted by a value linked to micro-environmental magnetic ﬁelds produced by adja-
cent nuclear spins. This frequency shift is termed chemical shift, and is the most
common parameter measured by NMR. Along with common 1H NMR spectroscopy,
the study of bio-molecules almost always involves 13C and 15N spins. Because of
the low natural abundance of such isotopes, recombinant proteins and nucleic acids
are usually labelled during their production using isotope-enriched bacterial nutrients
(13C glucose, 15N amino-acids) . To reduce spectral complexity,1H atoms can be
replaced, during production or through exchange, by 2H isotopes.
 Multidimensional NMR
Common NMR spectra are obtained using a pulse acquired Fourier transform scheme,
where the observable is the decay of the transverse magnetisation, called free induction
decay (FID). The detected signal is thus a function of the detection time t2. Protein
spectra usually show a strong overlap of signals, as shown on ﬁgure 3.8 (top), due
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to the high number of spins that are present and detected within the sample. To
tackle this diﬃculty, the spectra can be spread on a second dimension or more. For
example, the position of peaks in a 2D spectra can correspond to the chemical shifts
of both an hydrogen atoms (x axis) and its bonded nitrogen (y axis). This is obtained
using another time t1 (evolution time), that can be introduced in the pulse sequence
at speciﬁc positions, and the signal becomes a function of both t1 and t2, while its
Fourier transform comprises two frequency components. An example is shown on
ﬁgure 3.8 (bottom).
NMR techniques speciﬁcally used for our studies along with theoretical principles are
further described in chapter 7.
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Figure 3.8: Typical NMR spectrum of the amide region of a protein. The 1D spectrum
(top) shows large overlaps (degeneracy), which can be much reduced using Nitrogen









β2-microglobulin (B2M) is a protein that has been used as a model system for many
years, due to three main characteristics. First, B2M forms amyloid ﬁbrils, in vivo
and in vitro. Second, these amyloid ﬁbrils are involved in a disease called Dialysis
related amyloidosis (DRA), giving its study a direct medical relevance. And ﬁnally,
while small proteins usually fold within a few milliseconds at most, B2M folds within
a dozen minutes in physiological condition, and is as such a good model to study
protein folding.
4.1 Isolation, structure, function
B2M was ﬁrst isolated in 1968 in urine from patients with tubular proteinurias (mal-
function of the renal tubules) [13], and shown to be present in low amounts in serum,
urine, and cerebrospinal ﬂuid of sane individuals. It was fully sequenced in 1972 and
by homology described as a free immunoglobulin domain [128]. Finally, B2M was
linked to its function in 1973, as it was shown to be the small sub-unit of the Human
Leukocyte Antigens (HLA) complex[76].
HLA is the human major histocompatibility complex (MHC), and is involved in the
recognition of self and non-self, an essential part of the immune system. HLA are
present in all nucleated cells, thus excepting red blood cells. Peptides generated by
proteolysis inside the cell are presented outside the cell by these MHC antigens, so
that they can be identiﬁed as self or non self markers by cytotoxic T cells (Leuko-
cytes CD 8). Each MHC molecule can contain only one peptide at a time, although
peptide-speciﬁcity is very broad, as each MHC molecule can bind many diﬀerent pep-
tides. MHC molecules acquire their peptide during their own bio-synthesis, inside
the Endoplasmic reticulum, and this acquisition is essential for eﬃcient transport of
the MHC molecule to the cell surface [167]. This complex has a long lifetime in vitro
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(tens of minutes), even longer in-vivo, and a low Kd (4nM), making of it a very stable
complex [88].
B2M has an essential role in the binding of peptides by the MHC molecule inside the
Endoplasmic reticulum, as B2M-deﬁcient cell lines were not able to present peptides at
their surface in a stable manner [172]. Moreover, MHC molecules in solution displayed
an enhanced aﬃnity toward peptides in presence of B2M. B2M binding is believed
to act as a transition factor from a low aﬃnity to a high aﬃnity state [25]. B2M
being a free domain, it can be exchanged with another B2M present in the intra- or
extra-cellular medium, which facilitates the exchange of the peptide contained inside
the MHC[104]. B2M is also involved in the eﬃcient transport of the MHC molecules
from the Endoplasmic reticulum to the cell surface, as was shown using B2M-deﬁcient
murine cell lines [178].
MHC class I molecules are composed of two sub-units: one heavy chain, alpha, com-
posed of three sub-domains, and one small chain: B2M. The two chains are exposed to
the extra-cellular medium, and attached to the cell membrane via a trans-membrane
domain in the alpha3 sub-unit. B2M lies aside this alpha3 sub-unit, while the al-
pha1 and alpha2 domains, which are very polymorphic in order to bind the diﬀerent
peptides, are paired to form the cleft-like peptide binding site, as shown in ﬁgure 4.1.
Figure 4.1: Model of a MHC class I heavy chain in complex with B2M. In green the
transmembrane domain, in black the three heavy chain subunits, in blue B2M. The
peptide, displayed in red, is bound inside a cleft made of two alpha subunits of the
heavy chain.
The ﬁrst structure of the HLA complex was obtained in 1987 [18] from X ray crys-
tallography, and is shown in ﬁgure 4.2. This structure displays both alpha and
B2M chains. Membrane proximal domains (B2M and alpha3 sub-unit) have an
immunoglobulin-like fold. The contact interface between B2M and alpha3 is made of
their respective 4-strand beta-sheets. The alpha1 and alpha2 sub-units, each consist-
ing of a 4-strand beta-sheet and helical region, that pair to form a unique 8-strand
beta-sheet topped by two helices, forming the cleft-like peptide bonding site. Pep-
tide binding being essential for stability of the MHC complex, this structure, as most
structures of the MHC complex [145], [94], has a ﬁlled peptide bonding site. Peptides
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are usually tightly bound to the cleft from their carboxyl and amino termini, through
an interaction between the alpha 1 and 2 domains and the polar atoms from the pep-
tide main chain [112] (ﬁgure4.3). The generic interaction allowed by the involvement
of the main-chain atoms implies a tight binding for all types of peptides, and a tol-
erance for peptides longer than the nanomeric peptides that usually bind the MHC
molecules [56], [139].
Figure 4.2: Crystal structure of the extra-cellular part of the HLA complex, heavy
chain in green, B2M in purple
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(a) HLA cleft from top (b) HLA cleft from side
(c) HLA cleft with peptide from top (d) HLA cleft with peptide from side
Figure 4.3: Details of the peptide-presenting cleft of the HLA complex
The structure of B2M alone was obtained in 1985 for bovine B2M [10], in 2001 for
human B2M [168], [170], while it had been obtained in complex inside the MHC in
1991 [145]. B2M is a 119 residue protein, which includes a 20 residue signal peptide,
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leading to a 99 residue secreted protein, with a molecular weight of approximately
11.7kDa. B2M displays the beta-barrel like structure of immunoglobulin domains. It
consists of two beta sheets containing respectively three and four beta strands. The
two sheets are folded over one another in a sandwich-like conformation, and linked
by a central disulﬁde bond between cysteins 25 and 80, which are the only cysteins of
the sequence, as shown on ﬁgure 4.4. The beta strands are traditionally named with
letters from A to G, according to the primary sequence order, the strands A (6-12) B
(22-30) D (51-56) E (62-69) forming one beta-sheet, the strands C (36-41) F (78-83)
G(91-94) the other, as shown the secondary structure map of B2M, ﬁgure 4.4.
Overlap of diﬀerent structures, obtained either in complex inside MHC molecules or
alone in a crystal or in solution, is very high, with a main-chain root-mean-square
deviation (RMSD) of the order of 1 Angstrom. Event though the global fold of B2M is
manifestly conserved, as seen in the diﬀerent structures and conditions, one important
speciﬁcity of B2M's structure is its ﬂexibility. Both by NMR and crystallography, the
D strand, for example, is subject to conformational equilibrium dynamics, while the
N terminus of a single residue mutant of B2M populates two dramatically diﬀerent
orientations inside the same crystal [137]. Another example is the existence of a beta
bulge inside the beta strand D when in complex inside a MHC molecule, dividing it
into two smaller strands, while this strand is fully formed in structures in which B2M
is isolated [138]. Flexibility can also be seen in some loops, especially the DE loop, a
loop that will be shown of importance when discussing amyloidogenesis of B2M.
4.2 B2M and Dialysis Related Amyloidosis
Dialysis related amyloidosis is a serious and frequent complication found in patients
undergoing long term hemodialysis, that was ﬁrst reported in 1975, when the hemodial-
ysis technique was already 15 years old [175]. It mainly involves B2M deposition in
joints in the form of amyloid ﬁbrils [65]. These deposits induce bone abnormalities,
such as carpal tunnel syndrome and destructive arthritis [33]. B2M amyloid ﬁbril
formation is linked to a ∼30-fold increase of circulating B2M, normally catabolized
in the renal tubules, and not eﬃciently ﬁltered by dialysis membranes [64]. With
the improvement of medical techniques, patients undergoing hemodialysis can live a
prolonged life, but as prevalence of DRA increases with the duration of the dialy-
sis treatment, reaching almost 100% after 13 years of treatment [91], complications
and quality of life reductions are expected to rise as well, as already observed [179].
Progress in dialysis techniques, especially the use of high-ﬂux membranes and speciﬁc
B2M traps was able to decrease the prevalence of DRA [169], but is not suﬃcient
to emulate the B2M elimination by functional renal tubules. Medical and surgical
treatments can be used to relieve patients from symptomatic pain, but none has been
found yet to prevent DRA or bone abnormalities. The only preventive treatment is
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renal transplantation, but it has to be made early as its ability to eliminate amyloid
deposits is still controversial. This is why understanding B2M ﬁbril formation and
toxicity is a key element in the perspective of ﬁnding a medical treatment.
4.3 B2M as a marker for other diseases
B2M being part of the immune system through participation in the major-histocompatibility
complex, its circulating concentration has been shown to be linked to the activation
of the immune system. As inﬂammatory processes take place, the rise of the immune
response is linked to a higher production of B2M, and as a consequence a rise in the
serum circulating concentration of B2M. B2M has indeed been used as a marker of
the development of pathologies, such as sarcoidosis, multiple sclerosis, certain auto-
immune diseases, as a tumor evolution marker in certain carcinoma, and even as a
marker of the evolution of HIV in certain patients ([106], [1], [3]). It has also been
shown to be a good surrogate test for HIV infection for use by insurance companies
in jurisdictions where HIV-antibody testing of insurance applicants is forbidden [21],




Figure 4.4: (a) secondary structure map; (b) and (c) B2M crystal structure, with
the internal disulﬁde bond in yellow, W60 and W95 in orange, P32 in red. On (c),
β-strands A, B, E, D are in front, left to right respectively, while strands C, F and G




5.1 B2M discovered as an amyloidogenic protein
B2M has been linked to amyloid ﬁbrils in 1985 from N-terminal sequencing exper-
iments performed on ﬁbrils puriﬁed from tissues of a chronic hemodialysis patient
([65], [75]). The same year, amyloid ﬁbrils were obtained in vitro from pure B2M
[43], with a very simple protocol: B2M dissolved in 10 mM Phosphate Buﬀer Saline
(PBS) was dialysed against decreasing concentrations of PBS, and ﬁnally water, and
then left to dry overnight.
Deposition of B2M amyloid ﬁbrils in vivo, in DRA patients, is linked to a concentra-
tion of circulating B2M more than 30-fold higher than in healthy patients, as B2M
is no longer eliminated in the kidneys. But the correlation between concentration of
B2M, either in vivo or in vitro, and amyloid ﬁbril formation or deposition, is poor
[64]. For example B2M remains monomeric for months in physiological conditions of
pH and temperature, at a concentration more than 20-fold higher than that found
in DRA patients [120]. For this reason, other factors have been suggested that may
increase B2M ﬁbrillation, such as duration of kidney failure [46], post-translational
modiﬁcations [29], or interactions with other molecules in vivo [120], or in vitro in-
teraction with Cu2+ [118], glycosaminoglycans [120], lysophosphatidic acid [129] or
collagen [68].
5.2 B2M ﬁbril formation mechanism
Many experimental set-ups have been used to study the mechanism of B2M ﬁbril
formation. Most of them focus on the destabilization of the protein, either by mutation
(of Proline 32 or in the DE loop) or truncation (DeltaN6, DeltaK58), biochemical
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interaction with Cu2+ [118], organic solvents [135] or collagen[68], or physico-chemical
constrain such as ultrasonication, heat, high salt concentration and agitation. All
those changes, either intrinsic or environmental, have an inﬂuence on the cis/trans
equilibrium of the His31-Pro32 peptide bond. While it is in a cis conformation in
the native state, a trans conformation is observed for this peptide bond in ﬁbrils, as
was recently demonstrated using ssNMR [8]. Other regions such as the DE-loop have
been highlighted as important for the formation of ﬁbrils, as the perturbation of the
dynamics inside this part of the protein can have a dramatic eﬀect on polymerization.
For example, full length mutants that are cleaved at lysine 58, have been shown to
be highly aggregation prone [83], while the W60G mutation diminishes the capacity
of the protein to elongate ﬁbrils.
5.3 B2M and oligomers
As for other proteins, and in accordance with the standard model of the amyloid ﬁbril
formation mechanism, it is suspected that in-vivo B2M forms oligomeric intermediates
on the pathway to mature ﬁbrils [55]. To study this phenomenon, several destabilizing
conditions have been used such as copper adjuncts, reductant conditions (DTT), or
binding with nanobodies.
In 2011, Liu and coworkers [108] used incubation in presence of DTT to induce ﬁbril
formation. They observed that a ladder of oligomers were formed in the process, with
all stoichiometries, from dimers to higher than decamers. The resistance of these
oligomers to SDS, along with their susceptibility to DTT reduction in the loading
buﬀer used for a SDS gel, indicates that these oligomers are covalently bound through
disulﬁde bridges. The Xray diﬀraction structure of this dimer reveals, as expected,
inter-molecular disulﬁde bonds, through the rearrangement of the intra-molecular
bond that is present in native B2M. More strikingly, the dimer exhibits a domain-
swapped structure, as shown on ﬁgure 5.1, with identical domains (beta-strands E,
F and G) being exchanged between the two subunits, forming a native-like interface
similar to the interface between the two beta sheets in the monomer, while another
interface is formed by a new long beta sheet, corresponding in sequence to the loop
L4 and the D and E beta strands in the B2M monomer. Fibril structure is described
as a runaway domain-swapping with inter-molecular disulﬁde linkage, explaining the
formation of odd stoichiometry oligomers. The biological relevance of this mechanism
is of course an issue, because of the strong reducing conditions required to open
the disulﬁde bridge into thiols, but similar reactions have been described for other




Figure 5.1: Domain swapped dimer of B2M (one monomer in blue, the other in
orange) from [108]
In 2011, Domanska and coworkers [49] published the structure of a domain-swapped
dimer of B2M, stabilized by nanobodies, shown on ﬁgure 5.2. Nanobodies consist of
the antigen-binding domain of antibodies, and anti-B2M nanobodies were obtained
42
from immunization of camels and llamas. Selecting nanobodies which show ﬁbril
formation inhibition properties, they were able to isolate and co-crystallize a domain-
swapped dimer of B2M, claimed to be an on-pathway intermediate in ﬁbril formation.
Contrary to the DTT-induced dimer, this nanobody-trapped dimer conserves its intra-
molecular disulﬁde bridges, making the swapping a much smaller rearrangement, as
monomers only swap the C-terminal beta-strand G. In the process, in a similar fashion
to that of the DTT-induced dimer, a new inter-molecular beta sheet is formed, through
the lengthening of the F beta-strand. As the rearrangement is globally smaller, the
hinge is shorter, consisting of only four amino-acids. Even though runaway domain





Figure 5.2: Domain swapped dimer of B2M (one monomer in blue, the other in gray),
stabilized using nanobodies, from [49]
Miranker and coworkers have shown that B2M is a metal binding protein, the bind-
ing site identiﬁed through site-directed mutagenesis being His31. B2M has a higher
aﬃnity to Cu2+ than to any other divalent metal ion, and only Cu2+ can induce
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the formation of amyloid ﬁbrils in physiological conditions [52]. Upon binding with
Cu2+, B2M undergoes a conformational rearrangement, with a ﬁnal state acquired in
about one hour at 20°C, a timescale that is not dependent on either copper or protein
concentration, suggesting that the limiting factor is the rearrangement itself. This ac-
tivated state is termed M* by Miranker and coworkers. This M* states is then involved
in oligomerization. As observed in the comparison of CD spectra, global secondary
structures are conserved for monomers inside the oligomers, implying the formation
of oligomers with native-like fold domains. These oligomers are intermediates on the
pathway of formation of amyloid ﬁbrils, that can be induced in physiological condi-
tions with concentrations of copper (3µM) that are equivalent to those that can be
found in dialysates of patients undergoing long term hemodialysis. If copper-binding
triggers the formation of oligomers, and of the subsequent amyloid ﬁbrils, it is not
necessary for the stability of the ﬁbrils. While early oligomers disassemble back to
monomers upon addition of EDTA, mature ﬁbrils remain stable. Early oligomers,
within a timeframe of days to weeks, undergo modiﬁcations that makes them insen-
sitive to the addition of EDTA, and can be called chelate-resistant [27].
To isolate and crystallize copper induced oligomers, a single point mutation (H13F) is
required to reduce aggregation while keeping the copper binding aﬃnity and oligomer-
ization rates. Miranker and coworkers have been able to isolate and crystallize an hex-
americ form of B2M, induced by copper addition. Interestingly this hexamer has a
trans His31-Pro32 peptide bond, while it is in a cis conformation in the wild-type, na-
tive state B2M. The isomerization of this prolyl bond may be induced by the binding
of copper on His31, and would account for the rate limiting step of the oligomerization
process. The hexamer displays a closed-ring structure (ﬁg 5.3), three fold symmetric,
demonstrating two classes of interfaces, so that the hexamer can be described as a
trimer of dimers. One interface involves interaction between D beta-strands, while the
other corresponds to the stacking of ABE beta-sheets, each strand facing its counter-
part. The copper ions are not involved in the interfaces, but have binding sites that
are strictly intra-molecular, around His31, underlying the fact that it is the conforma-
tional rearrangement induced around Pro32 by copper binding that is the key event
in the oligomerization of B2M. As a side note, the binding site of the copper around
His31 in B2M is very similar to the binding of copper to the octapeptide region in
Prion Protein. Once the trans conformation of the H31-P32 peptide bond is suﬃ-
ciently stabilized through oligomerization, copper is released, making the oligomer a
chelate-resistant structure. It has been demonstrated that copper-binding induces
a 260-fold increase of the backbone isomerization rate of amides [44].
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Figure 5.3: Crystal structure of the H13F-B2M hexamer obtained in presence of
copper
In the structure of WT B2M, the side chain of His31 is exposed to solvent and in a
position orthogonal to the Pro32 amide plane, so that the two residues should be able
to form a tetrahedral coordination for copper through the isomerization of the bond.
To test this hypothesis, Miranker et al [19] produced a P32A mutant of B2M. Since
non prolyl peptide bonds have a minimal probability to be in a cis conformation,
P32A should be a good model of a stabilized trans conformation state. And indeed
P32A binds copper with a 10000 fold increased aﬃnity compared to WT B2M. In
the crystal structure of the P32A mutant, the side chain of His31 is solvent exposed
and the His31-Ala32 peptide bond is in a trans conformation. Interestingly, P32A
crystallizes in the form of a dimer (ﬁgure 5.4). The dimer interface is made of the
interaction of the D beta-strands of the two subunits, a D strand that is stabilized with
the disappearing of a beta-bulge around Asp53. This kind of interaction is similar
to that seen in one of the two interfaces of the hexamer of H13F B2M, and to the
beta-sheet hinge of the DTT-induced dimer. In such a conﬁguration, through this
D-D interaction, a strong 8-strand beta sheet is formed, with strands ordered as such:
ABED-DEBA. This ABED-DEBA sheet forms a hydrophobic stripe, that would be
stabilized through the formation of a twisted pair of these sheets, creating the cross-
beta core of amyloid ﬁbrils. That kind of arrangement implies an alternating head to
head (D-D) and tail to tail (A-A) interaction. Through all these observation, Miranker
et al suggest that P32A could be a good in-equilibrium model of the transient M*




Figure 5.4: Crystal structure of P32A-B2M dimer obtained in presence of Cu from
[19]
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5.4 B2M native oligomers
If crystallization is the method of choice to obtain precise structural information,
especially on high molecular weight species like B2M oligomers, the crystallization
process can be viewed as a selection of a unique structure, while other populated
states of the ensemble are discarded. NMR can be of help to assess for the presence
of multiple populated states, but it is of course limited in molecular weight. Other
methods such as SAXS can characterize higher mass species, but even though signal
analysis methods have been developed to deconvolute the signals speciﬁc to the diﬀer-
ent constituents, polydispersity is really an issue. Far-UV CD can be used to detect
diﬀerent species during the denaturation of B2M, but it is not able to characterize
them [116].
One technique allows detection and characterization of high molecular weight species
in a polydisperse sample: mass spectrometry. It was ﬁrst used to study B2M in
2004, and showed that diﬀerent states were populated during the acid unfolding of
the protein [24]. The deconvolution of the ESI-MS signals allowed the following
of the population of the diﬀerent states from pH=6 to pH=2. If only the native
conformation of B2M can be detected at pH=6, at pH=3,6 where a partially folded
state was supposed to be populated [116], a mixture of the native and this partially
folded state is detected. At pH=2,6, the two preceding states are still populated,
while an acid unfolded state appears.
Based on a diﬀerence of the charge state characteristic of those diﬀerent species, ESI-
MS should be even more powerful to detect the formation of oligomers. In 2006, Smith
and coworkers [159] followed the formation of B2M ﬁbrils at pH=2,5 and pH=3,6 using
ESI-MS. A comparison of the monomer concentration detected using mass spectrome-
try and the ﬁbril formation using Thioﬂavin-T ﬂuorescence showed diﬀerent behaviors
at the diﬀerent pHs. At pH=2,5, the lag phase in the ﬁbril formation correspond to
a constant concentration of monomer, while at pH=3,6, during the lag phase, the
monomer concentration is already dropping. This is conﬁrmed when looking at the
presence of oligomers during the lag phase. At pH=2,5, low populations of dimers,
trimers and tetramers are detected, while at pH=3,6, a whole ladder up to more than
a decamer is detected during the lag phase. This study shows the ability of B2M
to form oligomers of all sizes even at the very low concentration used in ESI-MS
(0,02mg/mL ~1,5µM). In a 2010 study, Santambrogio and coworkers [144] showed
using ESI-MS that wild type B2M at physiological pH forms dimers, trimers and
tetramers at concentration as low as 15µM, which is much lower than the usually ob-
served threshold for non speciﬁc aggregation, which is 100µM in ESI-MS. Moreover,
the more stable mutant W60G is shown to have a lower oligomerization propensity.
In conclusion, considering either native or speciﬁc conditions, B2M has a high propen-
sity to form oligomers. Stochiometries, structure, and stability are diverse, and the
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6.1 A central disulphide bridge
The ﬁrst factor that was studied in B2M folding was the intramolecular disulﬁde
bridge. Using CD, in presence of 1M Gd-HCl and at pH 7,8, Isenman and coworkers
[89] showed that B2M could not reach a native like fold when the disulﬁde bridge was
reduced into thiols, suggesting that the folding of B2M to the native state implied the
formation of the disulﬁde bridge. Yet in 2002, Ohhashi and coworkers [123] using the
same technique but without Gd-HCl and at a pH of 8,5 claimed that reduced B2M
reached a native-like fold, even though reduced B2M was very aggregation-prone.
This shows that the importance of the disulﬁde bridge is controversial, even though
all subsequent B2M folding studies use a protein with the intracellular disulﬁde bridge
formed. Moreover, although the folding of b2-m in vivo occurs in the endoplasmic
reticulum and is associated with formation of the disulﬁde bond, it has been shown
that this bond is not broken in the conversion of native b2-m into amyloid ﬁbrils in
vivo [11], and almost all models of B2M ﬁbrils have an intact intramolecular disulﬁde
bridge.
6.2 B2M folding studied in real time
The ﬁrst study in real time of B2M folding was made in 2001 by Chiti and co-workers
[37]. The folding was initiated using a 20 fold dilution from a 3M Gd-HCl buﬀer into
a Gd-HCl buﬀer with a concentration ranging from 0 to 1M, and followed using either
intrinsic ﬂuorescence, CD or ANS binding. Three folding phases can be distinguished
in the UV intrinsic ﬂuorescence data. First a very fast phase, or burst phase, that
happens during the time course of the deadtime of these stopped-ﬂow experimental
setups, which is of a few milliseconds, detected due to the diﬀerence between the
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extrapolation of the intrinsic ﬂuorescence at t=0 and the value corresponding to the
unfolded protein. Second is a fast phase, that is completed in less than two seconds
at 30°C, and that can be followed by the above mentioned techniques. Finally a slow
phase appears, with a time constant of 3.10−3s−1. The corresponding model is shown
on ﬁgure 6.1.
Figure 6.1: Sequential B2M folding model from [37]
In the CD data, the burst phase and the slow phase are detected, with similar
timescales as those observed by ﬂuorescence, but the fast phase could not be ob-
served. The far-UV spectrum obtained after the burst phase is signiﬁcantly diﬀerent
from the native state spectrum. There is a lack of signal in the band close to 200
nm that suggests the presence, at this stage of the folding, of unstructured regions
that have to undergo a conformational rearrangement to achieve a native-like con-
tent of beta-sheet structure. The absence of fast phase in this data suggests that
I1 and I2 are similar in terms of secondary structures, with regard to far-UV CD.
In presence of ANS, all three phases are observed, with similar time scales. While
the ANS-ﬂuorescence of the native and unfolded states of B2M are similar, there is a
signiﬁcant increase during the burst phase, followed by a two-phase decrease. This in-
crease of ANS-ﬂuorescence is characteristic of the exposition of hydrophobic residues
on the surface of the protein1. In conclusion, the folding mechanism according to this
article consists of a burst-phase collapse, during which most secondary structures are
formed, yet followed by a two-phase reduction of unstructured regions of the protein.
The model proposed by the authors is therefore sequential and shown in ﬁgure 6.1.
Another article describes similar intrinsic ﬂuorescence data, but comes to quite dif-
ferent conclusions on the folding mechanism of B2M. In 2006, Jahn and coworkers
[92] have studied the folding of B2M, initiated by dilution, with a ﬁnal concentration
in Gd-HCl ranging from 0,2 to 1,6M. Two phases appear during the folding, with
timescales similar to those observed by Chiti et al. A global ﬁt shows that the sim-
plest model to correctly ﬁt the data requires ﬁve states, as shown in ﬁgure 6.2. From
the kinetic time constants, the burst phase observed by Chiti clearly appears as the
transition from Ic to N, even if the authors did not search for and measure a burst
phase. The fast phase folding would correspond to the Ut to It, Ic to It, and Ic to
N transitions, since Ut and Ic should be the only species signiﬁcantly populated after
the burst phase.
1The interaction between ANS and the folding intermediate state can actually be mapped using
real-time NMR techniques, see ﬁgure 14.6 in annex.
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Figure 6.2: Parallel ﬁve-state model from [92]
The Jahn and coworkers' parallel model is therefore based on a statistical analysis,
while Chiti and coworkers use three qualitative analyses to support their sequential
model. First is the fact that, in their four state model, a complete folding (U to
N) during the fast phase should imply that a fast-phase unfolding, similar to the
fast phase folding, is observed when Gd-HCl concentration is within the transition
between folded and unfolded B2M. This is not incompatible with the Jahn et al.
model, as the fast phase corresponds to diﬀerent transitions in which only one leads
to the formation of N. A second argument is the fact that the near-UV CD spectrum
obtained just after the fast phase is very similar to that of the unfolded protein in
a certain region. In the Jahn et al. model, after the fast phase only It and N are
populated, the population of N being roughly half of the original population of Uc.
Due to the noise in the near-UV spectrum, a small population of N may not be
detectable, and would make the Chiti et al. compatible with the Jahn model, and
this will be corroborated by the NMR data, as described later on. A third argument
is that when a double jump experiment, consisting of an unfolding performed just
after the fast phase, no slow phase unfolding is observed. This slow phase unfolding
should arise from the unfolding of the protein that would be in the N state after this
fast-phase. But again, if N is lowly populated, this slow phase may not be detectable.
In conclusion, the Chiti et al. data and the Jahn et al. model are not incompatible,
and the latter using more data than what was available to Chiti and coworkers, it
should be considered as a more precise description of the folding mechanism of B2M.
These observations were complemented by Sakata and coworkers in 2008 [143], using
again intrinsic ﬂuorescence and extensive double jump studies in supplement to the
reproduction of the folding and unfolding studies already performed on B2M. Double
jump experiments correspond to either N → Uc → N or to Ut → It → Ut transitions,
or even N → Uc → Ut → N , using for this last jump a variable incubation time in
the unfolded state. These double jump experiments allow the direct measurement of
the time constants of certain processes that are usually coupled to other processes
or inaccessible, such as the It → Ut transition, as the usual unfolding transition
is N → Uc, in which It is not involved. Based on this extensive data, that both
reproduces and complements Chiti et al. and Jahn et al. data, Sakata et al. propose
a four state minimal model (ﬁg 6.3), and discard the Ic intermediate state of the
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Jahn model as a statistical artifact. Moreover, Saketa et al. insist on the fact that
microscopic rate constants described in the statistical Jahn model should induce a
detectable burst phase in the N → Uc → N double jump experiments, but that such
a phase is not detected in any of the data of the three articles.
Figure 6.3: Parallel four state folding model from [143]
These studies show how precise and powerful ﬂuorescence spectrometry can be to
decypher the folding mechanism of proteins. Yet the main limitation of the technique
is the necessary low concentration of protein that must be used, in these studies
around 10µM, that does not allow the study of folding in oligomerization-favorable
conditions.
6.3 B2M folding followed using NMR
In 2005, Kameda and coworkers [97] studied the folding of B2M using real-time NMR.
Yet, using standard HSQC pulse sequences, the temperature had to be brought down
to 2.8°C, to cope with the low time resolution of the method. A pH jump was used to
initiate the folding, and 1.5M urea was added to the buﬀer to prevent aggregation of
B2M, as the protein remains in a native fold at this denaturant concentration. The
dead time in this experiment was 6 minutes, and measurement of one 2D spectrum
required 20 minutes, and the whole folding reaction was completed in 15 hours. The
ﬁrst spectrum after the pH jump is completely diﬀerent from the unfolded state spec-
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trum, implying that the unfolded state transforms into the intermediate state within
the dead time of the experiment. In this ﬁrst spectrum, peaks that are speciﬁc of an
intermediate state can be detected, as they are clearly isolated from the native state
peaks. The intensity of these peaks moreover decreases over time, contrary to the
native state peaks. Rate constants of intensity growth were more or less the same
for all the residues, while the burst phase intensity, ie the intensity ratio between
the extrapolated initial value and the ﬁnal value, was residue dependent. From these
burst-phase intensity values, Kameda and coworkers deduce that the structure of the
intermediate is close to native in the region that is opposite to P32, and more disor-
ganized close to this residue, which is consistent with the isomerization of proline 32
being the major folding event. Although a two fold lower time constant was observed
in NMR compared to CD, it was considered consistent, due to the uncertainty of the
measures and the 2°C diﬀerence in the experimental temperatures.
6.4 Folding and amyloid formation/aggregation
As was seen earlier, the isomerization of the His31-Pro32 peptide bond is a key ele-
ment both in the oligomerization process that leads to the formation of amyloid ﬁbrils
and in the folding process of B2M. If no structures of the folding intermediate state
of B2M exist, due to its short-transient nature, the importance of this isomerization
in both events poses the question of the similarities and possible identities in the
species involved. Since It and M* (aggregation intermediate state, as seen in section
5.3) both have a trans His31-Pro32 peptide bond, could they be the same structural
state? Can P32A and DN6, having the same conformation at this position, be used as
in-equilibrium models for both intermediate states? Small proteins such as B2M are
thought to fold in a rough funnel-like energy landscape [176]. But as the energy land-
scape represents the ensemble of all the accessible conformations for the protein, the
folding funnel is only a part of a larger picture, especially when considering possible
formation of oligomers, or interaction with other proteins and constituents of the in-
tracellular medium. Competition between the two phenomenons, the intra-molecular
evolution that is folding, and the inter-molecular interactions, leads to an even more
complex energy landscape. If folding funnels of small, mono-domain proteins are now
quite well-known, our understanding of the energy landscape of protein aggregation is
minimal. The formation of weakly-bound oligomers could lead to the formation of an
ensemble of conformations of similar energy, equivalent to shallow energy wells, while
the formation of highly stable amyloid ﬁbrils would correspond to much deeper wells,
possibly even as deep as the one of the monomeric native state. But the picture is
even more diﬃcult as even in similar environments, a multitude of ﬁbril morphologies
are observed [95]. A representation of such a complex landscape can be found in
ﬁgure 6.4, extracted from reference [93].
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Figure 6.4: (a) Energy landscape of protein folding (in light grey) and aggregation
(in dark grey). (b) protein folding and/or aggregation pathways[93].
The concentration of the folding intermediate It, enhanced in equilibrium using ace-
tonitrile or during folding, correlates with a much higher ﬁbril formation rate [36].
This fact is consistent with the isomerization of the prolyl bond at P32 being the
highest energy barrier. Furthermore, using 2D NMR, DN6 has been shown to have a
1H −15N spectrum similar to that of It [55]. Yet P32A, which has a trans conforma-
tion and forms oligomers, doesn't show any improvement in the formation of ﬁbril,
contrary to DN6 [58]. Whether It is inter-converting easily with M*, or that they are
exactly the same state is not the most important question for the global understand-
ing of the energy landscape, and a rugged energy landscape can be expected in the
region that links the folding funnel and the aggregation.
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Part III
The folding of B2M: from
kinetics to a folding model
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Up to now, most studies of the folding of B2M have used traditional biophysical
methods such as UV-ﬂuorescence spectroscopy or circular dichroism. While these
techniques provide very accurate kinetic data, they can not oﬀer structural informa-
tion, and only a limited distinction between diﬀerent populated states. Folding models
have been developed, that derive from the indirect, kinetic detection of intermediate
states.
Multidimensional Nuclear Magnetic Resonance (NMR) is a technique that allows a
direct characterization of protein states, yet traditional uses of NMR lack the temporal
resolution necessary to the study of kinetic phenomena such as protein folding in real
time. One solution to this problem is changing some of the thermodynamic parameters
of the phenomenon, yet at the cost of physiological relevance, for example through
the decrease of temperature, but as shown in section 6.3, even at 2.8°C, traditional
NMR methods are not precise enough.
Recent development in NMR methods, along with the availability of high ﬁeld spec-
trometers and cryogenically cooled probes providing the required sensitivity, strongly
reducing the time needed to acquire correlation spectra, provide another solution to
follow the folding of small proteins. Two main drawbacks of real time NMR are
the high concentration of protein required, implying large amounts of isotope-labeled
samples. The description of these methods and their use for the study of B2M folding
is the object of this part.
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Chapter 7
Real time NMR: theory and
methods
7.1 NMR theory crash course
The NMR theory reminder presented here will focus on the topics necessary for the
experimental work described in this manuscript. For further readings, NMR theory
explained textbook by Jacobsen should be considered for a step by step progressive
approach, and protein NMR spectroscopy textbook by Cavanagh et al. for a more
rigorous and in-depth demonstration.
7.1.1 Nuclear Magnetic Resonance
Nuclear Magnetic Resonance (NMR) is a technique based on the interaction of an
electromagnetic radiation and nuclei placed in a constant magnetic ﬁeld. More specif-
ically, the interaction of the radiation and a quantum mechanical property of nuclei,
the spin. The spin is an intrinsic property of a particle, as is mass or electric charge.
If the spin of a nuclei has a non-zero value S, it may be used as a probe for NMR
experiments. Such non-zero spin nuclei that are useful for biomolecular NMR spec-
troscopy are 1H, 2H, 13C, 15N , 19F , 31P , among many others. A net spin (non-zero)
induces a magnetic moment, which can be seen as a small magnet, that will align
with constant magnetic ﬁelds, and can be perturbed by electromagnetic radiations.
Since magnetic moment is quantized, its accessible energy levels are limited, the
number (N) of which is linked to the value of the spin by the relation N=2S+1. For
example, for nuclei with S=1/2, like1H, 13C or 15N , only two states are accessible for
the magnetic moment. These states are degenerate in absence of an exterior magnetic
ﬁeld. Yet when a constant magnetic ﬁeld is applied, and due to the interaction of
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that ﬁeld and the magnetic moment of the nucleus, the states no longer have the
same energy. A transition from the lower energy level to the higher energy level
is therefore possible through the absorption of an electromagnetic radiation with
the corresponding energy. This energy is linked to a property of the nucleus, the
gyromagnetic ratio, and to the intensity of the external ﬁeld B0, by relation (7.1).
4E = γ~B0 (7.1)
To illustrate the interaction of the spin magnetic moment and an electromagnetic
radiation, an analogy with classical mechanics can be made, considering the magnetic
moment as a magnet. In equilibrium, the magnet is aligned with the external magnetic
ﬁeld B0 along the z axis. Disturbed by the electromagnetic radiation, the magnet will
deviate from the z axis. It will then precess around the z axis, at a frequency called
Larmor frequency, linked to the gyromagnetic ratio and the intensity of the external
magnetic ﬁeld. This frequency is the resonance frequency that is speciﬁc to each type
of nucleus. This frequency is modulated by the chemical environment of the nucleus
in a process called chemical shift, which provides the possibility to use them as probes
of the local environment in a molecule. The motion of electrons in the magnetic ﬁeld
B0 generates a secondary magnetic ﬁeld. For a given spin, this secondary magnetic
ﬁeld will enhance or oppose the B0 ﬁeld, and will inﬂuence the resonance frequency
of that spin, that is therefore shifted from the Larmor frequency. This shift is called
chemical shift.
7.1.2 Notions of spin relaxation
Relaxation is the process in which a spin system returns, from an oﬀ-equilibrium state,
to its equilibrium population distribution. Many mechanisms are possible pathways
for relaxation, but all involve interaction of spins with their environment. There are
two main mechanisms that inﬂuence spin relaxation in solution: dipole dipole interac-
tion and chemical shift anisotropy. Other relaxation mechanism include quadrupolar
interaction and scalar relaxation, but won't be developed here.
Dipole-dipole interaction Any nucleus that possesses a non zero spin generates
a magnetic dipolar ﬁeld. Inside a molecule, these individual magnetic ﬁelds inﬂuence
surrounding spins, creating an eﬀective ﬁeld Beff that is slightly diﬀerent from B0.
As the molecule tumbles in solution, this ﬁeld ﬂuctuates, thus creating a mechanism of
relaxation. The strength of the dipole-dipole interaction depends on the gyromagnetic
ratio, and is therefore more important for proton spins.
Chemical shift anisotropy The local magnetic ﬁelds induced by the electronic
environment that give rise to chemical shifts are by essence anisotropic. When the
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molecule reorients as a result of molecular motion (or tumbling), the local magnetic
ﬁelds vary. This variation is another mechanism of relaxation.
7.1.2.1 Macroscopic representation of relaxation
The approach introduced by Bloch was conceived to assess for the observations made
in early NMR experiments. Therefore it consists of a macroscopic, classical, descrip-
tion of bulk magnetization in a sample. For example, after a 90° pulse in NMR, the
bulk magnetization is aligned in the xy plane, the plane whose normal is the direc-
tion of the external magnetic ﬁeld B0, and is called a transverse magnetization. This
transverse magnetization precesses around the external magnetic ﬁeld, creating a cur-
rent in the receiver coil, producing the signal that is recorded in NMR. It is observed
that in accordance with thermodynamic theory, this magnetization relaxes to equi-
librium in a process that can be decomposed into two mechanisms. The NMR signal
is a decaying sinusoidal function called FID (free induction decay). This decay, that
corresponds to the decay of magnetization's projection in the xy plane, is called trans-
verse relaxation, and has a characteristic time called T 2. The magnetization recovery
along the z axis, called longitudinal relaxation, has a characteristic time T 1, which is
longer or at least equal to the characteristic time T 2 of transverse relaxation. T 1 and
T 2 are important values for the NMR spectroscopist, as T 1 provides an evaluation
of the recovery delay necessary between two NMR experiments, and T 2 is directly
related to the linewidth of peaks in NMR spectra.
This Bloch model can assess for most of the simple NMR techniques, and allows to
grasp a basic understanding of NMR principles without using quantum theory and the
description of spin systems. Yet more advanced NMR experiments such as HMQC
cannot be explained using the Bloch vectorial representation of spins, and a more
precise description of the evolution of spin systems is necessary.
7.1.2.2 Microscopic representation of relaxation
Rigorous description of NMR relies on quantum theory, using the product opera-
tor formalism or the density matrix formalism and the use of hamiltonians. Most
common microscopic representation of relaxation is semi-classical: the evolution of
the spin system is modeled using quantum theory, while the evolution of the lattice
(molecule) is modeled classically. Such a semi-classical representation of relaxation
was introduced by Bloch, Wangsnes and Redﬁeld (BWR)[20, 174, 133, 134] between
1953 and 1965.
In a few words, and with the simple example of a coupled two spin system, the
quantum mechanics treatment of the spin system leads to four energy eigenstates as

















Figure 7.1: Energy diagram of a heteronuclear two spin system, with each spin system
having two energy eigenstates αand β, leading to the four eigenstates αα, αβ, βα, ββ.
Single quantum transitions are marked SQ, double quantum transitions DQ, and
zero quantum transitions ZQ. DQ and ZQ transitions are often referred to with the
generic term multiple quantum transition.
that involve the change in the state of one of the two spins (single quantum transition),
or the two spins at once (multiple quantum transition). The transition energy for
single quantum transition corresponds to the Larmor frequency of the considered
spin, while multiple quantum transitions are linked to the sum and the diﬀerence of
the Larmor frequencies of the two spins. Transitions between these eigenstates require
energy transfer from the environment, that constitutes a local magnetic ﬁeld. The
energy transfer has to be of the speciﬁc amount corresponding to the energy of the
transitions, as a consequence of quantum theory. This means that the ﬂuctuations of
the local magnetic ﬁeld have to happen at speciﬁc frequencies to have an impact on
the spin system.
The ﬂuctuations of the local magnetic ﬁeld can be described by a spectral density
function, that corresponds to the energy present within the environment at any given
frequency. Since the main cause of local magnetic ﬁeld ﬂuctuation is overall and
internal motion of the molecule, relaxation of the spin system is linked either to
the dynamics of intramolecular motions or to the global molecular tumbling of the
molecule. The study of the relaxation properties of the protein provides insights on
the local dynamics at stake inside a molecule or on the global dynamic behavior of
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the molecule.
7.1.3 Relaxation NMR, molecular tumbling, linewidth, chem-
ical exchange
In this thesis, the study of relaxation in a protein is limited to the measurement of
eﬀective local relaxation rate constantsR1 = 1/T1 andR2 = 1/T2 for each amide group
of the protein. This gives information on the local dynamics along the amide backbone
of the protein. If the R1 and R2 values are fairly constant along the backbone, this
means that internal motions are similar throughout the protein. An estimation of the








Variations in R1 and R2 along the backbone may reveal diﬀerences in the internal
motions, such as more ﬂexible or more rigid parts of the protein. Since R2 is directly
linked to the linewidth of peaks, larger R2 values may lead to a disappearing of the
concerned peaks, for example in presence of chemical exchange, as explained below.
Parts of the protein experiencing chemical exchange may completely disappear from
the spectra, giving rise to undetectably large peaks.
7.1.4 Relaxation NMR: R1 and R2 measurements
7.1.4.1 Inversion-recovery method to measure R1
R1 is the relaxation rate of the magnetization along the z-axis. The usual method to
measure R1 is the inversion recovery scheme. First a pi-pulse inverts the magnetization
along the z-axis. Then a τ delay allows for a partial recovery of the magnetization.
Finally, a pi/2-pulse converts the z-magnetization to measurable x-y magnetization
(ﬁgure 7.2). The intensity of the obtained peaks can be ﬁtted using an exponential
function: I(τ) = Iinf (1− 2 exp (−R1τ)), which gives the relaxation rate R1.
τ
FIDI
Figure 7.2: Inversion recovery 1D pulse sequence. Filled and open symbols correspond
to 90° and 180° rf pulses, respectively.
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7.1.4.2 CPMG Spin echo method to measure R2
In an ideal world, R2 is directly related to the linewidth of peaks in a spectrum through
the decay of the FID. But in the real world, magnetic ﬁeld inhomogeneity makes the
FID decay faster, with a relaxation rate R∗2 = R2 + R
i
2. Therefore the measurement
of R2 is not straightforward. A spin echo sequence can be used to refocus chemical
shift evolution that is due to the magnetic ﬁeld inhomogeneity, as shown on ﬁgure
7.3. The pi-pulse reverses the chemical shift evolution so that at the end of the second
τ/2 delay, the coherence is refocused. Yet not all of the coherence is recovered, due
to the intrinsic relaxation rate R2. Therefore, variation of the τ delay and ﬁt of the
peak intensities with an exponential function I(τ) = I(0) exp (−R2τ) leads to the
measurement of R2. Since diﬀusion may induce a bias in the measurement, especially
for smaller molecules or less viscous solvents, instead of using longer and longer τ
delays, the spin echo block can be repeated with a ﬁxed short τ delay. This method






τ/2 τ/2 τ/2 τ/2 τ/2 τ/2 τ/2 τ/2
(b)
Figure 7.3: Spin echo (a) and CPMG (b) 1D pulse sequence. The τ delay is variable
in the spin echo pulse sequence, while in the CPMG pulse sequence, the variable is
the number of repetitions of the spin echo. Filled and open symbols correspond to
90° and 180° rf pulses, respectively.
7.1.5 Chemical exchange and relaxation
Chemical exchange is deﬁned as the exchange of a nucleus or nuclei between diﬀerent
environments, either through a chemical reaction or a conformational rearrangement.
This includes intramolecular motions, post-translational modiﬁcations, oligomeriza-
tion, exchange of amide protons in aqueous solutions, etc.
63
For a given nucleus that is in exchange between two magnetically distinct sites, the
resonance frequency will be diﬀerent depending on the site it is in. The key pa-
rameters of this exchange are the diﬀerence in the resonance frequencies ∆ν, and
the characteristic time the nucleus populates one or the other site 1/k. The relative
positions of k and ∆ν on the frequency axis give rise to diﬀerent regimes.
Slow exchange (k  ∆ν) means that on average each nucleus is detected in either of
the two sites, but does not undergo exchange during the NMR detection. The two
sites give rise to dinstinct peaks in the spectrum, at their speciﬁc chemical shifts.
Fast exchange (k  ∆ν), on the other hand, means that each nucleus undergoes many
exchanges during the NMR detection. Therefore only the average signal is detected in
the NMR spectrum, leading to a single peak with chemical shifts that are a weighted
average of the chemical shifts of the two sites.
Between those two extreme regimes, a whole range of intermediate exchange regimes
are available, depending on how close ∆ν and k are. These intermediate exchange
regimes are characterized by a broadening of the peaks due to the chemical exchange
process. The chemical exchange can be considered as a peak in the spectral density
function at the given 1/k frequency in the case of a conformational rearrangement.
7.2 Longitudinal relaxation optimized NMR
As seen in section 3.7, 1D 1H spectra of proteins show strong overlaps between peaks
corresponding to diﬀerent protons, limiting the information that can be extracted
from the data. Multidimensional NMR is an elegant way to reduce the peak den-
sity of spectra, through resonance frequency correlation. Yet the drawback of the
method is that obtaining multidimensional spectra takes time. As seen in section
3.7, multidimensional NMR requires the sampling of indirect dimensions, and there-
fore the acquisition of numerous scans which grow exponentially with the number
of dimensions. For example, typical minimum experimental times are 2 seconds for
a 1D spectrum, 4 minutes for a 2D spectrum and 8 hours for a 3D spectrum. The
experimental time of a nD experiment TnD is given by equation 7.3 where τrep is the
repetition delay between two scans, Ns is the number of repetitions used for averag-
ing, and N i the number of increments in the considered indirect dimension. Such a
long experimental time is a real drawback to study kinetic processes such as folding,






There are two ways to reduce the time requirement of multidimensional NMR: re-
ducing the number of scans, and/or acquiring them faster. Scan number reducing
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techniques include spectral aliasing, linear prediction, projection NMR, single scan
NMR, or sparse, non uniform data sampling. These techniques won't be developed
here, only projection NMR will be shortly presented in section 7.3.
The duration of the acquisition of one scan consists of the pulse sequence duration,
the acquisition time, and the recovery delay between scans. This recovery delay
is essential to allow the magnetization to relax, since sensitivity is proportional to
the available magnetization at the beginning of each scan. Two approaches can be
mentioned to account for the maximization of the magnetization within short recovery
delays: Ernst angle excitation and longitudinal relaxation enhancement.
7.2.1 Ernst angle excitation
Ernst and coworkers developed[57] a method to maximize sensitivity in a situation in
which the recovery of magnetization is incomplete. The application of an excitation
pulse with an optimized eﬀective ﬂip angle (Ernst angle:βErnst) can compensate this





The optimal excitation angle is 90° when the recovery delay Trec is at least four times
the longitudinal relaxation time constantT1. As shown on ﬁgure 7.4, the Ernst angle
decreases as Trec is shortened. While at 90° the maximum sensitivity is obtained
for Trec ≈ 1, 25 · T1, the maximum for an excitation angle of 60° is obtained for
Trec ≈ 0, 6 · T1. Moreover, Ernst angle excitation with shorter recovery delays often
imply increased sensitivity compared to a 90° pulse with Trec ≈ 1, 25 ·T1. Ernst angle
excitation is therefore a method to accelerate the acquisition of NMR spectra, by
reducing the recovery delay between successive scans.
7.2.2 Longitudinal relaxation enhancement
The Solomon equations are coupled ﬁrst order diﬀerential equations that describe the
time evolution of spin polarization in a coupled spin system. Equation (7.5) shows
the Solomon equations for a system of two spins I1and I2, with Inz the z-component
of the angular moment of the spin n and I0nz its thermal equilibrium value, ρ and σ



















Figure 7.4: Optimized excitation angle (Ernst angle) as a function of the relative
interscan delay Trec/T1
Auto-relaxation describes the dependency of the spin magnetization recovery on the
deviation of the spin magnetization to its thermal equilibrium. Cross relaxation
describes its dependency on the magnetization state of surrounding spins, through
dipolar interaction. For macromolecules such as proteins, it can be shown that cross
relaxation can be seen as a diﬀusion process of the spin polarization within the spin
system. If all the spins are in the same state, ie excited unselectively, the diﬀusion is
slowed down to a minimum. But if only a few spins are excited, other spins around
are available for this magnetization diﬀusion process. Therefore selective excitation
of spins leads to a dramatic enhancement of the longitudinal relaxation rate.
As a result, selective excitation schemes, in which the pulse sequence will selectively
manipulate certain spins of the systems (such as amide or methyl protons), provide a
shorter longitudinal relaxation time T1, and as such the possibility of a faster acqui-
sition of NMR spectra with conserved or even enhanced sensitivity.
7.2.3 SOFAST HMQC experiments
 Heteronuclear multiple quantum coherence (HMQC)
HMQC is an inverse 2D heteronuclear experiment, just as HSQC, inverse because it is
1H-observed, whereas ﬁrst 2D correlation experiments were 13C observed. Due to the
four fold higher gyromagnetic ratio of 1H compared to 13C, inverse experiments have
an advantage of 8 fold in S/N ratio. HMQC correlates chemical shifts of directly bound
atoms H-X, in protein spectroscopy usually amide (H-N) or methyl and aromatic (H-
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C) groups. With a simpler pulse sequence than that of HSQC, HMQC relies on zero-






Figure 7.5: Basic H-X HMQC pulse sequence, with pi pulses in white andpi/2 pulses
in black.
Sequence of a basic HMQC experiment is shown on ﬁgure 7.5. First 1H pulse trans-
forms magnetization from Iz into Ix, and ﬁrst 1/2J delay makes the 1H magnetization
antiphase with respect to Sz: 2IxSz. Chemical shift evolution is neglected, because
it will be refocused with the last delay. The Spi/2-pulse leads to a combination of ZQC
and DQC: −2IxSy. Chemical shift evolution of the I spin is refocused during the t1
delay by the 1H pi-pulse, therefore only S chemical shift occur during the ZQC and
DQC. The last Spi/2-pulse converts back the ZQC and DQC back to 1H antiphase co-
herence 2IxSz, which is refocused during the ﬁnal 1/2J delay, leading to the detection
of both the 1H and 13C or 15N frequencies.
 SOFAST-HMQC
The band-Selective Optimized Flip-Angle Short-Transient heteronuclear multiple quan-
tum coherence (SOFAST-HMQC) [148] experiment yields signiﬁcantly increased sen-
sitivity for short acquisition times when compared to other existing techniques. It
exploits longitudinal relaxation enhancement and Ernst angle excitation to enhance
the repetition rate at which data can be collected.
SOFAST-HMQC is not limited to 1H - 15N correlation spectroscopy, but can be used
to obtain 1H - 13C correlation spectra of diﬀerent functional groups of aliphatic or
aromatic protons. One example is the speciﬁc correlation spectrum of methyl protons,
that have a good spectral separation (-0.5 to 1.5 ppm) from other aliphatic or aromatic
protons. Methyl protons are valuable probes as they are mostly located inside the
hydrophobic core of proteins, that may fold diﬀerently from the global backbone
probed by the amide protons. Due to their rapid rotation, methyl groups possess
three equivalent protons, yielding a theoretical three fold increase in the intensity of
the signal, allowing the use of lower protein concentrations or the detection of states
that have a lower population. Both 1H - 15N and 1H - 13C SOFAST HMQC [148]
pulse sequence are presented on ﬁgure 7.6.
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Figure 7.6: SOFAST-HMQC pulse scheme, X and Y can be either 15N or 13C to use
amide or methyl protons as probes respectively. Selective pulses are round shaped, pi
pulses are shown in white, black pulses are pi/2 pulses if not otherwise stated.
7.2.4 SOFAST and FTA-SOFAST
The turbulence induced by the fast mixing of two buﬀers poses problems when used
with pulse schemes containing pulsed ﬁeld gradients used for selective refocusing, due
to sensitivity to translational diﬀusion eﬀects. These eﬀects can be attenuated using
a Fluid Turbulence Adapted pulse sequence, such as FTA-SOFAST. In the standard
SOFAST pulse sequence, gradients enclose the indirect evolution time T 1, inducing
delay between gradients that can go up to 20-30ms, leading to incomplete refocusing
and the concomitant loss of magnetization. To avoid this slow build-up of the signal
because of ﬂuid turbulence, the pulsed-ﬁeld gradients can be moved to the end of the
pulse sequence, with an inter-gradient delay ﬁxed to 1 to 2ms, and an additional 1H
refocusing pulse can be added. This sequence (ﬁgure 7.7) has proved excellent water
suppression abilities and high sensitivity, reducing the dead-time to 1 or 2 seconds,
while using the standard SOFAST pulse scheme leads to a dead time of up to 15
seconds [147].
Figure 7.7: Fluid turbulence adapted SOFAST pulse scheme. Selective pulses are




Band-selective Excitation Short-Transient (BEST) relies on selective pulses to achieve
a longitudinal relaxation enhancement as previously described. This strategy can be
applied to a whole set of multidimensional experiments, like the HSQC- and TROSY-
type experiments. BEST provides sensitivity enhancement that allows the reduction
of the experimental time needed to acquire multidimensional spectra, for example
HNCO or HNCA spectra that are used to assign the resonances of a protein. The
SOFAST experiment is in this respect a particular case of the BEST strategy, with
the added sensitivity enhancement based on the use of Ernst angle excitation.
7.3 Projection NMR
Projection NMR allows the measurement of an experiment of dimension n using a
series of spectra of dimension k (with k ≤ n− 1)[102, 163, 155]. Such an experiment
is noted (n, k) −D experiment. Projection NMR is based on a particular scheme of
spectral sampling of the indirect dimensions, which are sampled along a tilted axis
that form projection angles αiwith indirect dimensions ti. In a simple case of a H-X-
Y(3, 2)−D experiment, and a projection angle α, we have α1 = α and α2 = pi/2− α,
ﬁgure 7.8 (a). The spectrum obtained is the projection of the 2D X-Y spectrum along
an axis that forms the angle α1 with X and α2 with Y.
Experimentally this is obtained using the same time variable t1 for all projected
indirect dimensions, with time increments linked to that of the ﬁrst indirect dimension:
∆ti = λi∆t1 with λi = cosαi/ cosα. In this simple H-X-Y(3, 2) − D experiment,
λ = tanα and observed indirect chemical shifts are given by relation (7.6).
{
w+α = wX + λwY
w−α = wX − λwY
(7.6)
Direct analysis of this data allows the recovery of the Y chemical shift using the
central peaks method: an H-X spectrum is recorded, equivalent to a projection with
α = 0, and for each peak in this H-X spectrum, symmetrical peaks are looked for in
the +α and −α spectra. When found, relation (7.6) gives wY from λ and w+α or
w−α, see ﬁgure 7.8 (b).
7.4 B2M folding experiments: standard procedures
Lyophilized wild-type B2M is re-suspended in an unfolding buﬀer (1.5M Urea, pH=2).





















Figure 7.8: (a) H-X-Y(3, 2) −D experiment sampling scheme (b) The central peaks
method to ﬁnd the ωY by symmetry, using λ and ωX , for a 1H isolated peak (left) or
a 1H degenerate peak (right).
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(Phosphate 300mM pH=7.2 or HEPES 900mM, pH=7.2). The measured pH after
the pH jump is 6.8. The mixing of the unfolded protein in its buﬀer and the refolding
buﬀer is made in a 3:1 respective proportion. For example in NMR experiments
B2M is re-suspended in 300µL of the Urea buﬀer, and 100µL of the HEPES buﬀer
is added to initiate folding. The concentration chosen initially for B2M in NMR
experiments is 750µM ﬁnal, and thus an initial unfolded concentration of 1mM. Such
a high concentration implies the use of 3.6mg of protein for each folding experiment.
First experiments showed that in these conditions and at this concentration, wild-
type (WT) B2M had a strong propensity to aggregate during the pH jump, leading
to a sample ﬁlled with a milky white precipitate, even in the presence of 1.5M urea.
This precipitation was hypothetically due to a seeding by aggregates formed since
or already present as soon as the re-suspension step of the process. The elimina-
tion of such aggregates or seeds should then eliminate the precipitation. To achieve
this, two strategies were developed: ﬁltration and centrifugation. Filtration through
0.2µm ﬁlters can be done just before the experiments, and leads to elimination of the
precipitation, but at the cost of sample losses both in volume and in concentration.
For this reason, preparative ultracentrifugation was used as a standard method for all
experiments. The technique consists in the centrifugation of the unfolded sample at
120 000 g for at least 45 minutes (using a Beckman Optima TL ultra-centrifuge), the
supernatant being used for the experiment, while the aggregates that are centrifuged
to the bottom of the tube are discarded.
This method allows elimination of all stable aggregates larger than ~25nm in diameter
as shown using electron microscopy (ﬁgure 7.9), while leading to minimal losses in
volume or in protein concentration.
The mixing of the two buﬀers is performed using an adhoc device, a syringe injector.
One main objective in these kinetics studies is to minimize the initial dead time
during which data are not collected. When the mixing can be done directly inside the
measurement apparatus, the dead-time can be reduced to less than a second, as shown
in the description of the fast-mixing syringe injector for NMR experiments. The dead-
time can be longer than just the mixing time due to the experimental time needed to
obtain the ﬁrst data point. For example 15 seconds are needed in NMR to obtain the
ﬁrst HMQC spectrum after the pH jump, so even if the mixing is synchronized with
the beginning of the acquisition, with a few seconds as a margin of error, dead-time
can be considered to be of the order of 10 seconds.
After the pH jump and the dead-time, the kinetic evolution of refolding B2M can be
followed through the repetition of acquisitions. NMR being harmless to the sample,
acquisitions can be performed at the limiting rate of the technique, every 15 seconds,
giving very detailed data on a process that reaches its ﬁnal state on a timescale of
the order of one to six hours depending on the temperature.
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(a) Just after pH jump
(b) 15 minutes after pH jump
(c) 3 hours after pH jump
Figure 7.9: Representative electron microscopy measurements that were made at
25°C, using negative staining with sodium silico-tungstate, at diﬀerent times during
the folding, with samples diluted 200 fold, from 750µM, just before measurement.
Measurements show the inexistence of aggregates larger than 25nm in diametre along
the folding.
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7.5 Fast Mixing Device
In order to obtain information on the folding process as soon as possible after its
initiation, the initiation step must be as fast as possible. To realize a pH jump, as
required here, two solutions have to be mixed and the ﬁnal sample put into the NMR
magnet to start the experiment. If the mixing is done by hand, using a glass Pasteur
pipette for example, adding the time needed to ﬁt the NMR tube in the ﬂoater, and
the time for it to reach the measuring coil's position, the dead-time can be estimated
to ~30 seconds to a minute. One way to reduce the dead-time is to perform the mixing
directly inside the magnet, using a syringe injector, described on ﬁgure 7.10 [147].
This fast-mixing device is composed of a long Teﬂon tube, that is ﬁxed inside the NMR
tube on one side, and goes outside the magnet up to a syringe on the other side. The
diameter of the Teﬂon tube is reduced at its NMR tube end, to increase the velocity
of the injected liquid and favour a better and faster mixing. This diameter-reduced
tube is slightly inserted in the meniscus of the liquid present in the NMR-tube, again
to favour a better mixing. The NMR tube used is a Shigemi, its plane bottom being
favourable for the formation of turbulence upon the injection, making the mixing
even more eﬃcient. Shigemi tubes also have the asset of limiting the volume of
sample needed for experiments down to 350-400µL. The Teﬂon tube is maintained in
position inside the Shigemi tube using Teﬂon mountings, made of a Teﬂon tube of
outer diameter that closely matches the inner diameter of the Shigemi tube. Using
such a syringe injector, the mixing can be achieved in less than 100ms, as shown
by dye injection, and taking into account the turbulence that appear in the sample
upon mixing, with the use of an adapted pulse scheme, experimental dead-time can
be reduced to less than two seconds.
7.6 Labeled B2M protein production
One of the assets of B2M, being a good model for amyloid and other misfolding stud-
ies, can also become a real drawback. Since it is easy to misfold, or said the other
way, diﬃcult to fold correctly, B2M can be diﬃcult to produce for biophysical stud-
ies. If some of the most common techniques such as UV-ﬂuo or circular dichroism
do not require more than a few milligrams of protein, extensive studies using crys-
tallography or even worse NMR may require up to hundred milligrams of protein.
Therefore obtaining a robust recombinant protein production protocol is crucial for
these techniques.
NMR of biological samples speciﬁcally requires isotopic enrichment of the protein, to
introduce 13C and 15N in much higher proportions than in nature, for a higher signal
to noise ratio of NMR spectra. 13C natural abundance is only circa. 1%, and 15N
is only circa 0.4%, which implies for example for a 2D CH correlation experiment,
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about 100 fold less labeled protein than unlabeled protein for the same signal to noise
ratio. For the best control of isotopic enrichment, minimal growth media are used for
production in E.coli, meaning media that contain the minimal inorganic salts neces-
sary for bacteria growth and thus protein production, in which is added an isotope
enriched carbon and/or nitrogen source. The use of such a minimal media usually
reduces the yields of protein production, making the optimization of the production
protocol even more important.
The major diﬃculty that was faced during 15N or 13C−15N enriched B2M production
was that the central disulﬁde bridge would not form correctly, resulting in a misfolded
protein. This could only be detected by NMR and not exclusion chromatography,
implying that the misfolding was not disturbing the global fold of the protein. Several
oxidizing conditions were tested during the refolding phase of the puriﬁcation of the
protein, two processes were proven eﬀective, either a long folding rest in 6M Urea
at low temperature in presence of gazeous dioxygen, or a ﬂash refolding procedure
performed at low temperature. The latter appeared much more eﬃcient even though
time consuming due to the protein concentration step necessary, and was therefore
used with a yield of 50mg per liter of culture for 15N B2M and 20mg per liter of
culture for 13C −15 N B2M. Such a protocol required at least two weeks of work per
liter of culture, from bacteria growth to size-exclusion puriﬁcation. The extensive
protocol is shown in section VI of the annex.
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Folding of B2M followed using
real time 2D SOFAST NMR
8.1 Standard experiment:
8.1.1 Data acquisition and processing
NMR experiments were performed on a Varian INOVA spectrometer operating at
800MHz (1H frequency), equipped with a cryogenic probe. SOFAST pulse scheme
allowed to reduce the overall single-scan time down to 100ms. Nitorgen decoupling
was achieved using a WURST-40 train [105], while the States-TPPI [113] scheme was
employed for sign discrimination with respect to the nitrogen carrier frequency. Each
experiment was performed with only one scan per T 1 increment, and phase cycling
was performed in subsequent spectra to eliminate artifacts (see 8.1.2). 2D spectra
were acquired every 15 seconds. The experiments were processed with NMRPipe.
In the indirect dimension F1, the original data set of 60 real points was extended
by linear prediction (30points) and zero-ﬁlled to 128 points, and a squared sine-bell
apodization function was employed, with a shift of pi/4. In the direct dimension F2,
a sine-bell function with a shift of 2pi/5 was employed. Following two-dimensional
Fourier transform, a fourth order polynomial baseline correction was applied to the
spectra.
8.1.2 Data analysis
Subsequent spectra were summed to account for the phase cycling. Applying the phase
cycling in a two-scan acquisition divides by two the time resolution of the experiment,
while phase cycling can be implemented on consecutive single-scan spectra with the
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same artifact elimination eﬃciency. Thus the ﬁrst step of the data analysis is to sum
spectra 1 and 2, 2 and 3, ..., using ad-hoc python scripts and NMRpipe. The only
drawback of this method is that the apparent dead time must be considered as half
an acquisition longer than that of a standard single scan acquisition. Spectra are then
inspected using NMRview.
8.1.3 Results
The following conditions are used for this standard experiment: concentration is
750µM and temperature 25°C, while the folding buﬀer is the phosphate buﬀer. While
at pH2 B2M has a typical unfolded protein HMQC spectrum (ﬁgure 8.1), immedi-
ately after the pH jump the scattering of the amide proton resonances implies that
B2M adopts a folded conformation. Moreover the unfolded state resonances have
completely disappeared even in the ﬁrst spectrum acquired after the pH jump, show-
ing that the collapse of the unfolded state to a folded state is faster than the time
resolution of the experiment (ﬁg 8.1). When comparing the ﬁrst spectrum after the
pH jump and a spectrum of B2M after the folding is completed, a folding intermedi-
ate state clearly appears, with resonances that can be either isolated from the native
state ones, or with a partial or total overlap.
Figure 8.1: Spectral evolution along the folding: (a) Unfolded protein, (b) Just after
pH jump, (c) Native state. Peaks highlighted in blue correspond to isolated native
peaks, in red to peaks that overlap in the native state and in the intermediate state,
n green to isolated intermediate state peaks. The concentration is 750µM and tem-
perature 25°C, while the folding buﬀer is the phosphate buﬀer. The spectra were
acquired on a 600MHz Varian INOVA spectrometer using the SOFAST pulse scheme,
as described in section 8.1.1
Two classes of peaks can be easily drawn: isolated intermediate state peaks (class I)
and isolated native state peaks (class N). The build up of the N class signal accounts
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for the population of the N state, while the decay of the I class signal accounts for
that of the I state. A third class can be distinguished, containing peaks that overlap,
fully or partially, in the I and N states, thus the term I+N for this third class. Peaks
were classed I+N only when they were isolated from other peaks, and as such could
be linked to a single residue resonance. The signal of this I+N class provides useful
information on the presence of additional NMR-invisible folding intermediates, or in
the diﬀerence of local dynamics between I and N states. First result of this folding
experiment is that kinetics of signal decay or build-up are similar inside each class
(ﬁgure 8.2). Therefore, the volume of the peaks of each class was measured in all the
480 spectra using nmrView and TCL scripts, and summed to obtain three signals,
one for each class. Results are shown in ﬁgure 8.3.
Figure 8.2: Examples of the evolution of diﬀerent individual peaks within the three
peak classes N, I, I+N. The volume is normalized to the ﬁnal value. Time constants
and other ﬁtting parameters and corresponding standard error are shown, as obtained
using Monte Carlo simulations.
The native state arises within timescales similar to those observed in UV-Vis spec-
troscopy. Yet interestingly a bi-exponential ﬁt is necessary to assess for the evolution
of the NMR signal, that was not seen in UV-Vis experiments. This implies a folding
mechanism more complex than a simple two-state model. On the contrary, the decay
of the I class signal can be ﬁtted with a mono-exponential function. Furthermore, the
signal of the I+N class is not constant as would be expected in a two-state model,
but is rising as a bi-exponential function of time with similar time constants as the N
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Figure 8.3: Folding of B2M in a Phosphate buﬀer at 25°C, using peak class N (a), I (c),
I+N (e). The volume of the peaks is summed inside each class and is normalized to
the ﬁnal or initial value (black); residuals corresponding to mono-exponential (orange)
and bi-exponential (green) ﬁtting functions are shown.
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class. The observation of a bi-exponential build-up of the N class signal and the not-
constant signal of the I+N class both point toward the existence of another folding
intermediate, that is not visible in NMR. Another explanation for the not-constant
signal of the I+N class would be diﬀerences in the relaxation properties of the I
state. Diﬀerences in the internal mobility, the dynamics of the I state would result
in diﬀerent spin relaxation properties, and thus in diﬀerent NMR peak intensities (or
volumes) for similar populations of the I and N states.
The evaluation of the line-widths, that are related to the relaxation properties, show
no signiﬁcant diﬀerences between I and N state peaks. Furthermore, when performed
with a longer recycling delay d1 (thus indirectly monitoring 1H T1), the folding spectra
display the exact same signal build-up for the I+N class as with the usual shorter
d1 (ﬁgure 8.4). This rules out the possibility that the missing intensity for the I+N
class is due to diﬀerent relaxation properties of a monomeric intermediate state. A
second intermediate state is populated during B2M folding, with a population up to
34% just after the pH jump, a state that is invisible in NMR, either because of the
dynamics of the state or because it is an oligomer.
Another fact highlighted by these folding results is the burst phase that exists for the
N state: initial population, just after the pH jump and a dead-time of a few seconds,
is not close to zero. The N state is populated, as derived from zero-time extrapolation
of the N class signal, as much as 7% at the beginning of the folding, just after the
pH jump. This burst phase, during which some B2M molecules fold directly and very
quickly from the unfolded state to the native state can be linked to the description
of a fast folding phase observed in UV-vis [97, 37]. The populations concerned are
signiﬁcantly diﬀerent, but this can be explained by diﬀerent experimental conditions,
especially diﬀerent solvents and temperature. Still in the article by Kameda et al.
[97], in which they use conventional HSQC pulse sequences to follow the folding at
2.8°C, only a mono-exponential evolution is described for the population of the native
state during folding. This can be explained, aside from the diﬀerent temperature
that may dramatically aﬀect the folding mechanism, by the lower time resolution of
conventional HSQC with respect to sofast HMQC, that would not allow to go as deep
in the description of the ﬁne details of the diﬀerent states' population evolutions.
k1(s
−1) k2(s−1)
N (2.5± 0, 3) · 10−3 (4.7± 0, 6) · 10−4
I (1.70± 0, 03) · 10−3 -
I+N (4.7± 0, 4) · 10−3 (5.3± 0, 4) · 10−4
Table 8.1: Kinetic time constants for the folding of B2M in a Phosphate buﬀer at
25°C, with corresponding standard errors evaluated using Monte Carlo simulations.
A model for the folding mechanism can be derived from the kinetic time constants
summarized in table 8.1. With three independent time constants (two for N, that are
similar to those of I+N, and one for I), two-state models and models with two folding
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Figure 8.4: Evaluation of the inﬂuence of the 1s recycling delay d1 introduced inside
the SOFAST pulse sequence (red) on the evolution of the three classes of peaks N (a),
I (b) and I+N (c), compared to the signal obtained with the usual shorter d1 of 0.2s
(black).
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intermediates on parallel pathways have to be discarded. Five states are required to
describe adequately the observed kinetics data. Diﬀerent models can be proposed, all
including three long-lived intermediates, all of them NMR invisible but one. Figure
8.5 presents one of the ﬁve-state models, but the obtained data are not suﬃcient to
discriminate between the diﬀerent possibilities.
Figure 8.5: Five state folding model for B2M in a phosphate buﬀer at 25°C, derived
from statistical analysis of the folding data obtained in NMR. Stars signal NMR-
invisible states.
8.2 Following the folding with methyl protons as probes
As previously seen in section 7.2.3, the SOFAST-HMQC can be adapted to use methyl
protons as probes instead of amide protons. This can be of particular interest for two
reasons. The ﬁrst is the location of the methyl protons inside the protein, that is
diﬀerent from that of amide protons. Methyl groups are located on the side chain
of amino-acids, while amide protons are located on the backbone of the protein.
While methyl groups will usually fold into the hydrophobic core of the protein, amide
groups, being in the backbone, can be either exposed to or hidden from the solvent.
The second reason that makes the use of methyl protons as probes being the increased
sensitivity, as there are three protons for each methyl group. This additional sensi-
tivity can be handy when dealing with lower protein concentrations. Methyl groups
having a speciﬁc location in the structure of the protein, they may not exhibit the
same folding kinetic time constants as amide protons, as the hydrophobic core may
require further packing after the backbone has reached its global conformation.
To study this possibility, the folding of B2M at a concentration of 200µM was followed
acquiring alternatively an amide SOFAST spectrum and a methyl SOFAST spectrum.
Results are shown on ﬁgure 8.6. No diﬀerence can be observed between the folding
rates of amide and methyl protons, but the gain in sensitivity is clear. Yet surprisingly
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the signal for the N class for the methyl protons seem to have a small bi-exponential
component.
8.3 Folding of the W60G-B2M mutant
W60G is a single point mutant known to have a reduced conformational ﬂexibility,
and a lower propensity to form amyloid ﬁbrils, than that of the wild type B2M
[59]. Folding studies of this mutant using UV-Fluo spectroscopy revealed a strong
diﬀerence to the folding of the wild type protein, as W60G folds within seconds,
and the slow folding phase that is characteristic of the folding of WT B2M is absent
[59]. Yet when W60G refolding is followed using SOFAST-HMQC, the build up of
the N state signal shows a clear mono-exponential slow phase, and a burst phase of
∼8%. This diﬀerence in the UV-Fluo and the NMR results points towards similar
environments of W95 in the intermediate and native states, because ﬂuorescence of
B2M mainly comes from W60 and W95, making intermediate and native states of
W60G indistinguishable using UV-Fluo spectroscopy. The fact that the I+N signal
is not constant either for W60G (ﬁgure 8.8) implies the existence of a NMR invisible
intermediate state. Yet because the kinetic build-ups for I+N and N signals can be
ﬁtted with mono-exponential functions, a simpler four-state model can be proposed
for the folding of W60G (ﬁgure 8.7). The population of the NMR invisible states
is lower in W60G folding (15%, vs 34% in WT folding), which correlates with the
higher thermodynamic stability of the mutant protein and its lower propensity to
form amyloid ﬁbrils.
Figure 8.7: Four state model for W60G-B2M folding in a phosphate buﬀer at 25°C.
I* is NMR-invisible. Percentages correspond to the proportion of unfolded proteins
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Figure 8.6: Folding curves corresponding to standard (amide) SOFAST (left) and
C-H (methyl) SOFAST (right). On both sides, top line corresponds to the native
state class, middle line to the intermediate class, bottom line to the I+N class. In
each class, the intensities of the peaks are summed, and then normalized to the ﬁnal
or initial value. Data is ﬁtted using mono- or bi-exponential functions depending on
the evaluation of the residuals, that are shown below each graph. 84
Figure 8.8: Folding of W60G in a Phosphate buﬀer at 25°C using peak class N (b), I
(d), I+N (f). The volume of the peaks is summed inside each class and is normalized to
the ﬁnal or initial value (black); residuals corresponding to mono-exponential (orange)
and bi-exponential (green) ﬁtting functions are shown. Data is obtained using the
SOFAST pulse scheme, as previously described.
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8.4 Conclusions
To conclude on this part, both WT B2M and W60G-B2M populate NMR-invisible,
thus structurally native-unlike, folding intermediate states with levels that are far
from negligible. The population levels of these NMR-invisible intermediates correlate
with the propensity of the protein to form amyloid ﬁbrils. The folding mechanism of
WT B2M is likely to include ﬁve states (unfolded, one NMR visible intermediate, two
NMR invisible intermediates, native). The structure of the NMR visible intermediate
is clearly native-like, and the isomerization of the His31-Pro32 peptide bond is the
major event of B2M folding.
 The problem of the NMR-invisibility of two of the intermediate states
While the isomerization of P32 had been pointed out through the use of traditional
biophysical methods (such as UV-ﬂuo and Circular dichroism) as the main phe-
nomenon occurring during the folding of B2M, NMR studies show that a whole region
of the protein is not aﬀected by this isomerization. Along the detection of intermedi-
ate states that were not distinguishable by other methods, this is a main illustration
of the potential of NMR to bring structural insights to the study of short-lived species,
especially intermediate states.
This potential is of course lowered by the inherent limits of the technique: two of the
three intermediate states derived from the NMR data are not directly observable in
NMR. Two main arguments can explain the NMR-invisibility of these states: either
they are oligomeric states, too large to be detected in NMR, or the dynamics of these
states imply a peak line-width that is also too large to be detected. Should NMR
be discarded as a method to study these invisible states? The fact that they could
be indirectly detected suggests that information on these states may be obtained
indirectly using NMR.
One strategy is based on one of the explanations for the NMR-invisibility of the
intermediates states. If NMR-invisible intermediate states are oligomeric, changes in
the experimental conditions should imply detectable changes in the detected NMR
signals. Indeed, if conditions that favor the formation of oligomers are used, the
population of these invisible states, that is measurable in NMR, should be impacted.
 Comparison of the folding models obtained using NMR or UV-ﬂuo techniques
In order to compare our NMR results with the folding studies based on UV-ﬂuorescence
spectroscopy, the probes at the origin of the signal in the two methods must ﬁrst be
considered. NMR methods used here use amide protons as probes, corresponding
to 97 probes along the amino-acid backbone of the protein, while UV-ﬂuorescence
focuses on the side chain of the two tryptophan residues W60 and W95 (displayed
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on ﬁgure 4.4(b)). As shown by studying the folding of mutant W60G in UV-ﬂuo,
only a fast phase can be detected during the folding, which implies that W95 is
aﬀected by the folding only during the transition from the unfolded state to the
intermediate states. All intermediate states, and the native states, have a similar
micro-environment concerning W95 ﬂuorescence. Considering the folding of the wild-
type protein in UV-ﬂuo, and as such the contribution of W60, all intermediate states
have a similar micro-environment, but are diﬀerent both from the native and unfolded
state.
While the folding of W60G could be considered as a simple two-state transition di-
rectly from the unfolded to the native state based on the UV-ﬂuo data, NMR exper-
iments show that at least two intermediates are necessary to account for the kinetics
observed. One of them is directly visible in NMR, the other being NMR-invisible,
while the two are invisible in UV-ﬂuo. The folding of the wild-type protein shows a
similar diﬀerence between the two techniques: while one [143] (or two considering the
earlier studies[37, 92]) intermediate states are detected in UV-ﬂuo, three intermediate
states are necessary to model the evolution of NMR signals.
These diﬀerences in the detection of intermediate states, due to the diﬀerence in the
probes that are used in the two techniques, makes the evaluation and comparison
of diﬀerent folding models a diﬃcult task. A ﬁrst order analysis could be that all
intermediate states detected in NMR are just populating an UV-ﬂuo indistinguishable
ensemble of states that would replace in the model the intermediate states detected in
UV-ﬂuo. Yet it is more diﬃcult to account for the bi-exponential slow phase folding
detected in NMR, while all kinetics detected in UV-ﬂuo for the slow phase are mono-
exponential. This bi-exponential behavior implies the parallel folding pathways of the
NMR-based folding models.
A parallel folding pathway implies that the population of the native state is increas-
ing from two diﬀerent sources (intermediate states), with two diﬀerent kinetics. One
hypothesis can be made to explain the non-detection of these two kinetics in UV-
ﬂuo: that one of the intermediate states is indistinguishable from the native state
considering the UV-ﬂuo signal, which means that their W60 micro-environment is
similar. This would imply that the main event on this pathway would not be the
isomerization of P32, but a rearrangement that would not aﬀect either W95 or W60.
This rearrangement would have been detectable in NMR, had not the intermediate
state concerned been NMR-invisible. The diﬀerent probes used by NMR and UV-ﬂuo
explain the fact that models that seem clearly diﬀerent are not in principle incom-





It was shown in chapter 7 that following the folding of a protein in real time using
NMR gives access to the folding mechanism, even if the measurements are made
only in one set of conditions (buﬀer, temperature, ...). Yet the protein folding free
energy landscape is thought to be a rugged landscape, sensitive to the evolution
of thermodynamic or environmental factors. Diﬀerent states may be populated at
diﬀerent temperatures, or their populations may vary. Real-time NMR can be used
to study the robustness of a folding model obtained in one set of conditions, exploring
the evolutions of the folding. In this chapter, the inﬂuence of two factors on the
folding of B2M is investigated: buﬀer conditions and temperature.
9.1 B2M folding: solvent dependence
Two refolding buﬀers were used in these B2M folding NMR studies. One was Phos-
phate 300mM pH=7.2, the other was HEPES 900mM pH=7.2. The reason for the
use of a phosphate buﬀer is that it is the most common buﬀer in B2M folding studies
using other spectroscopic methods, such as UV-Fluo (see 6.2). To be able to com-
pare NMR experiments to UV-ﬂuo experiments among others, a phosphate buﬀer
was used in the ﬁrst experiments. But phosphate buﬀers have a drawback in terms of
NMR sensitivity, due to their high conductivity [100], when using NMR spectrometers
equipped with cryogenic probes. The HEPES buﬀer, even with its three fold higher
concentration, has a conductivity that is 100 fold lower than that of phosphate buﬀer.
As sensitivity is an issue when concentration decreases, the HEPES buﬀer was used
in all following experiments.
To assess for an inﬂuence of the buﬀer on B2M folding, the NMR folding experiments
at 25°C were repeated with a HEPES buﬀer. The comparison of the two folding
experiments is shown in ﬁgure 9.1. The ﬁrst result is that for the I+N class, the
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signal is ﬁtted with a bi-exponential function for the phosphate buﬀer, while it is
ﬁtted with a mono-exponential function for the HEPES buﬀer. More dramatic, the
folding is globally slower in HEPES (1.3.10−3s−1) than in phosphate (1.7.10−3s−1)
at 25°C. Those diﬀerences may be explained by the higher viscosity of the HEPES
buﬀer, due to its higher concentration, the choice of which has anecdotal causes, but
further work would be needed to really assess for the causes of these diﬀerences.
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(b) Folding in HEPES buﬀer
Figure 9.1: Comparison of the folding of B2M in two diﬀerent buﬀers, using peak
class N (top), I (middle), I+N (bottom). As previously described, the volume of the
peaks is summed inside each class and is normalized to the ﬁnal or initial value (black
for Phosphate buﬀer, orange for HEPES buﬀer); residuals corresponding to mono-
exponential (top line) and bi-exponential (bottom line) ﬁtting functions are shown
under each graph.
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9.2 B2M folding: temperature dependence
The same experimental conditions, ie with a HEPES refolding buﬀer, can be used to
study B2M folding dependence on temperature. Figure 9.3 shows the evolution of the
signal for the diﬀerent classes of peaks (N, I, I+N) at three diﬀerent temperatures:
15°C, 20°C and the already presented 25°C.
The evolution for the N state class of peaks as a function of temperature shows no
impact of temperature on the global aspect of the curves: all have to be ﬁtted with
bi-exponential functions. The kinetic time constants (table 9.1) seem to double with
every ﬁve degrees increase. The burst-phase (table 9.2) appears to be lower at 20°C,
but no coherent evolution along the temperature increase arises, staying around the
10% observed at 25°C. The same kind of temperature dependence appears for the I
state class, as all used ﬁt functions are mono-exponential, and the same doubling of
the time constant for each 5°C increase is observed.
15°C 20°C 25°C
N (3.4± 0.07) · 10−4s−1 (6.1± 0.2) · 10−4s−1 (1.3± 0.03) · 10−3s−1
I (3.2± 0.1) · 10−4s−1 (6.4± 0.3) · 10−4s−1 (1.2± 0.05) · 10−3s−1
I+N (3.3± 0.1) · 10−4s−1 (6.2± 0.5) · 10−4s−1 (1.3± 0.1) · 10−3s−1
Table 9.1: Temperature dependence of the kinetic time constants obtained using
mono-exponential functions of time
15°C 20°C 25°C
N (87.5± 0.9)% (84.6± 1.0)% (89.8± 1.1)%
I+N (39.3± 0.7)% (32.1± 1.2)% (25.5± 1.1)%
Table 9.2: Burst phases at a concentration of 750µM
The evolution of the I+N class along temperature changes shows more diﬀerences.
First, as was seen in the solvent dependence, folding curves at 25°C and 20°C can
be ﬁtted with mono-exponential functions. Yet surprisingly the I+N curve at 15°C
reveals a bi-exponential function of time. As was shown before, a bi-exponential
evolution implies a more complex folding mechanism. There seems to be one more
intermediate state at 15°C than at 25°C or 20°C, the mechanism at this temperature
could then resemble that observed in phosphate buﬀer.
Furthermore, while the same evolution of the time constants as in the I and N classes
is observed, the burst phase has a strong temperature dependence, going from 25%
at 25°C up to 39% at 15°C. The amplitude of the burst phase being directly related
to the population of the non-native intermediate state, this population increases as
temperature goes down. Two hypotheses, based on the existence of NMR invisible
intermediate states, were proposed to explain the lack of signal at the beginning of the
folding: either those intermediate states are unfolded states, or ensembles of unfolded
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states, or they are constituted of oligomeric states or ensembles of oligomeric states.
Since the population of unfolded states should rise with the increase in temperature,
all other parameters equal, this hypothesis should be discarded. On the contrary, an
increase in the population of the NMR-invisible states with decreasing temperature is
consistent with those states being oligomeric. The temperature dependence of B2M
folding points towards the existence of oligomeric intermediate state(s).
Finally, based on all the kinetic time constants measured, that can be reduced to a
single time constant for any given temperature, the energy of activation of the global
folding process can be evaluated using equation 9.1 and the temperature dependence
of the folding rate. Of course with only three diﬀerent temperatures, the result must
only be considered as an order of magnitude. The obtained value, of the order of
magnitude of 90kJ/mol, is also consistent with the cis-trans isomerization of a proline
[34].














Figure 9.2: Extraction of the activation energy using Arrhenius equation, ln(k) =













































































Figure 9.3: Folding of B2M measured at three temperatures: 25°C (left), 20°C (cen-
ter), 15°C (right), using peak class N (top), I (middle), I+N (bottom). As previously
described, the intensity of the peaks is summed inside each class and is normalized to
the ﬁnal or initial value (orange); residuals corresponding to mono-exponential (green
or black) and bi-exponential (blue) ﬁtting functions are shown under each graph.
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9.3 Fitting the folding signals: mono or bi-exponential
functions?
NMR signals for classes N and I+N have diﬀerent aspects depending on temperature.
For a protein concentration of 750µM, N class kinetic traces are ﬁtted with a bi-
exponential function at 25°C and 15°C, but a mono-exponential function at 20°C.
Since the noise level is roughly the same, it cannot explain the diﬀerence of aspect of
the curves. Another example is the aspect of the I+N curve, at a protein concentration
of 750µM, that is mono-exponential at 25°C and 20°C, but bi-exponential at 15°C.
These diﬀerences of aspect reveal a very complex folding mechanism. Are mechanisms
totally diﬀerent depending on the temperature, for example simpler at 20°C, as in this
case all curves can be ﬁtted with mono-exponentials? Or at 20°C are we witnessing
a crossing in the evolution of the kinetic rates, due to diﬀerent activation energies?
For example, the phenomenon corresponding to the faster kinetic rate at 25°C could
correspond to the slower at 15°C, both rates being equal at 20°C while the folding
mechanism remains just as complex at all temperatures. The complexity being too
high, one must consider reducing the model to only mono-exponential kinetic curve
ﬁttings, and those are the ﬁttings used to extract kinetic time constants and burst
phases as displayed in tables 9.1 and 9.2.
9.4 B2M folding: Simpliﬁed model
Building a model for the folding of a protein can be very complex. With only one
condition, 750µM, 25°C, phosphate buﬀer, ﬁve states are already needed to comply
to the observed kinetic parameters. When globally looking the conditions in which
the folding of B2M was followed, the picture can seem senseless. For example the
folding follows bi-exponential kinetics for the apparition of the N state at 25°C and
15°C, but not at the intermediate temperature of 20°C. Solvent and temperature have
eﬀects on the folding mechanism of B2M. In order to extract some sense from all this
data, the model must be simpliﬁed. This is why only a mono-exponential ﬁt was used
to extract the kinetic parameters that will be used to build a folding model. Two
characteristics of the folding are essential in the building of the model:
 the folding intermediates can be divided into two categories, one is the NMR
visible intermediate state that was identiﬁed before (termed I), the other being
the NMR invisible state, that may be an ensemble of states, and is expected to
be oligomeric (termed I*).
 the folding characteristic time constants can be reduced to a unique time con-
stant corresponding to the isomerization of the H31-P32 peptide bond from the
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trans to the cis conformation, implying that all folding intermediate states are
in a trans conformation.
Finally, the burst phase on the build-up of the N class signal means necessarily that
circa 10% of the population of the protein folds within the dead-time of these NMR
experiments directly to the native state. From these considerations, a simpliﬁed model
can be proposed, relevant to the real-time NMR timescale. The model presented on
ﬁgure 9.4 consists of one unfolded state (U), that folds either directly to the native
state (N) or to the NMR-visible intermediate state I, both with kinetics that are
considered fast relative to the isomerization rate of the proline, and to the dead
time of the NMR experiments. An equilibrium between I and I* appears at a rate
that again is fast relative to both the isomerization rate and the dead time of the
experiments, considering that I* is fully populated in the ﬁrst spectrum of the NMR
experiments. The fact that proteins in a trans conformation for the proline can only
fold to the native state through the I state explains the unique slow kinetic time
constant that is observed. More complex models could be built based on the same
data, and this is clearly a simpliﬁcation giving up the bi-exponential characteristics
of certain folding kinetic curves. This simpliﬁed model can be complemented with
details on the unfolded state, that may be split into two states in slow equilibrium
corresponding to the two possible conformations for the H31-Pro32 peptide bond
[37, 92, 143], taking into account the fast folding phase observed in UV-ﬂuo.
These simpliﬁed models are clearly compatible with models presented in section 6.2,
the equilibrium I - I* replacing in the models the unique It intermediate state, which
is not problematic as long as I and I* are indistinguishable in UV-ﬂuo.
Studying the evolution of protein folding can be achieved using real time NMR and
appropriate thermodynamic or environmental changes. In the case of B2M, folding
is clearly dependent on those factors, which can lead to unresolvable complexity.
Yet through careful modeling, insights such as the isomerization of the proline being
the main folding event, or the fact that the two intermediate states are probably in




Figure 9.4: Folding models derived from the NMR folding data obtained at diﬀerent




Probing the NMR invisible
state
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Part III established that B2M populates a NMR-invisible state during its folding, and
that this invisible state is probably oligomeric. This part aims at the characterization
of this NMR-invisible state, ﬁrst through the indirect means of NMR spectroscopy,
then with other biophysical methods such as Small Angle X-ray Scattering or infrared
spectroscopy, and ﬁnally test the P32A mutant of B2M as an in-equilibrium model
for this transient NMR-invisible state.
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Chapter 10
Detecting a transient, invisible
oligomer using real time NMR
Probing NMR-invisible states using NMR can seem counter-intuitive. Yet just as a
lack of signal could be interpreted as an indirect proof of existence of this invisible
intermediate state, NMR can be used to characterize it. Especially, following the
folding in NMR is a mean to test the hypothesis that the invisible state is an oligomeric
state, using the inﬂuence of concentration.
10.1 The inﬂuence of concentration on the folding of
B2M
Five diﬀerent ﬁnal concentrations were used to study B2M folding dependence on
protein concentration, using two diﬀerent atomic probes: 750µM, 375µM, 188µM
using amide protons as probes, and 150µM and 50µM using methyl protons as probes.
Figures 10.1 and 10.2 displays the results of the folding at these concentrations at
20°C. Samples were prepared as previously stated, and diluted in the Urea buﬀer to
reach the desired concentration.
All N class signals show mono-exponential evolutions in these conditions. Concentra-
tion doesn't seem to inﬂuence the mechanism of folding of B2M in that matter. For
all concentrations, at 20°C, the kinetic time constants seem to be similar (~6.10−4
s−1), and the burst phase is around 10%. Concentration doesn't seem to be of inﬂu-
ence for the apparition of the native state. In a similar fashion, concentration doesn't
inﬂuence the decay of the I class signals, and time constants are similar to those of
the N class.
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But interestingly, when considering the I+N class, the population of the NMR-
invisible state(s) decreases with the decrease of protein concentration, from 32% at
750µM to 19% at 188µM, and the I+N signal is even constant at the lowest concentra-
tion considered, 50µM. These results are clearly consistent with NMR-invisible states

































































Figure 10.1: Folding of B2M followed at three diﬀerent concentrations: 750µM (yel-
low, left), 375µM (green, center), 190µM (blue, right), using peak class N (top),
I (middle), I+N (bottom). As previously described, the intensity of the peaks is
summed inside each class and is normalized to the ﬁnal or initial value; residuals cor-



























































Figure 10.2: Folding of B2M followed at three diﬀerent concentrations: 190µM (left),
150µM (center), 50µM (right) , using peak class N (top), I (middle), I+N (bottom).
As previously described, the intensity of the peaks is summed inside each class and is
normalized to the ﬁnal or initial value; residuals corresponding to mono-exponential
ﬁtting functions are shown under each graph.
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10.2 B2M folding: discussion on both temperature
and concentration inﬂuence
To get a better knowledge of the B2M folding energy landscape, the dependence on
temperature and concentration, and to increase the robustness of the conclusions
drawn, three concentrations (750µM, 375µM, 188µM) were studied at the three tem-
peratures (25°C, 20°C, 15°C), giving 11 conditions with the two lower concentrations
studied using Met-SOFAST-HMQC at 20°C. Results are presented in table 10.1 for
the kinetic time constants, in table 10.2 for the burst phase parameters for classes
N and I+N, and on ﬁgures 14.1, 14.2, 14.3 and 14.4 in annex VI. A ﬁrst conclusion
that can be drawn is that N, I and I+N classes have similar kinetic time constants
in any given temperature-concentration conditions. This supposes that the folding
is mediated by only one time constant. Of course this is a simpliﬁcation, as certain
curves, as previously stated, should be ﬁtted with bi-exponential functions of time.
Yet this can be considered as a ﬁrst order analysis. The unique kinetic time constant
corresponds to that of a proline cis-trans isomerization. This folding rate does not
depend on concentration at any given temperature.
Class T 750µM 375µM 188µM
15°C (3.4± 0.07) · 10−4s−1 (4.1± 0.1) · 10−4s−1 (4.1± 0.2) · 10−4s−1
N 20°C (6.1± 0.2) · 10−4s−1 (6.4± 0.2) · 10−4s−1 (6.2± 0.3) · 10−4s−1
25°C (1.3± 0.03) · 10−3s−1 (1.2± 0.07) · 10−3s−1 (1.3± 0.06) · 10−3s−1
15°C (3.2± 0.1) · 10−4s−1 (3.8± 0.2) · 10−4s−1 (3.6± 0.4) · 10−4s−1
I 20°C (6.4± 0.3) · 10−4s−1 (5.2± 0.6) · 10−4s−1 (4.9± 0.8) · 10−4s−1
25°C (1.2± 0.05) · 10−3s−1 (1.1± 0.08) · 10−3s−1 (1.2± 0.1) · 10−3s−1
15°C (3.3± 0.1) · 10−4s−1 (4.2± 0.7) · 10−4s−1 (4.6± 1.3) · 10−4s−1
I+N 20°C (6.2± 0.5) · 10−4s−1 (7.6± 1.2) · 10−4s−1 (6.3± 1.7) · 10−4s−1
25°C (1.3± 0.1) · 10−3s−1 (1.1± 0.2) · 10−3s−1 (1.0± 0.8) · 10−3s−1
Class T 150µM 50µM
15°C - -
N 20°C (6.7± 0.2) · 10−4s−1 (6.6± 0.9) · 10−4s−1
25°C - -
15°C - -
I 20°C (6.2± 0.2) · 10−4s−1 (6.5± 0.6) · 10−4s−1
25°C - -
15°C - -
I+N 20°C (6.4± 1.1) · 10−4s−1 not measurable
25°C - -
Table 10.1: Summary of measured kinetic time constants for the folding of B2M
Based on the results displayed in table 10.2, the burst phase for the N class doesn't
seem to depend either on concentration or on temperature, with a constant value
around 10-15%. This value represents the population of the protein that goes directly
from the unfolded state to the native state. This is usually explained by the existence
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Class T 750µM 375µM 188µM 150µM 50µM
15°C (87.5± 0.9)% (86.9± 1.4)% (89.6± 2.1)% - -
N 20°C (84.6± 1.0) ·% (82.3± 1.3) ·% (83.7± 2.2) ·% (82.4± 1.0) ·% (88.1± 2.5) ·%
25°C (89.8± 1.1) ·% (89.2± 3.2) ·% (91.2± 2.7) ·% - -
15°C (39.3± 0.7) ·% (30.2± 1.1)% (22.8± 2.1)% - -
I+N 20°C (32.1± 1.2) ·% (22.4± 1.4) ·% (12.9± 3.0) ·% (9.2± 2.1) ·% ∼ 0
25°C (25.5± 1.1) ·% (16.7± 2.4) ·% (11.0± 5.0) ·% - -
Table 10.2: Summary of measured exponential parameters (burst phase) for the fold-
ing of B2M
of an equilibrium between a cis H31-P32 peptide bond unfolded conformation (Uc)
and a trans H31-P32 peptide bond unfolded conformation (Ut). While the protein
in a trans conformation must undergo a kinetically unfavourable trans to cis isomer-
ization, the proteins having a peptide bond that is already in a cis conformation
in its unfolded state can fold directly to the native state within seconds, as shown
by Uv-Fluo experiments. This Uc-Ut equilibrium doesn't seem to be dependent on
temperature in the considered range, with a trans conformation being more stable in
unfolding conditions while a cis conformation is favoured in the native state.
The major result of this study is of course the dependence of the I+N class burst
phase on concentration and temperature. The population of the NMR-invisible state
rises both with the increase in concentration and with the decrease in temperature,
and goes from undetectable levels at very low concentration up to 40% at 15°C and
a concentration of 750µM. This is consistent with the hypothesis of NMR-invisible
folding intermediate state(s) being oligomeric. In the following, these oligomeric states
will be termed I2, while the monomeric I state will be termed I1.
10.3 The oligomeric intermediate state is in equilib-
rium with the monomeric intermediate
10.3.1 Unfolded state does not show oligomerisation
While the ﬁrst explanation that comes to mind is that the oligomeric intermediate
state is in equilibrium with the monomeric intermediate state, another hypothesis is
yet to be considered: this oligomeric state may derive from an oligomer present in
the acid-unfolded state, and fold to the native state on a path that would be strictly
parallel to that of the monomeric intermediate state.
The oligomerisation of the acid-unfolded state can not be studied using SAXS as
in chapters 11 and 12 because of interparticular eﬀects, shown in annex on ﬁgure
14.5. Therefore relaxation NMR methods (1H R1 and R2) were used to evaluate the
eﬀective local tumbling correlation time τc (see equation 7.2) of the acid-unfolded
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state at diﬀerent concentrations along the backbone of the protein. Figure 10.3 shows
that the τc of the acid-unfolded state is independent of concentration, which means
that the hypothesis of an oligomerisation of this state has to be discarded, and that
the oligomeric and monomeric intermediate states are therefore in equilibrium.
Figure 10.3: Relaxation NMR measurements for the acid-unfolded state of WT B2M,
showing that the τc is independent of concentration. For methodological description,
see 13.4.1
10.3.2 Characterization of the I1 - I2 equilibrium
Several hypotheses can be drawn on the I1 - I2 equilibrium to account for the data
obtained using real time NMR. These data can be resumed in a few points: Only
one set of peaks can be detected. The linewidth of the peaks, as measured in the
SOFAST-HMQC spectra, is similar to that of the native state. The introduction of a
longer recycling delay d1 has no inﬂuence on the intensity of the peaks of the detected
intermediate state. From these elements, three hypotheses:
 I1and I2 are in slow exchange. I1 is monomeric and NMR-visible, while I2
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is oligomeric and invisible. This means that I2 is a large oligomer, so that the
peaks are broaden by its relaxation properties due to a large tumbling correlation
time.
 I1and I2 are in fast exchange. I1 is monomeric, while I2 is a low molecular weight
oligomer. Therefore the intermediate state spectrum that we see in NMR is a
weighted average of the I1 and I2 states spectra. But both the linewidth and the
T1 relaxation parameter should be diﬀerent between this averaged intermediate
state and the native state.
 I1and I2 are in slow exchange. I1 is monomeric, while I2 is a low molecular
weight oligomer that should be NMR-visible. I1 and I2 spectra exactly overlap,
so that only one spectrum is visible. But again both the linewidth and the
T1 relaxation parameter should be diﬀerent between this averaged intermediate
state and the native state.
So based on this discussion, the most plausible explanation is that I2 is a large oligomer
in slow exchange with I1. But considering the low precision of the two criteria retained
here (linewidth of a SOFAST-HMQC spectrum and longer d1 recycling delay), the two
other hypotheses should not be discarded just yet, and further work should focus on
the size of the I2 oligomeric intermediate state. One last element on this equilibrium,
its possible timescale range has an upper limit: since I2 is fully populated on the ﬁrst
spectrum after the pH jump, the equilibrium has to be faster than the deadtime of





Biophysical methods for a
further characterization of the
oligomeric intermediate
If NMR can only provide indirect evidence of the presence of additional intermedi-
ate states, other biophysical techniques may be used for their direct characterization.
Since the invisible state that appears during the folding of B2M is an oligomer, Small
Angle X-ray Scattering (SAXS) is a technique of choice, as it allows the measurement
of the average molecular weight of the sample, as shown in section 3.5. Infrared spec-
troscopy allows the detection of the secondary structure content of a macromolecule,
whatever its size, and may as such provide useful information on the structure of the
oligomeric intermediate state. Finally, UV-ﬂuorescence spectroscopy in combination
with the use of Thioﬂavin-T would detect amyloid-like structures inside the oligomeric
state, which is relevant considering the energy landscape of B2M presented in section
6.4.
11.1 SAXS: characterizing the stoichiometry of the
oligomeric intermediate
Small angle X-ray scattering can provide precise information on the molecular weight,
radius of gyration, and if the signal is good enough, the shape, of a protein in solution.
Most common conditions for SAXS imply the use of monodisperse samples, because
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the signal being additive, the parameters obtained are the average of the parame-
ters of all the molecules inside the sample. Following a kinetic reaction, and as such
following the transformation of one molecule into another, implies working on a poly-
disperse sample. Yet, considering the folding of B2M, the average molecular weight
and radius of gyration would be valuable hints, as NMR data suggest the existence
of an oligomeric intermediate state. With a population that goes up to 40% at the
beginning of the folding, this oligomeric intermediate state(s) should be detectable
using SAXS.
11.1.1 Methods
To allow a good comparison, buﬀer conditions that were used in SAXS are the same
as those used in NMR, and experiments were made at room temperature. One SAXS
curve is obtained as the average of either 10 illuminations of 10 seconds each, or 20
illuminations of 5 seconds each. The SAXS curve of WT B2M is shown in ﬁgure 11.1.
It is a curve that is typical of a globular protein, except at the very low angles, where
the signs of an aggregation appear. Even though B2M being an amyloid forming
protein, and as such aggregation prone, it can be surprising to ﬁnd aggregates despite
the ultra-centrifugation that was used to prepare the sample, following the same
protocol as for NMR experiments. As the SAXS signal is the addition of the signals
of all the constituents of the sample, and as the larger the object, the fastest the decay
of the signal along the growth of the angle of scattering, reliable information can be
obtained on the protein that is not aggregated as long as the signal at the very low
angles is discarded.
SAXS can also be used to follow the folding of B2M. As the highest population of the
oligomeric intermediate state is reached just after the pH jump, the time between the
initiation of the folding and the beginning of the measurements, the so called dead
time, is important in this experiment. The dead time is linked to the time needed
to obtain a homogeneous mixing after the pH jump, and to the time needed to start
the measurement after that. Two experimental set-ups have been used to initiate the
folding: one using the robotised sample changer available on site (ESRF Grenoble),
the other using a by hand mixing. Using the robot has the very interesting advan-
tage to allow the security manoeuvres to be executed before the mixing is induced.
Security manoeuvres, which cannot be eliminated, include closing the sample holder,
making a security search inside the experimental hutch, and closing the experimental
hutch. To be able to avoid this, or at least to make it before starting the folding,
can help reducing the dead time. Yet, despite this advantage and the upgrades in
the experimental set-up that induced a greatly improved dead time, by-hand mixing
was favored, as the robot was not able to successfully and homogeneously mix the
Urea-dissolved unfolded protein and the folding buﬀer, probably due to the viscosity
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of the samples. By-hand mixing lead to a dead time of about 50 seconds before the
beginning of the ﬁrst exposure to X-rays.
Once the folding is initiated and the measurements are started, the time resolution
is also limited. First because a standard SAXS curve is acquired in 100 seconds,
but also, to avoid radiation degradation of the protein, a new sample must be used
for each data point along the folding, consisting of 30µL of protein. The amount of
protein available being limited, the number of points along the folding, and the time
at which the measurements are made, have to be carefully chosen.
11.1.2 Discarding the signal corresponding to the large aggre-
gates
The ability to discard the signal corresponding to the very low scattering angles
depends on two conditions. First the population of aggregates must be constant,
otherwise the phenomenon observed during the SAXS experiment is not the folding,
but the dissociation of the aggregates, or a combination of both. Second condition is
that there must be no interaction between the monomers and the aggregates, because
for example if the size of the aggregates changes, the relative signals of the aggregates
and of the lower molecular weight species will change, making the SAXS data on
folding unusable. To examine whether these two conditions are veriﬁed, the folding
was studied using negative staining electron microscopy. The experiment was made
at room temperature. Three measures were made: just after, 15 minutes after, and
3 hours after the initiation of the folding. Buﬀer conditions are the same as in SAXS
and NMR (HEPES buﬀer). Electron microscopy demands concentration conditions
that are diﬀerent from those used in SAXS and NMR: a maximum of 50 µg/mL, circa
4µM for B2M.
In order to be in conditions that are as close as possible to those previously used,
the folding was made at 750µM, and samples were taken for measurement at deﬁned
times after the pH jump, diluted 200fold, and dried during the negative staining pro-
cedure. The process of dilution and drying takes about 30 seconds, which means
that oligomeric states would have evolved to monomeric states. Figure 7.9 display
representative pictures of the three samples. It shows that aggregates are present,
with a diameter of about 20nm. The population and size of these aggregates seems
to be constant, even though electron microscopy is not a precise method for quanti-
tative evaluations, and the evaluated size may be diﬀerent to that present in solution
during folding experiments, due to the 30 seconds evolution time in a diluted envi-
ronment. In conclusion, discarding the signal corresponding to these aggregates in
SAXS seems robust. Another remark is that ﬁltration would not help getting rid of
these aggregates, as they are too small.
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11.1.3 Assessing SAXS precision using in-equilibrium mea-
surements
Guinier analysis, as explained in section 3.5, can be performed on the SAXS curve
of WT B2M and gives an extrapolation of the forward scattering intensity and an
estimation of the average radius of gyration of the protein. The forward scattering
intensity is directly proportional to the concentration and the molecular weight of
the protein in solution. The molecular weight can be calculated by comparison to a
standard of known molecular weight (BSA), using the concentrations of the sample
and the standard measured with a UV spectrophotometer equipped with a nanodrop
device. Results are shown in table 11.1. Measured average molecular weight of the
sample is 11.8kDa, radius of gyration (of the protein and its hydration shell) 20.1Å,
with robust statistics. Theoretical values are 11.73kDa and 19.06 Angstroms, as
calculated using Protparam and Crysol. These equilibrium values are close to the
theoretical ones.
I0 Rg(A˚) Fidel. ﬁrst point used last point used Mw(kDa)
WT B2M 2,09 20,1 0,98 43 77 11,8
BSA 11,75 30,7 0,91 39 81 66,42
Table 11.1: Guinier analysis of WT B2M in equilibrium
But the calculation of the molecular weight is based on two values, one, the concen-
tration measurement, which takes into account the proteins that are in the ∼ 20 nm
diameter aggregates, the other, the forward scattering intensity, which doesn't. This
leads to an underestimation of the average molecular weight in the sample. As such,
the higher than expected molecular weight and radius of gyration may be revealing
the existence of a native oligomeric state.
11.1.4 Folding of B2M: two oligomeric states?
As seen in section 11.1.1, the number of measurements during the folding is limited,
but carefully chosen, should allow a good evaluation of the phenomena at stake.
Figure 11.2 shows the overlay of SAXS curves obtained at diﬀerent moments during
the folding.
As explained above, the ﬁrst points, at low angles, shown on ﬁgure 11.2, have to
be discarded to take into account the aggregation. Visually, the forward scattering is
decreasing along the folding, as shown by the evolution of the intensity of the signal at
lower angles. There is no more evolution after 60 minutes of folding. As the forward
scattering intensity is directly related to the average molecular weight, this proves
that average molecular weight decreases during the folding of B2M, conﬁrming the
existence of an oligomeric folding intermediate state.
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Figure 11.1: SAXS curve of WT B2M. SAXS curve is obtained as the average of
10 illuminations of 10 seconds each, and subtraction of the solvent diﬀraction curve,





















Figure 11.2: SAXS curves evolution, WT B2M, during folding. SAXS curve are
obtained as the average of 20 illuminations of 5 seconds each, and subtraction of

























Figure 11.3: First (a) and second (b) batch of 20 illuminations obtained during the
folding of WT B2M
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If standard SAXS curves consist of the average of 10 to 20 illuminations, those il-
luminations can be considered individually, giving additional time resolution at the
expense of the signal to noise ratio. Figure 11.3 displays the 20 illuminations obtained
just after the pH jump and the 20 illuminations obtained at t=400s. It is clear that
the forward scattering intensity, and thus the average molecular weight, is already
decreasing from the beginning of the folding, the ﬁrst and second SAXS curve of
ﬁgure 11.2 being the average of these evolutions. Table 11.2 displays the result of
the Guinier analysis made on the SAXS curves obtained along the folding, ﬁgure 11.4
shows the decay of I(0) and the average molecular weight.
Time (s) I0 Rg(A˚) Fidel. ﬁrst point used last point used
100 3,03 23,9 0,99 63 84
360 2,46 22,8 0,993 42 71
860 2,3 22 0,99 41 68
2000 2,18 21,2 0,994 46 73
3600 2,1 20,6 0,942 47 72
7200 2,08 19,9 0,959 47 82
10800 2,09 20,1 0,99 47 74
Table 11.2: Guinier analysis along the folding of WT B2M
First observation is that a bi-exponential function is necessary to correctly ﬁt the
evolution of the forward scattering intensity. The two rates obtained are 6.8.10−3
s−1 and 7.3.10−4 s−1. The slow phase of the folding clearly corresponds to what is
observed in NMR under similar conditions, while the fast phase is not observed in
NMR. This new phase shows the existence of another oligomeric intermediate state,
termed I3. NMR data gives access to the population of the oligomeric intermediate
state during the folding. The monomeric intermediate state has the same theoretical
molecular weight as the native state monomer, and both populations are also known
from NMR data. From these populations and the theoretical molecular weight of the
monomer (11.73kDa), the average molecular weight of the oligomeric population at
a given time t of the folding can be calculated using equation (11.1), derived from






w (t)−Mmonow ∗ xmono(t)
1− xmono(t) (11.1)
From 6 minutes to 35 minutes after the pH jump, which is the time range in which the
fast-phase oligomer I3 has disappeared and the oligomeric intermediate state I2 is still
signiﬁcantly populated, the average molecular weight of the oligomeric population is
20kDa. Considering the underestimation of the molecular weights due to the presence
of aggregates in the sample, and concentration imprecision, the low molecular weight
oligomer corresponding to the slow-phase folding I2 seems to be a dimer.
This experiment was repeated with a lower protein concentration (200µM ﬁnal) as
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Figure 11.4: Evolutions (black triangles or orange diamonds) and ﬁts (solid line, red or
orange) of I(0) along the folding of B2M at a concentration of 750µM (a) and 200µM
(b). On (a), + correspond to the values obtained from individual illuminations. The
right y axis gives the average molecular weight corresponding to the I(0) value on the








100 3,03 17,1 0,75 33,0
360 2,46 13,9 0,79 22,0
860 2,3 13,0 0,86 20,2
2000 2,18 12,3 0,94 20,3
3600 2,1 11,9 0,98 -
7200 2,08 11,8 1 -
10800 2,09 11,8 1 -
Table 11.3: Average molecular weight of the oligomeric fraction. Monomeric fraction
is the I+N fraction measured in NMR at T=20°C.
shown on ﬁgure 11.4. First remark is that the average molecular weight of the sample
during the folding is lower than at high concentration. This means either that the
stoichiometries of the oligomeric species are lower or that they are less populated.
NMR data, along with common thermodynamic considerations, suggests that indeed
the population of oligomeric species decreases with concentration. If the population
measured in NMR at 200µM is taken into account, between 6 and 35 minutes, the
molecular weight is of 20kDa, the same as at high concentration, consistent with the
low molecular weight oligomer I2 being a dimer.
Second remark is that the folding fast phase is also less important than at high con-
centration, leading to the same hypothesis as for the lower molecular weight oligomer,
either a lower stoichiometry or population. As for the high concentration experiment,
no insights on the population of this state can be obtained from the NMR data, it
is therefore diﬃcult to evaluate the molecular weight of this oligomer. But since it
seems to be undetectable in NMR, the population is likely to be small compared to
that of the lower molecular weight oligomer. To have such a visible impact in SAXS,
I3 is therefore probably much bigger than a dimer.
11.2 Infrared Spectroscopy
As shown in section 3.4, Attenuated total reﬂectance (ATR) fourier-transform infrared
spectroscopy (ft-IR) can be used to detect secondary structures, especially when con-
sidering the Amide I absorption band. This technique may yield information on the
secondary structure of the intermediate states.
The ATR ft-IR spectrometer requires the deposition of a drop of the liquid sample
on its germanium crystal, which implies the use of 10µL for each measurement, to
avoid a bias due to the drying of the drop. In these ATR ft-IR experiments, folding
is initiated using by-hand mixing, and the deposition of the sample drop inside the
spectrometer implies a dead time of about 30 seconds. Thanks to the properties of
ATR spectrometers, buﬀers that are not deuterated can be used, oﬀering the possi-
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bility to use the same buﬀers as in other experiments. These experiments were lead





















Figure 11.5: Evolution of the infrared spectrum of B2M along the folding. Spectra
are obtained using ATR ft-IR. The folding is initiated in a reactor, and samples
are analyzed along the folding. Experiments were lead at room temperature, and a
concentration of 750µM ﬁnal.
The IR signal corresponding to the amide I band is plotted on ﬁgure 11.5, along with
its evolution during the folding. As stated in section 3.4, the amide I band can be used
to estimate the secondary structure content of a protein, or its changes along time.
Since it is composed of the vibration of all the C=O groups of the backbone of the
protein, the obtained information is rather a global trend than a precise structural
information. Here, along the folding, intensity is increasing in two bands, around
1620cm-1 and 1675cm-1, which are speciﬁc of beta sheets, and decreasing around
1640cm-1, which can be speciﬁc of either unstructured regions or alpha helices. Since
the context of the observation is the folding of B2M, this should be interpreted as
the disappearance of unstructured regions, along with an increase in the beta sheet
content. This means that the main event observed in infrared spectroscopy is the
transition between the monomeric intermediate state and the native state, and not
the interconversion between the monomeric and the oligomeric intermediates. This is
not such a surprise, for two reasons. First, the population change between I1 and I2
represents only about 20% of the total signal at this temperature and concentration,
while the population change between I1 and the native state represents about 70%.
The disappearance of intermolecular beta sheets with the disappearance of the I2
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state is therefore compensated by the folding to the native state, with the formation
of intramolecular beta sheets.
The use of a single set of experimental conditions does not allow to conclude on the
existence or absence of intermolecular beta sheets at the beginning of the folding,
because undistinguishable intramolecular beta sheets form at the same time. But if
concentration could be lowered, as much as I2 would only be negligibly populated,
the relative change in the beta sheet content would be increased, proving the com-
pensation at high concentration by the disappearance of intermolecular beta sheets.
Yet at 9mg/mL, we are already at the limit of detection of the spectrometer that was
used, which means that further work of optimisation of the experimental conditions
would be necessary to obtain that kind of information.
11.3 UV-ﬂuorescence spectroscopy with the use of
Thioﬂavin-T
As seen in section 3.2, Thioﬂavin-T is a ﬂuorescent reagent speciﬁc of amyloid struc-
tures, binding inside long stabilized beta-sheets. It does not require the formation of
full-length ﬁbrils, but also binds to large oligomers that have an amyloid-like struc-
ture. Following the folding of B2M in presence of Thioﬂavin-T may be a way to
characterize the oligomeric intermediate states.
The experiment was made using a signal stabilized through the measurement of the
variations of the incident beam. The experiment was run at room temperature. Buﬀer
conditions are similar to those used in SAXS or IR, and the ﬁnal concentration is also
750µM. Thioﬂavin-T is mixed in the refolding buﬀer, which is added to the unfolded
protein to induce the pH jump. The deadtime corresponds to the time needed to mix
the refolding buﬀer and the unfolded protein inside the measurement cell, to put this














Figure 11.6: Folding followed with UV ﬂuorescence, in presence of Thioﬂavin-T
(black), and corresponding ﬁt (red)
Results (ﬁgure 11.6) show a decrease of the Thioﬂavin-T ﬂuorescence at the very
beginning of the folding with a kinetic rate of 5.6.10−3 s−1, and for the rest of the
folding, a constant signal. This means that Thioﬂavin-T binds one of the intermediate
states, which disappears within 5 minutes. It corresponds to the higher molecular
weight oligomeric intermediate state I3 detected in SAXS, which decays with a rate
constant of the same order of magnitude.
In conclusion, following the folding of B2M in presence of Thioﬂavin-T allows us to
further characterize the oligomeric intermediate states. Indeed, at least two states,
or ensemble of states, can be distinguished. One is a long-lived, low molecular weight
intermediate state, that does not bind Thioﬂavin-T, either because is does not adopt
an amyloid like structure, or because of its too low molecular weight, termed I2.
The other is a short-lived, higher molecular weight intermediate state, which binds
Thioﬂavin-T, and as such adopts an amyloid like structure, termed I3.
11.4 Back to NMR, detection of a short lived inter-
mediate state
A full investigation of the NMR spectra acquired during the folding of B2M, based on
the ﬁndings in SAXS and UV-ﬂuorescence, reveals the existence of three 1H −15 N
correlation peaks that disappear a few minutes after the pH jump, as shown on ﬁgure
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11.7 and 11.8. This ﬁnding is consistent with the hypothesis of a short lived inter-
mediate state, as seen in SAXS and UV-ﬂuorescence. These peaks may correspond
to a ﬂexible part of the protein (the C-terminus for example) in the oligomeric state,
allowing their detection while the rest of the protein remains NMR-invisible due to
the slow tumbling of these oligomers in solution.
Figure 11.7: Spectra of WT B2M just after the pH jump and 200 seconds later,
obtained using FTA-SOFAST. Diﬀerent classes of peaks are highlighted: I1 in green,
N in dark blue, I3 in light blue, I +N in red, showing the existence of a species that
disappears within a few minutes.
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Figure 11.8: Evolution of the volume (normalized to ﬁtted initial value) of the peaks
attributed to I3 during the folding of WT B2M
11.5 Conclusions
From NMR data, the NMR-invisible state I2 could be assigned to an oligomeric state.
From the SAXS and UV-ﬂuorescence data, this oligomeric state has to be split into
two states, one long lived low molecular weight oligomer, probably a dimer which will
still be named I2, or ensemble of long lived low molecular weight oligomers, and a
short lived higher molecular weight oligomer or ensemble of oligomers, I3.
Clearly the size of the higher molecular weight oligomer(s) I3 explains its almost
NMR-invisibility. But a dimer, or an ensemble of low molecular weight oligomers
(dimer, trimer, tetramer) should be visible on the NMR spectra. These oligomeric
states I2 are in equilibrium with I1. Three hypotheses were drawn in chapter 10.3.2
to account for the data:
 I1and I2 are in slow exchange. I1 is monomeric and NMR-visible, while I2
is oligomeric and invisible. This means that I2 is a large oligomer, so that the
peaks are broaden by its relaxation properties due to a large tumbling correlation
time.
 I1and I2 are in fast exchange. I1 is monomeric, while I2 is a low molecular weight
oligomer. Therefore the intermediate state spectrum that we see in NMR is a
weighted average of the I1 and I2 states spectra. But both the linewidth and the
120
T1 relaxation parameter should be diﬀerent between this averaged intermediate
state and the native state.
 I1and I2 are in slow exchange. I1 is monomeric, while I2 is a low molecular
weight oligomer that should be NMR-visible. I1 and I2 spectra exactly overlap,
so that only one spectrum is visible. But again both the linewidth and the
T1 relaxation parameter should be diﬀerent between this averaged intermediate
state and the native state.
From the SAXS data, and the fact that I2 is probably a dimer, the ﬁrst hypothesis
has to be discarded. This means that the criteria of the linewidth comparison with
the N state and the longer recycling delay experiment are not precise enough to give
reliable information on the equilibrium. The two remaining hypotheses can not be
discriminated based on the data available, therefore further work of characterization
is to be done, using for example spin relaxation measurements in real time NMR.
The use of SAXS, NMR and UV-ﬂuo as complementary methods provides consistent
data, allowing a ﬁne characterization of the B2M folding process. A large amyloid-
like oligomeric state is lowly populated at the very beginning of the folding, while a
long-lived low molecular weight oligomer is present in important proportions until the
protein is properly folded. This discovery sheds a new light on the folding of B2M,
providing bridges between the folding and the aggregation processes. The oligomeric
states transiently populated during folding maybe the same as the intermediate states
on the pathway to the formation of amyloid ﬁbrils. Putative folding model is shown
on ﬁgure 11.9, where the involvement of I3 remains unclear.
The folding data, both NMR and SAXS, can be ﬁtted altogether using this model,
as shown in ﬁgure 11.10, with good agreement, parameters being used for the ﬁt are
the equilibrium constant between I1 and I2, the isomerization rate of the Proline
32, and the initial populations of N at the diﬀerent concentrations. Obtained values
are similar to those previously observed: 8.2.10−4s−1 for the isomerization rate, and
around 10% for the N-state burst phases respectively. One new element from this
global ﬁt is the equilibrium constant of the I1 − I2 equilibrium: KI1−I2 = 552. Of
course the ﬁt is not perfect: for example at 750µM, the I1 to N conversion seems to
be faster than what is expected using the model. This can be explained: the model
used implies that the I1 to N conversion rate is proportional to the initial population
of I1, which depends on the concentration. Since such a dependence is not observed
in the NMR data, the folding mechanism is probably more complex than this model,
maybe with a dimeric native state in equilibrium with the monomeric native state,
and a new parallel folding pathway from I2 to this N2 state.
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Figure 11.9: Putative model for the folding of B2M. The location of I3 in this mech-
anism is still unknown.
122
(a) C=0.05mM (b) C=0.15mM
(c) C=0.188mM (d) C=0.375mM
(e) C=0.750mM (f) C=0.200mM
(g) C=0.750mM
Figure 11.10: Experimental data of the folding of B2M at 20°C ﬁtted using the model
presented on ﬁgure 11.9, with NMR data (a)-(e) (the N class in green, I class in blue,
I+N class in red, intensities of peaks summed inside each class, and normalize to
initial or ﬁnal value) and SAXS data (f) and (g). Fits are represented by solid lines.
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Chapter 12
Single point mutants as
in-equilibrium models?
Creating protein mutants as in-equilibrium models of short-lived states of that protein
is a method of choice in structural and functional biology. This method has been
applied to B2M, as was seen in chapter 5, for example with the use of the P32A B2M
mutant. P32A has as main characteristic a trans peptide bond between residues 31
and 32, and as such is presented as mimicking the trans conformation of the proline
32 either during folding or amyloid ﬁbril formation. Data obtained on It oﬀers the
possibility to test the capacity of P32A to be a good in-equilibrium model for this
transient state. Does it populate oligomeric states, with both low and higher molecular
weight? Are the characteristics of the equilibrium between these states, if they can
be detected, similar to those observed for It, ie model the I1-I2 equilibrium and the
presence of I3?
Another single point mutant that may be used as a model is W60G. It has been shown
to be less aggregation-prone (section 5.2) both in equilibrium and during folding, and
to have a simpler folding mechanism (section 8.3). It may be an in-equilibrium model
of a purely monomeric B2M native state.
As shown on ﬁgure 12.1, the NMR spectra of P32A and W60G are very similar to
those of the WT I state and N state, respectively. This is a ﬁrst footprint validation





Figure 12.1: Spectral comparison of W60G (red) and the N state of the WT protein
(black) (a) and of P32A (red) and the I state of the WT protein (black) (b). In
(b), the diﬀerent linewidth in the indirect dimension is due to diﬀerent experimental
setups.
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12.1 Evaluating the average molecular weight using
SAXS
12.1.1 Comparison of the in equilibrium SAXS curves of WT,
W60G and P32A B2M
As seen in section 3.5, SAXS can be used to measure the average molecular weight in
a sample. If oligomers are present, the average molecular weight will be higher than
that of the monomer. Figure 12.2 displays the SAXS curves of WT B2M and the two
mutants P32A and W60G.
















Figure 12.2: SAXS curve of P32A 5.36mg/mL (blue), WT 6.75mg/mL (red), W60G
6.35mg/mL (black), obtained using the average of 10 illuminations of 10 seconds each.
It is evident from this data that the average molecular weight of P32A is higher
than that of WT, that is higher than that of W60G (see also table 12.1). This
means that the oligomeric fraction of P32A is much higher than the other two species,
but also that the WT B2M is not monomeric in these conditions. With an average
molecular weight lower than that of the WT protein, W60G appears as a model for a
monomeric state of B2M. The fact that the measured molecular weight is lower than
the theoretical one is due to the presence of large aggregates in solution, leading to
an under estimation of the measured molecular weight. This data for the WT B2M is
consistent with the existence of an oligomeric native state in equilibrium conditions.
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Concentration (mg/mL) Io Rg (Å) Average Molecular Weight (kDa)
P32A 5,36 2,83 23,3 20,1
WT 6,75 2,09 20,1 11,8
W60G 6,35 1,78 19,4 10,06
Table 12.1: Guinier analysis of P32A, WT and W60G B2M in equilibrium
12.1.2 Further characterization of the oligomerization of P32A
As seen before, the average molecular weight of P32A in equilibrium is 20.1 kDa at
400µM, clearly higher than that of WT B2M (12kDa). This means that in equilibrium
P32A populates oligomeric states, just as WT B2M does during folding. This does
not give insights on the stoichiometry of this oligomeric state, or even if several
oligomeric states are populated. Equation (12.3) shows that, in the case of a two state
equilibrium (12.1), the stoichiometry can be linked to the variation of the population
of the oligomeric state and the variation in the normalized forward scattering intensity.
Practically, considering the extrapolation to inﬁnite dilution, where the population
of the oligomer is zero, and the average molecular weight is the molecular weight of



































= 1− n (12.5)
Based on this, the SAXS curves of successive dilutions of P32A (ﬁgure 12.3) can be
used to extrapolate the molecular weight of ideal monomeric P32A, and as such the
fractions of oligomers that would be needed to assess for the SAXS data. This is
still not suﬃcient to deﬁnitely characterize the stoichiometry. Equation 12.5 can be
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used to calculate the stoichiometry n in function of the oligomeric fraction at a given
concentration, with αIo obtained from the linear regression shown on ﬁgure 12.4. As
shown on ﬁgure 12.5, if P32A oligomeric fraction is similar to that observed during
the folding, then it is likely to populate a range of oligomers going from dimers to
tetramers.


















Figure 12.3: SAXS curves of successive dilutions of P32A, obtained using the average
of 10 illuminations of 10 seconds each.
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Figure 12.4: Variation of the normalized forward scattering intensity against the




















Figure 12.5: Calculated stoichiometry of the oligomeric state of P32A in function of
the oligomeric fraction at a total P32A concentration of 6.5mg/mL
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Figure 12.6: Singular Value Decomposition of the dilution of P32A, as calculated
using the SVD-plot utility of the PRIMUS software.
In order to check the two-state model hypothesis, singular value decomposition can
be performed on the dilution data. Singular value decomposition is a statistical tool
that can detect the minimal number of components (eigenvectors) that are needed
to assess for the global signal of a mixture, here the number of states populated by
P32A. The eigenvectors corresponding to the dilution data are displayed on ﬁgure
12.6. Even though eigenvectors from the third from the top (pink trace and below)
seem to contain essentially noise components, the statistics given by the singular
value decomposition state that four states are populated, one monomeric, and three
oligomeric. From this statistical analysis, P32A seems to be populating an ensemble
of small oligomers, from dimer to tetramer.
But again, if P32A populates a dimeric state in equilibrium, shouldn't it be visible
in NMR? If the dimeric and monomeric states are in slow exchange, hypotheses to
explain this invisibility are either that the dimer is highly dynamic, or that it is itself
in fast exchange with the higher molecular weights oligomers: trimer and tetramer.
If the two states are in fast exchange, then the peaks that appear on the spectrum
are the weighted average of those of the two states. In that case of fast exchange, the
oligomerization of P32A should be detectable also using NMR relaxation measurement
experiments.
12.2 NMR 15N relaxation experiments
15N relaxation experiments consist in the measurement of the T 1 (longitudinal) and
T 2 (transverse) relaxation times of all amide nuclei along the protein backbone.
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T 1 and T 2 measurements along the sequence of P32A are shown on ﬁgure 12.7. The
T 1/T 2 ratio, linked to the τc of the protein by equation 7.2 where νN is the resonance
frequency of Nitrogen at the considered magnetic ﬁeld, is shown on ﬁgure 12.8. It can
be compared to the T 1/T 2 ratio of another mutant of B2M, W60G (also on ﬁgure
12.8), that is considered a monomeric state model of the protein. The T 1/T 2 ratio of
P32A is signiﬁcantly higher than those of W60G, consistent with P32A populating a
higher τc state, in this case an oligomeric state. Equation 12.6 shows the correlation
for monomeric proteins between the τc and the molecular weight [141].
τc(ns) ≈ 0.6MW (kDa) (12.6)
131









Figure 12.7: 15N T 1 and T 2 (in seconds) of P32A at 750µM with error bars, versus
arbitrary residue numbers
The oligomerization of P32A can further be characterized using the same experimental
set-up as in SAXS: dilution. Figure 12.8 shows the T 1/T 2 ratios of P32A and W60G
at 750µM and 180µM. While the T 1/T 2 ratios of W60G are mostly insensitive to
dilution, P32A displays a sharp decrease of its T 1/T 2 ratios, and consequently its τc,
to reach at low concentration values equivalent to those of W60G. P32A is close to
monomeric at a concentration of 180µM.
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Figure 12.8: 15N T 1/T 2 ratios of P32A and W60G at 750µM (black) and 180µM
(red), against arbitrary residue numbers.
12.3 Conclusions
To sum up the ﬁndings of this chapter,
 W60G is a good in-equilibrium model of the monomeric native state of B2M
W60G has a lower average molecular weight than the WT protein, in equilibrium, as
seen in SAXS, which means that W60G is less prone to populate oligomeric states
under these conditions. As shown by relaxation NMR, W60G is almost insensitive
to dilution, which implies that oligomeric states are not populated in equilibrium,
even at high concentrations. From those two results, W60G can be considered as a
monomeric model of B2M native state.
 P32A may be an in-equilibrium model of the I1-I2 equilibrium
P32A has a NMR spectrum that is very similar to that of I1-I2, forms low molecular
weight oligomers, probably a ladder from dimer to tetramer. These are characteristics
that are common to P32A and I1-I2. But on the other hand, P32A doesn't form higher
molecular weight oligomers, like I3. Relaxation results would have to be compared to








Structural characterization of proteins using NMR is highly demanding in experi-
mental time. To assign a protein, and link the data to speciﬁc residues, a set of 3D
experiments are needed, corresponding usually to a few hours of measurement time for
each spectrum. Structural data also demands long experimental times, for example
when using 1H −1 H NOE or residual dipolar couplings (RDC).
That kind of standard strategies to obtain structural data is not suited for the study
of short-lived species such as folding intermediates. Therefore we have developed
a two step strategy: ﬁrst optimizing the signal to noise ratio that can be obtained
during the lifetime of the sample, either by increasing this lifetime, or by optimizing
the experimental conditions; second using techniques that are less experimental time
demanding. This part shows this two step strategy and draws perspectives on the
development of methods for the fast acquisition of structural data.
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Chapter 13
B2M W60G as a test case
13.1 Cumulative discrete data acquisition vs contin-
uous data acquisition
When studying the kinetics of the folding of B2M, the balance has to be made between
time resolution and signal to noise ratio. As peaks are classiﬁed in classes, in which
the signal is summed, the signal to noise ratio needed is lower than if we were studying
individual peaks. This is why the experimental time required for the acquisition of
one spectrum could be reduced to about 15 seconds.
But obtaining residue resolved structural information demands the use of experimen-
tal time consuming 3D NMR methods, of the order of hours. A clear diﬃculty when
the subject of study is a transient, short-lived state. A ﬁrst step is therefore to op-
timize the signal that can be obtained during the lifetime of the protein state. For
B2M, the intermediate state has a lifetime of about half an hour at 15°C.
A single standard 3D experiment run during the whole lifetime of the intermediate
would be an experiment during which the sample is evolving, with population decreas-
ing for the intermediate state, which would imply line broadening. Two solutions can
be considered to assess for this line broadening, either accumulating successive acqui-
sitions, or using apodization to correct for a continuous acquisition.
13.1.1 Cumulative discrete data acquisition
The idea is to run an experiment on a time frame during which the sample can
be considered unchanged, ie small compared to the timescale of the folding. The
experiment can then be repeated over successive time frames, and the signal summed
to obtain one higher signal to noise ratio spectrum. This is the approach that has
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been used in the previous paragraphs of our study. For the reconstruction of pure
I-state NMR spectra, two points need further consideration.
First, after a certain point in the folding, the population of the intermediate state
is so low that adding more NMR spectra would only result in the addition of noise,
and as such a reduction of the overal signal to noise ratio. As shown on ﬁgure 13.1,
after 25 minutes, the addition of more spectra implies a decrease of the signal to noise
ratio of intermediate state peaks, so this limit can be considered the NMR eﬀective
lifetime of this state under a given set of experimental conditions.













Figure 13.1: Average Signal to Noise ratio of the reconstructed I-state spectrum along
the summation of successive spectra during the folding of the protein (HEPES buﬀer,
750µM, 25°C)
Second is the fact that the protein molecules leaving the intermediate state do not
disappear, they fold into the native state. As was shown earlier, the spectrum of the
native state partially overlaps with that of the intermediate state. Adding the signal
from successive time frames during the folding implies that a growing signal from the
native state is added, a signal that can be monitored through the NMR signals of
speciﬁc, isolated, native state peaks. Simply adding spectra of successive time frames
does not result in an intermediate state spectrum, but in a I+N mixed spectrum.
But since there are isolated peaks speciﬁc of the native state, the amount of native
signal in this I+N spectrum can be measured. The subsequent subtraction of a highly
deﬁned native-state spectrum, normalized with the measured native signal in the I+N
spectrum, results in a spectrum of only the intermediate state, with an increase of
the signal to noise ratio by more than 3 fold with respect to a single NMR spectrum
recorded at the beginning of the folding process, as shown on ﬁgure 13.2.




Figure 13.2: First spectrum after pH jump (a) and reconstructed I state spectrum
(b), using NMR data obtained during the folding using the SOFAST pulse scheme
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or processing, yet it requires that the experimental time of one acquisition remains
small relatively to the evolution timescale of the studied phenomenon. For B2M
folding, this allows the use of fast pulsing 2D methods (such as SOFAST or BEST).
13.1.2 Continuous data acquisition
During the acquisition of the real-time spectrum, the I-state converts into the N-
state, therefore the resonances of both the I- and the N- states are sampled. The
reconstruction of the I-state spectrum is obtained by a proper combination of the
real-time spectrum and the steady-state spectrum. It is important to keep in mind
that in the real-time spectrum, the three dimensions diﬀer by the times eﬀectively
needed for the frequency sampling (Δtreal : time separating two consecutive sampling
points):
 for the 1st dimension, that corresponds to direct 1H frequency sampling, consec-
utive sampling points are separated by the NMR dwell time, and the sampling
is completed within 50 to 100 ms;
 for the 2nd dimension, i.e. indirect sampling of the ﬁrst heteronuclear dimension
(either 13C or 15N) in the inner loop, the separation of two sampling points
corresponds to the time required to record a 1D spectrum (including phase
cycling), typically 200  500 ms using BEST-TROSY techniques, yielding a
eﬀective acquisition time along this dimension on the order of less than 1 minute;
 for the 3rd dimension, i.e. indirect sampling of the second heteronuclear dimen-
sion (either 13C or 15N) in the outer loop, the eﬀective acquisition time is equal
to the full duration of the experiment, i.e. around 40 minutes.
The diﬀerence in eﬀective sampling times implies that the eﬀect of the folding kinetics
on the peak shapes can be safely neglected during both t1 and t2, while it will surely
aﬀect the t3 dimension. Hence, because of the convolution with the respective kinetic
folding proﬁles in the third spectral dimension, N-state resonances appear as narrow
lines surrounded by negative tails, while I-state resonances appear as broadened lines.
The reconstruction of the pure I-state spectrum implies the removal of the N-state
contribution to the real time spectrum, taking into account this modiﬁcation of the
line shape of the peaks. This is done considering the kinteic evolution of the native
state as an apodization function, as explained below. Line broadening for the I-state
resonances can be reduced using experimental hints. First, theory shows that the line
broadening induced on 13C resonances is more important than for the 15N resonances
recorded in constant-time mode, therefore 13C is sampled using the second dimension
(t2). Second, a constant time scheme can be used to further reduce the line broadening
of the 15N resonances. These two experimental methods show suﬃcient eﬃciency to
proceed with the diﬀerent analyses shown in sections 13.2 and following.
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Method summary: First a 3D spectrum is recorded during the refolding process
(the real-time spectrum). The experimental time of this 3D data acquisition has to
match the lifetime of the I-state; in other words, the acquisition should stop once the
intensity of the I-state signals reaches the noise level. To remove the contribution of
the N-state resonances to the real-time spectrum, a second 3D spectrum is acquired
under steady-state conditions (steady-state spectrum), i.e. immediately after the end
of the folding process. This data set is typically acquired over a much longer time
period in order to increase the signal-to-noise ratio (S/N). During data processing, an
apodization function, corresponding to the folding kinetics of the N-state, is applied
to the steady-state, pure N-state spectrum. Finally, a pure I-state spectrum, devoid of
any N-state contributions, is obtained as the diﬀerence between the real-time and the
apodized steady-state spectra. Kinetics-induced line broadening in the I-state spectra
can be limited by choosing short scan times and long maximal evolution times in the
last incremented dimension.
13.2 Assigning a transient state
13.2.1 Projected 3D HNCO experiment
The HNCO has been chosen as the ﬁrst 3D experiment to be tested because it is
the most sensitive of the common assignment experiments. Since a standard HNCO
requires at least one hour of experimental time, the standard scheme cannot be used
to study the intermediate state of B2M. several strategies have been developed over
the years to make the acquisition of 3D spectra faster, such as spectral aliasing or
data sampling.
As seen in section 7.3, projection NMR allows the acquisition of the information
contained in a 3D experiment using a much less time consuming set of 2D experiments,
each of which being performed within a few minutes. This allows the repetition of
the acquisition along the folding, through a cumulative discrete acquisition scheme,
as described in section 13.1.1.
A projection scheme using three projection angles was used to assess for the 3D HNCO
experiment: +pi/4, −pi/4, 0. The 0 angle corresponds to a standard 2D-HN experiment.
Following the general theory exposed in aforementioned section, on projection planes
+pi/4, -pi/4 and 0 the observed indirect chemical shift is given by equation (13.1). This
shows clearly the easy analysis based on a central peak (0) and two symmetrical peaks
(+pi/4,-pi/4) that contain the CO chemical shift information.

w+pi/4 = wN + wCO




But as seen on ﬁgure 13.3, instead of the detection of most of the CO groups of the
protein, the signal to noise ratio allows the detection of only a few peaks. Since the
HNCO experiment is the most sensitive of the experiments used to assign a protein,
the assignment of B2M's intermediate through projected HNCA or HNCB is out of
reach using this cumulative technique.
13.2.2 Continuous HNCO and HNCA
The strategy outlined in section 13.1.2 was ﬁrst applied to HNCO, the most sensi-
tive 3D triple-resonance experiment. At high magnetic ﬁeld strengths (≥800 MHz),
BEST-TROSY generally outperforms BEST-HSQC in terms of sensitivity and spec-
tral resolution[60]. The 15N=13CO projections of the real-time, N-state, and recon-
structed I-state 3D BT-HNCO spectra recorded at 800 MHz 1H frequency are shown
in Figure 13.4(b). The quality of these HNCO data was suﬃcient to detect a similar
number of correlation peaks (71) as observed in the I-state 1H=15N SOFAST-HMQC
spectrum (Figure 13.5). The next step was to record a BT-HNCA spectrum required
for sequential NMR assignment. This experiment was performed at a magnetic ﬁeld
strength of 1000 MHz in order to further boost the experimental sensitivity. An aver-
age SNR increase of ∼ 50% was observed for BT-HNCA when comparing steadystate
data recorded at 800 and 1000 MHz (Figure S2).
The HNCA data (Figure 13.7) allowed unambiguous sequential assignment of 63 H=N
moieties out of the 95 non-proline B2M residues. This corresponds to the majority of
correlation peaks detected in the 1H=15N correlation spectrum (Figure 13.5). Inter-
estingly, the peptide regions encompassing Met1-Lys6, Val27-Glu36, Ser53-Lys58, and
Phe62-Leu65 could not be assigned, because they did not give rise to detectable NMR
signals in the 3D spectra, most likely due to extensive line broadening as shown in
section 13.3.
13.3 Chemical shift analysis
The chemical shift dispersion observed in the 1H=15N correlation spectrum of the I-
state (Figure 13.5) provides a ﬁrst indication that the overall structure of this transient
state is native-like. This is further supported by the 13CO and 13CA secondary
chemical shift (SCS) data, calculated as the diﬀerence between the measured chemical
shifts and tabulated random coil values corrected for next neighbor eﬀects[149]. These
SCS data are sensitive reporters of local structure (backbone dihedral angles). In
particular, a series of consecutive negative SCS values are indicative for β-strand
structures. Comparison of measured values for the N- and I-states (Figure 13.8 (a))
shows that the location and population of β-strands in B2M is very similar in these




Figure 13.3: Projected HNCO spectra of the I-state with angle pi/4(a) and −pi/4 (b),
using the projection BEST-HNCO pulse scheme.
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Figure 13.4: Strategy used to reconstruct pure I-state 3D spectra. (a) Kinetic proﬁles
of the N- and I-states are shown during the folding of W60G-B2M, along with the
3D cubes of the acquired HNCO spectra. The red and blue dots are intensities of
resolved I- and N-state peaks measured in a series of 2D SOFAST-HMQC spectra
recorded during W60G-B2M folding. (b) Projections of the real-time (left), steadys-
tate (center), and reconstructed (right) 3D HNCO spectra of B2M. The experimental
time for the real-time 3D spectra recorded at 800 MHz for a 0.8 mM 13C,15N-labeled
W60G-B2M sample was 40 min.
143
Figure 13.5: Assigned 1H-15N SOFAST-HMQC spectra of (a) N-state and (b) I-state
of W60G. Note that some 15N resonances (Tyr26, Val93, Glu69, Asp96 and Val27,
Tyr63, Thr68, His51, Thr73, Gly18, Gly29, Phe30, Thr86, Gly43, and Gly60) appear
folded in the spectrum due to the reduced 15N spectral width used for this experiment.
All assignments were obtained from a real-time 3D BEST-HNCA spectrum, except
for Thr4 (I-state) that has been assigned in analogy to previous NMR studies using
triﬂuoroethanol (TFE) that enhances the equilibrium population of the I-state [135].
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Figure 13.6: 15N-13C projections of 3D BEST-TROSY-HNCA (steady-state) spectra
recorded at 1H frequencies of (a) 1000 MHz and (b) 800 MHz. The spectrometer
operating at 800 MHz is an Agilent instrument installed in our laboratory (IBS) in
Grenoble, while the 1000 MHz instrument is a Bruker spectrometer located at the
Centre de RMN à Très Hauts Champs in Lyon (France). The vertical dashed lines
indicate the position of the 1D slices shown at the left side of each 2D projection.
Note that the contour levels are scaled to the corresponding noise levels. By compar-
ison of the intensities of several (N-state) peaks in the two 3D spectra, an average
SNR enhancement of 50% was estimated at the higher magnetic ﬁeld strength. (c)
Normalized intensity ratios of I-state signals measured in the reconstructed HNCA
spectra recorded at 800 and 1000 MHz.
Figure 13.7: Example strip plots extracted from the reconstructed I-state spectra of
(a) 3D BT-HNCO and (b) 3D BT-HNCA recorded on a 0.8 mM 13C,15N -labeled
W60G sample at 800 MHz (HNCO) and 1 GHz (HNCA). The assignment walk for
residues Thr73-Val82 is highlighted by dotted (red) lines.
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data indicate a less pronounced population of β-strand conformation. In addition
to local secondary structural changes, 1H and 15N chemical shifts are also sensitive
to hydrogen bonding and tertiary contacts, e.g., to aromatic side chains that induce
ring-current shifts. Signiﬁcant changes (Δδ(H,N) > 1.5 ppm) in 1H, 15N chemical
shifts between the N- and I-states are found for residues Gln8, Val9, Ser11, Leu39,
Val49, Glu50, Asp59, Ser61, Asn83-Val85, and Leu87 (Figure 13.8(b)), i.e. generally
neighboring unassigned (and undetected) regions of the protein in the Istate. A plot
of the observed chemical shift deviations and the NMR-invisible protein regions on the
3D cartoon structure of B2M (Figure 13.8(c)) points out that structural diﬀerences
between the I- and N-states exist in the apical region close to Pro32, with a particularly
strong eﬀect in the second half of the β-sandwich (A, B, D, E), while strands F and
G are less aﬀected.
Figure 13.8: (a) Secondary 13C chemical shifts (ΔδCO + ΔδCA) measured for the
N-state (open bars) and I-state (ﬁlled red bars) of W60G-B2M. The 1H, 15N chemical
shift diﬀerence ΔδHN = [(10ΔδH)2 + ΔδN2]0.5 between I and N is plotted in (b)
as a function of sequence and in (c) on the cartoon structure of B2M. NMR-invisible
I-state regions are indicated by cyan bars in (a) and (b), and dark blue bars in (c)
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13.4 Relaxation measurements in the I state
13.4.1 R2-BEST-TROSY for relaxation measurements
R2-BEST-TROSY is a NMR experiment that allows detection of R2 relaxation rates
for all NH groups in the protein. BEST stands for band selective excitation short
transient and is based on the use of selective 1H pulses to enhance longitudinal re-
laxation, much like SOFAST, see 7.2.3. TROSY stands for transverse relaxation
optimized spectroscopy, and is based on the principle of cross correlated relaxation.
In-depth theory developments show that two relaxation mechanisms such as dipole-
dipole interaction and chemical shift anisotropy not only have speciﬁc eﬀects on a
spin system, but also lead to positive or negative interferences. This will for example
cause the two lines of a scalar-coupled IS spin system doublet to have diﬀerent line
widths due to their diﬀerent relaxation behavior. The TROSY scheme will select the
coherence with the longest relaxation time, therefore yielding the sharpest linewidth.
As seen in section 7.1.4, R2 measurements necessitate the introduction of a spin echo
with a variable delay in the experiment. This is made in the R2-BEST-TROSY pulse
sequence using the parameter ∆, as shown on ﬁgure 13.9.
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Figure 13.9: R2-BEST-TROSY pulse sequence used for the measurement of
R(Nx+2NxHz) relaxation rates (adapted from A. Favier & B. Brutscher, J. Biomol.
NMR. 2011, 49, 9-15). Filled and open symbols correspond to 90° and 180° rf pulses,
respectively. Amide 1H pulses typically cover a bandwidth of 4 ppm (centered at 8.5
ppm), and have the following shapes and durations at 800 MHz: (1) REBURP, 1.5 ms
(δ1), (2) PC9, 2.2 ms (δ2), and (3) EBURP-2, 1.4 ms (δ3). An asterisk indicates time
and phase reversal of the corresponding pulse shape. The transfer delays are adjusted
to τ1=1/(4 JNH) - 0.5 δ1 - 0.5 δ2, τ 2=1/(4 JNH) - 0.5 δ1 - κ δ3 and τ 3=1/(4 JNH) -
0.5 δ1. These settings account for spin evolution during the various shaped 1H pulses.
The parameter κ ≈ 0.7 can be ﬁne tuned to equilibrate the transfer amplitudes of
the diﬀerent coherence transfer pathways for optimal suppression of the unwanted
quadruplet components in the spectrum. Pulses are applied along the x-axis unless
indicated. The phase φ0 needs to be set to +y or =y, depending on the spectrometer,
to add the signals originating from 1H and 15N polarization. Pulsed ﬁeld gradients
are applied along the z-axis (PFGz) with durations (and ﬁeld strengths) of 300μs (35
G/cm) for G1, 50μs (15 G/cm) for G2, 100μs (30 G/cm) for G3, 1000μs (6 G/cm)
for G4, 1000μs (35 G/cm) for G5, 100μs (35 G/cm) for G6. The relative durations of
G5 and G6 are ﬁne tuned to fulﬁll the relation G5/G6 = γH/γN. The phase cycling
is: φ1 = =x,x; φ 2 = =y; φ 3 = =x; φ acq = =x,x. For quadrature detection in T 1,
echo-antiecho data are recorded by inverting the sign of gradient G6 together with
phases φ 2 and φ 3.
13.4.2 HET-SOFAST
HET-SOFAST[146] uses longitudinal relaxation properties of proton spins for the fast
detection of structural compactness and heterogeneity along the polypeptide backbone
of proteins.
An additional band selective inversion pulse is added to the standard SOFAST-HMQC
pulse sequence at the beginning of the recycle period or contact time tc on the Hsat
proton channel (ﬁgure 13.10). The experiment measures the eﬀect of this perturbation
(saturation) on the spin polarization of the amide protons after a contact time tc. Two
data sets are recorded, with and without the Hsat inversion pulse. The ratio of the
peak intensities ( = Isat/Iref ) measured in the two spectra then provides insight into
the interaction between amide protons (HN ) and saturated protons (Hsat).
Two types of proton interactions may be monitored by the HET-SOFAST experiment.
If the Hsat pulses are applied to the aliphatic protons, the experiment measures the
1H−1H spin diﬀusion or NOE eﬀect (λnoe). If the water polarization is inverted, the
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intensity ratios (λnoe) provide a measure of the amide water hydrogen exchange rates.
The two observables, λnoe and λex yield complementary information on the structure
and mobility of the polypeptide chain. The λnoe values report on the local 1H spin
network, i.e. the number, density, and mobility of protons close to a particular amide,







Figure 13.10: HET-SOFAST pulse sequence, similar to the SOFAST pulse sequence
with an added selective saturation pulse at the beginning
13.4.3 Results
The missing NMR signals for several consecutive regions that are structurally close
to Pro32 indicate the presence of conformational dynamics in this part of the protein.
Toward these regions, the NMR signal decreases gradually, as nicely seen from the
plot of intensity ratios of I- versus N-state peaks in HNCO spectra (Figure 13.11(a)).
To obtain additional, more quantitative information on the local conformational dy-
namics in the I-state of B2M, we performed two simple spin relaxation measurements
during protein refolding. Such measurements require the recording of a small number
of 2D 1H=15N correlation spectra (pseudo-3D experiment) using diﬀerent parameter
sets, e.g., varying a relaxation delay. The total acquisition time for such a pseudo-3D
experiment is generally only a few minutes, much shorter than the protein folding
time. Therefore, data acquisition is repeated several times during realtime folding.
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Figure 13.11: (a) Ratios of peak intensities measured in I-state and N-state 3D HNCO
spectra. (b) λNOE values obtained from HET-SOFAST experiment. (c) R2(Nx +
2NxHz) relaxation rates measured with R2- BEST-TROSY sequence (Figure S4). N-
and I-state values are plotted in black and red, respectively. Both experiments were
performed at 800 MHz on a 0.6 mM 13C,15N-labeled W60G-B2M sample. In (d) the
measured R2 values are color-coded on the cartoon structure of B2M. NMR-invisible
I-state regions are indicated by cyan bars in (a)= (c), and dark red in (d).
First, a HET-SOFAST experiment[146] was performed that exploits the diﬀerence in
amide 1H T 1 relaxation in the presence/absence of aliphatic 1H saturation to probe
the structural compactness (local 1H density) and sub-ns time scale dynamics. The
intensity ratios (λNOE = Isat/Iref) measured for individual amide protons in the N-
and I-states of W60G are compared in the graph of Figure 13.11(b). Low λNOE
values are indicative of rigid, compact local structure, while λNOE values close to
1 are expected for highly ﬂexible loop regions. From these data we can conclude
that, within the experimental error, the two states behave very similarly in terms
of local structural compactness and fast time scale dynamics, even in the regions
with signiﬁcant diﬀerences in 1H , 15N chemical shifts (Figure 13.8). Of course, no
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conclusion can be drawn for the protein regions that are NMR invisible.
In a second experiment, we measured the transverse relaxation rates of the 15N co-
herence Nx + 2NxHz (TROSY line) by inserting a variable spin=echo delay into the
1H =15N BEST-TROSY experiment (see section 13.4.1). This R2-BEST-TROSY ex-
periment yields information on both fast motions (ps=ns), comprising the molecular
tumbling and local bondvector ﬂuctuations, and conformational exchange dynamics
occurring on the μs=ms time scale. Relaxation rates were obtained by ﬁtting the
cross-peak intensities measured for three relaxation times T (1, 20, and 60 ms) to the
function I(T ) = A exp(=R2T ) (Figure 13.12). The measured rates are shown in Fig-
ure 13.11(c). A ﬁrst interesting conclusion from these data is that, for protein regions
that do not show signiﬁcant chemical shift variations between I- and N-states, the
measured relaxation rates are also very similar (∼ 10s−1). This observation indicates
similar molecular tumbling correlation times for the I- and N-states, excluding the
hypothesis of a fast monomer=oligomer exchange process as a possible explanation
for the missing I-state correlation peaks. This is consistent with a monomer-oligomer
equilibrium occurring on timescales of 1 to 10 s−1, as described in section 10.3.2.
Figure 13.12: Peak intensity decays measured for selected residues in the Istate (top)
and N state (bottom) of W60G-B2M. Three residues (Tyr26, Glu50, Asp59) show
faster transverse relaxation in the I-state than in the N-state, while the relaxation
rates measured for a fourth residue (Glu44) are approximately equal in both states.
Most interestingly, transverse relaxation in the I-state is increased in regions close
to the NMR-invisible residues, further supporting the idea that the absence of NMR
signal is due to conformational exchange processes on the μs=ms timescale in the
apical side of the protein close to Pro32 (Figure 13.11(d)). Based on the observed
proﬁles of chemical shift changes and 15N transverse relaxation rates, it is tempting
to speculate that this conformational exchange process involves a collective opening




In summary, the results of this chapter demonstrate the ability of sensitivity-enhanced,
fast real-time 3D NMR spectroscopy combined with high-ﬁeld NMR instruments to
provide insight into the structural and dynamic properties of a protein folding interme-
diate of B2M at atomic resolution. In particular, we have shown that, once sequential
NMR assignment has been obtained, quantitative information on local dynamics at
various time scales can be obtained from real-time spin relaxation measurements. This
approach can be readily applied to other biologically relevant systems and provides a
powerful strategy for NMR-based characterization of protein states with half-lifetime
of a few tens of minutes. As demonstrated here, fast real-time 3D NMR represents a
unique method for the characterization of long-lived transiently populated protein
states. It may also prove useful for in-cell NMR studies[150] where the protein of in-
terest has often a similar short lifetime, and where structural changes occurring after
some cellular stimulus may be monitored by real-time NMR methods.
If the speculated opening motion conformational exchange in the apical half of W60G
is attractive, the question remains of the extension of this result to the WT protein.
As seen in section 8.3, the folding mechanism of W60G is diﬀerent from that of WT
B2M. Especially, it populates the oligomeric states of B2M folding with a smaller
fraction. Yet, does the monomeric state I1 of WT B2M also show this conformational
exchange? Is it linked to the oligomerization equilibrium that occurs during folding?
Only the study of WT B2M itself would allow such a conﬁrmation. This study will
push even further the need of optimization of the NMR methods presented in this




B2M is both a fruitful and diﬃcult object of study. B2M production is complex, re-
quiring optimization to obtain a well folded protein and reach yields suitable to NMR
and SAXS studies. B2M folding is highly sensitive to buﬀer, temperature, concen-
tration and often preparation conditions. Yet our studies, using several biophysical
methods, revealed essential features of the folding mechanism and of the structure
and dynamics of folding intermediates of this protein.
A ﬁrst outcome of our studies is that folding and oligomerization are co-existing pro-
cesses. A major ﬁnding is the existence of a monomer-oligomer equilibrium between
I1 and I2 folding intermediate states. Indirectly detected using real time NMR meth-
ods like SOFAST, I2 was directly detected and characterized using SAXS: I2 is likely
to be a dimer. Folding intermediate states of B2M had been shown to favor ﬁbril
formation: this is easily explained by the existence of a dimeric folding intermediate
state with a signiﬁcant population.
A combination of biophysical methods allowed the characterization of this monomer-
oligomer equilibrium. Using SAXS, and later conﬁrmed by NMR relaxation exper-
iments, stoichiometry is shown to be a monomer-dimer equilibrium. Hints on the
timescale of this equilibrium can also be deﬁned using real time NMR experiments:
the equilibrium is fast compared to the dead time of the experiment, even though the
available data can not discriminate between a fast or a slow exchange relatively to
the NMR timescale. Further work based on the methodology applied to the folding
of the W60G-B2M mutant, including a further optimization of the sensitivity of the
experiment, will give a sharper picture of the I1-I2 equilibrium of the WT protein,
and may provide information on the timescale of the equilibrium.
The thorough study of the folding of B2M pushes biophysical methods to their limits:
sensitivity and acquisition time for NMR, polydispersity for SAXS. Yet in both cases
a large oligomer (I3) that disappears within minutes was detected, and conﬁrmed
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using UV-ﬂuorescence. Characterization of I3 will demand further methodological
developments, a new experimentation plan including a full dilution scale, or double
jump experiments for example. Another possible strategy is the use of a perdeuterated
methyl protonated samples of B2M for NMR experiments, that may lead to a direct
characterization of I3. A question that arises is the comparison of this large oligomer
and oligomeric intermediate states that are populated during the formation of ﬁbrils.
Other biophysical methods, such as ESI mass spectroscopy, may be an interesting
input.
Tackling the limits of biophysical methods leads to methodological developments. For
example, to study the structure and dynamics of I1, the continuous data acquisition
method allowed the assignment of this species that has a half-lifetime of ∼ 20 minutes.
A conformational exchange was discovered for the I1 state of the W60G-B2M mutant,
through the development of a spin relaxation measurement experiment: R2-BEST-
TROSY. The methods developed for this study may be later used to study the folding
and folding intermediate states of other proteins, or in other contexts in which the
short lifetime of the protein is an issue, as for in-cell NMR experiments.
Our studies are of course far from an application or a concrete result in the ﬁght
against misfolding diseases such as dialysis related amyloidosis or Parkinson's. But
the discovery of oligomeric folding intermediate states underlines that oligomerization
(including ﬁbril formation) and folding should not be studied separately, and are
processes that are closely related. Methodological developments included in our work
can be applied to other proteins as well as other contexts. Hopefully these questionings
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Résumé de la thèse
Remarque: ce résumé est présent à titre d'information, et n'est pas à considérer
comme une source.
Le repliement des protéines est le procédé par lequel une protéine atteint une con-
formation stable et fonctionnelle. Le principe d'Anﬁnsen dit que cette conformation
est unique, et déterminée uniquement par la séquence d'acides-aminés de la protéine,
faisant ainsi le lien entre l'information génétique codée dans l'ADN et la fonction
agissante de la protéine via une interaction clé-serrure et donc une structure tri-
dimensionnelle spéciﬁque. Toutefois cela doit aujourd'hui être nuancé, la conforma-
tion des protéines devant être considérée plutôt comme un ensemble d'états similaires,
plutôt que comme une structure rigide et statique. De plus, des protéines intrinsèque-
ment désordonnées sont aujourd'hui découvertes, montrant que la fonction peut ne
pas être liée à une structure bien déﬁnie. L'acquisition d'une structure tertiaire pourra
même être obtenue lors de la liaison avec une autre protéine ou un substrat.
La vision traditionnelle du repliement des protéines dérive du paradoxe de Levinthal,
qui dit que si une chaine polypeptidique devait de manière séquentielle expérimenter
toutes les conformations possibles avant d'atteindre, par hasard, sa conformation
fonctionelle, cela impliquerait un temps de repliement plus long que l'age de l'Univers.
Et pourtant, la plupart des petites protéines se replient en quelques millisecondes. Ce
paradoxe suggère que les protéines suivent un chemin préférentiel de repliement. Cela
peut être illustré par un paysage énergétique de repliement en entonnoir, qui peut
contenir des minima locaux correspondant à des états intermédiaires de repliement.
La principale limite à l'étude du repliement des protéines est son échelle de temps : la
microseconde ou la milliseconde pour la plupart des petites protéines. Les méthodes
traditionnelles d'étude des structures des protéines ont des résolutions temporelles
de l'ordre de la seconde dans le meilleur des cas. Les solutions traditionnelles à ces
diﬃcultés sont la baisse de la température, qui allonge le temps de repliement, et les
développements méthodologiques.
Les protéines mal repliées sont habituellement détectées par la cellule et dégradées
par protéolyse, mais certaines maladies sont dues à des protéines ayant subi une
mutation, qui ne peuvent atteindre leur conformation fonctionnelle, ou à des protéines
qui ne peuvent atteindre leur conformation fonctionnelle dans certaines conditions.
Par ailleurs, un dysfonctionnement du système protéolytique peut aussi entrainer des
pathologies.
Les amyloses sont un groupe déﬁni de conditions médicales dans lesquelles des pro-
téines normalement solubles et innoﬀensives polymérisent pour former des ﬁbrilles in-
solubles, et apparaissent donc dans la catégories des maladies du mauvais repliement.
Les ﬁbrilles amyloides grandissent et s'associent aux constituants extracellulaires,
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comme le plasme ou des protéoglycanes, pour former des dépôts amyloides dans les
tissus. Les maladies d'Alzheimer, Parkinson, certains cancers, ainsi que l'amylose liée
à la dialyse présentent des dépots amyloides. Cette dernière est en particulier liée à
la polymérisation de la Beta-2-microglobuline, protéine du système immunitaire, qui
peut dans des conditions physiologiques être soluble et circulante.
De nombreuses techniques permettent l'étude du repliement des protéines, sous un an-
gle soit cinétique, soit structurelle. L'étude du repliement suppose l'étude d'échantillons
complexes, incluant l'existence d'états transitoires, une polydispersité certaine, une
propension à l'agrégation, diﬀérentes échelles de taille et de temps, ainsi que des
cinétiques rapides. Une étude sérieuse du repliement des protéines suppose donc
l'utilisation de méthodes complémentaires. On citera la spectroscopie UV-visible, le
dichroïsme circulaire, la spectroscopie à infra-rouge, la diﬀraction X aux petites an-
gles (SAXS), et la RMN. La b2m est une protéine utilisée comme modèle depuis de
nombreuses années, en raison de trois caractéristiques. D'abord la B2M forme des
ﬁbrilles amyloïdes à la fois in vivo et in vitro. Ensuite ces ﬁbrilles amyloïdes sont
impliquées dans une maladie appelée amylose liée à la dialyse, leur donnant une im-
portance médicale directe. Enﬁn alors que les protéines de petite taille tendent à
se replier en quelques millisecondes, la B2M se replie en une douzaine de minutes
dans des conditions physiologiques, ce qui permet d'étudier son repliement avec des
méthodes biophysiques usuelles.
La formation des ﬁbrilles amyloides de B2M est étudiée depuis 1985, principalement
via diverses déstabilisations de la protéine, comme des mutations ou troncatures, in-
teraction avec des ions cuivre, des solvants organiques, du collagène, ou des contraintes
physico-chimiques comme la température, une concentration élevée de sel, ou une ag-
itation importante. Tous ces changements ont une inﬂuence sur l'équilibre cis/trans
du lien peptidique entre His31 et Pro32. Ce lien est dans une conformation cis dans
l'état natif, alors qu'une conformation trans est observée dans les ﬁbrilles. D'autres
régions de la protéine, comme la boucle DE, ont été désignées comme participant à
la polymérisation de la B2M.
La formation des ﬁbrilles amyloides passe pour B2M comme pour la plupart des
protéines par la formation d'oligomères. L'utilisation de DTT a permis de mettre en
évidence la formation d'une échelle d'oligomères de diﬀérentes tailles, menant à la for-
mation de ﬁbrilles amyloides. Par ailleurs, l'utilisation d'anticorps à domaine unique
a aussi permis d'obtenir une structure crystallographique d'un dimère de la B2M, an-
noncé comme un intermédiaire sur le chemin de la formation des ﬁbrilles amyloides.
Enﬁn, l'utilisation d'ions cuivre a permis d'établir un changement conformationnel de
B2M impliqué dans une oligomérisation puis la formation de ﬁbrilles amyloides.
Le repliement de la B2M a principalement été étudié dans la littérature par dichroïsme
circulaire et par spectroscopie UV-visible. Les premières expériences par Chiti et al
en 2001 ont montré que le repliement de la B2M présentait trois étapes. Tout d'abord
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l'état déplié était très rapidement transformé en un premier état intermédiaire, avec
un temps caractéristique inférieur au temps mort de l'expérience, à savoir quelques
millisecondes. Puis ce premier état intermédiaire donne naissance à un deuxième état
intermédiaire, en moins de trois secondes. Puis une troisième phase de repliement,
lente, est terminée en une dizaine de minutes, pour atteindre l'état natif. Ce mod-
èle de repliement est linéaire. La phase rapide de trois secondes n'est pas détectée
par dichroisme circulaire, ce qui suggère que les deux états intermédiaires ont des
structures similaires pour ce qui concerne cette méthode.
L'utilisation des mêmes méthodes par Jahn et al en 2006, en ajoutant une série
de conditions de repliement (faisant varier la concentration ﬁnale de Gd-HCl), fait
apparaître un schéma de repliement parrallèle comprenant cinq états. Il n'est toutefois
pas incompatible avec le modèle de Chiti, en raison de la faible population des états
aux moments précis qui pourraient discriminer entre les deux modèles. Une troisième
étude par Sakata et al en 2008 conclut, par l'utilisation de méthodes similaires et des
expériences de double saut, à un schéma à quatre états. Le repliement de la B2M est
donc complexe, et suppose une analyse ﬁne des données recueillies.
Le fait majeur du repliement de la B2M est la transition trans vers cis du lien pep-
tidique His31-Pro32. Cette transition étant impliquée dans l'oligomérisation de la
B2M et dans la formation de ﬁbrilles, il apparaît possible que les deux phénomènes
soient liés.
Les développements récents de la résonnance magnétique nucléaire (RMN) ont per-
mis de réduire le temps nécessaire à l'acquisition de données. Plusieurs méthodes
peuvent être mises à contribution, comme l'acquisition parcellaire, ou l'utilisation des
propriétés de relaxation notamment longitudinale. Cela a mené à la conception des
méthodes BEST et SOFAST, méthodes permettant d'acquérir des spectres 2D en
quelques secondes par exemple. La RMN permet d'obtenir de nombreuses informa-
tions sur la structure, la dynamique, des protéines, mais aussi sur les phénomènes
cinétiques. Elle permet notamment d'évaluer l'échelle de temps de phénomènes dy-
namiques ou cinétiques, mais aussi de détecter les parties de la protéine impliquées
dans tel ou tel changement structurel.
La méthode de base de ces études est le repliement utilisant un saut de pH à partir
d'un état acide dénaturé de la B2M. Ce saut de pH est provoqué par un injecteur
permettant de réduire le temps mort des expériences RMN à quelques secondes. La
B2M utilisée a été obtenu par production recombinante, et marquage isotopique sim-
ple (N15) ou double (C13-N15). L'évolution cinétique du repliement est suivie par
des acquisitions successives, environ toutes les quinze secondes.
Le suivi du repliement de la B2M fait apparaître plusieurs informations. Tout d'abord,
juste après le saut de pH, le spectre acquis ne montre aucune trace de l'état acide
dénaturé. Cet état a laissé place à des états dont le spectre est typique d'espèces au
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moins partiellement repliées, au cours du temps mort de l'expérience. Cela correspond
à la phase immédiate (burst phase) et à la phase rapide évoquée dans la littérature. Il
est possible sur ces spectres d'isoler trois classes de pics : ceux correspondant à l'état
natif, ceux montrant une superposition de deux états, et ceux typiques d'une espèce
intermédiaire. L'intensité mesurée pour les pics de l'état natif est de 10% de la valeur
à la ﬁn du repliement. On retrouve ensuite la phase lente précédemment décrite,
avec passage de l'état intermédiaire It à l'état natif N. Toutefois, la classe des pics
comportant une superposition I et N ne donne pas lieu à une intensité constante au
cours du repliement. Cela signiﬁe qu'un autre état intermédiaire au moins, invisible
en RMN, est peuplé de manière non négligeable au cours du repliement.
Cela permet de construire de nouveaux modèles de repliement. Toutefois la question
de la caractérisation de l'état intermédiaire invisible en RMN reste posée. Plusieurs
hypothèses peuvent expliquer cette invisibilité. Soit cet état est oligomérique, donc de
taille trop importante pour être détectable, soit cet état est trop dynamique pour être
détecté. Les modèles obtenus par RMN peuvent être considérés comme compatibles
avec les modèles de la littérature.
Cet état intermédiaire invisible peut cependant être étudié par RMN. En eﬀet ce
manque initial d'intensité est un témoin de la population de cet état. En faisant varier
les conditions expérimentales, on peut voir que la population de l'état intermédiaire
invisible augmente avec la hausse de la concentration et la baisse de la température.
Cela laisse supposer que cet état intermédiaire invisible en RMN, et qui n'avait pas
été décrit dans la littérature, serait un oligomère.
Cet état intermédiaire invisible par RMN est en équilibre avec l'état intermédiaire
visible. Plusieurs hypothèses apparaissent quant à cet équilibre. Soit l'échange est
lent comparé à l'échelle de la RMN, et alors l'état invisible est soit un grand oligomère,
soit un petit oligomère dont le spectre est exactement superposé à l'état intermédiaire
monomérique. Soit l'échange est rapide, et l'état invisible est un petit oligomère.
L'utilisation d'autres méthodes biophysiques permet d'aller plus loin dans la carac-
térisation de cet état invisible par RMN. La plus importante d'entre elles, puisqu'il
s'agit de détecter et de caractériser des oligomères, est la diﬀraction de rayons X aux
petits angles (SAXS). Cette technique peut être utilisée en temps réel, pour suivre le
repliement de la B2M, avec des contraintes méthodologiques liées à la consommation
de protéine, réduisant le nombre de données mesurées au cours du repliement à moins
d'une dizaine. Le temps mort est par ailleurs plus long qu'en RMN, de l'ordre d'une
à deux minutes.
Le suivi du repliement par SAXS montre que le poids moléculaire moyen dans l'échantillon
diminue au cours du repliement. Cela montre directement la présence d'oligomère au
cours du repliement, dont la population diminue pour aller vers l'état natif. La ciné-
tique globale observée est similaire à celle obtenue en RMN. Le traitement des données
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SAXS permet par ailleurs de dégager deux types d'oligomères : l'un disparaissant en
quelques minutes, l'autre suivant la cinétique observée en RMN. Le premier oligomère
est supposé être un grand oligomère, alors que le second est très probablement un
dimère, selon les données SAXS.
Une autre méthode biophysique, à savoir la spectroﬂuorimétrie UV en présence de
thioﬂavine T, permet de caractériser encore plus précisément ces états intermédiaires
oligomériques. Ainsi la thioﬂavine T, qui se lie aux structures similaires à des ﬁbrilles
amyloides, se lie au premier oligomère détecté en SAXS et qui disparaît en quelques
minutes, alors qu'elle ne se lie pas à l'état intermédiaire dimérique. Cela montre que
le grand oligomère possède probablement une structure proche de celle rencontrée
dans les ﬁbrilles amyloides.
En cherchant spéciﬁquement ce grand oligomère, avec l'échelle de temps concernée, il
est en fait possible de détecter trois pics spéciﬁques dans les spectres RMN obtenus
lors du repliement. Ces pics correspondent probablement à quelques acides aminés
ﬂexibles, probablement à l'une des terminaisons de la protéine.
Ces découvertes posent toutefois la question de la détection de l'état intermédi-
aire dimérique par RMN. En eﬀet un dimère d'une protéine comme la B2M de-
vrait être détectable directement par RMN. Cette caractérisation par SAXS permet
ainsi d'éliminer l'hypothèse d'un échange lent entre état intermédiaire oligomérique
de grande taille et état intermédiaire monomérique. Toutefois les données ne sont pas
suﬃsantes pour trancher entre l'hypothèse d'un échange rapide ou d'un échange lent
avec superposition exacte.
Les données RMN et SAXS peuvent être modélisées simultanément pour aboutir à
un modèle de repliement à trois états intermédiaires : un état monomérique, un état
dimérique ou oligomérique de petite taille, et un état oligomérique de grande taille à
structure ﬁbrilloide.
Les états d'équilibre (natifs) de la B2M et de mutants de la B2M peuvent être
étudiés par SAXS. Cette étude montre que le mutant P32A peut constituer un modèle
d'équilibre des états intermédiaire, présentant une oligomérisation importante dans
des conditions physiologiques. Par ailleurs, le mutant W60G apparaît comme un mod-
èle de l'état natif monomérique de la B2M. Les données SAXS montrent en eﬀet que
même dans des conditions physiologiques, la B2M peuple de manière non négligeable
des états oligomériques.
D'autres méthodes RMN permettant la caractérisation de l'état intermédiaire monomérique
ont pu être développées, permettant l'attribution de cet état au cours du repliement
de la B2M, grâce à une forte réduction du temps d'acquisition nécessaire, et la mise
en place d'une acquisition dite continue. L'attribution permet d'attribuer au résidu
correspondant les évolutions de déplacement chimique au cours du repliement. Le
développement de méthodes rapides d'étude de relaxation RMN permet par ailleurs
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de montrer qu'il existe un certain échange conformationnel pourrait expliquer le fait
que certaines parties de la protéine dans l'état intermédiaire monomérique restent
invisibles par RMN. Le développement de toutes ces méthodes montre que la RMN
permet d'obtenir des données sur la structure et la dynamique d'états transitoires
d'une protéine.
La B2M est un objet d'étude complexe mais riche en enseignements. L'utilisation
de techniques biophysiques complémentaires montre tout son intérêt dans ce cadre.
La découverte de multiples intermédiaires de repliement et leur caractérisation est
l'avancée majeure de ce travail, montrant les liens entre oligomérisation et repliement.
Par ailleurs, les méthodes développées ici pourront être appliquées à d'autres pro-
téines.
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Figure 14.2: Folding of WT-B2M at 20°C. Top line: N class. Center line: I class.
Bottom line: I+N class. Left column: 750µM B2M. Center column: 375µM B2M.



































































Figure 14.1: Folding of WT-B2M at 25°C. Top line: N class. Center line: I class.
Bottom line: I+N class. Left column: 750µM B2M. Center column: 375µM B2M.



























































Figure 14.3: Folding of WT-B2M at 20°C. Top line: N class. Center line: I class.
Bottom line: I+N class. Left column: 188µM B2M. Center column: 150µM B2M













































































Figure 14.4: Folding of WT-B2M at 15°C. Top line: N class. Center line: I class.
Bottom line: I+N class. Left column: 750µM B2M. Center column: 375µM B2M.
Right column: 188µM B2M.
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Isotopically enriched human B2M production protocol
Buﬀers
Lysis buﬀer
10 mM Tris-HCl pH 7.5
2.5 mM MgCl2
0.5 mM CaCl2
0.013 mg/ml DNase I
4 x 10-3 mg/ml lysozyme
10X Triton buﬀer









100 mM Tris-HCl pH 8.0
400 mM L-Arginine-HCl
2 mM EDTA
5 mM Glutathione- Reduced




 Preculture one day in LB medium, and then overnight in M9 medium.
 Grow transformed bacteria on M9 media for labelled growth at 37C
 Induce at OD600 of ~1.0
 Harvest at least 12 hrs later
 Harvest bacteria by centrifugation
 20 min @ 5000 x g
 resuspend pellet in lysis buﬀer (~10ml per gram original cell paste)
 Lyse bacteria by soniﬁcation and collect inclusion body (IB) pellet
 30 sec on, 30 sec oﬀ, 10 min process time in ice bath
 spin down for 20 min @ 16000 x g
 Retain pellet, decant supernatant
 Wash IB Pellet in lysis buﬀer (~10ml per gram original cell paste)
 homogenise pellet in solution
 Incubate at 37C for 1 hour
 Spin down for 20 min @ 16000 x g
 Retain pellet, decant supernatant
 Wash IB pellet in triton buﬀer until pure
 homogenise in 10x triton buﬀer (30 ml), spin down for 20 min @ 5000 x g
 homogenise in 1X triton buﬀer (30 ml, 1:10 dilution of 10X buﬀer), spin
down for 20 min @ 8000 x g (repeat as necessary until pure (usually two
or three times is enough))
 homogenise in 1X triton buﬀer (30 ml), spin down for 25 min @ 16000 x g
 Retain pellet, decant supernatant
 Solubilise IB pellet in solubilisation buﬀer (~10 ml for each gram of original cell
paste)
 Homogenise and leave with gentle stirring at room temperature overnight
 Spin down for 20 min @ 16000 x g, retain supernatant
 Flash refolding: Dilute solubilised β2m in 2 litres of refold buﬀer for one litre of
M9 culture
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 Slow dilution (drop by drop) of β2m at 4C with slow agitation
 Concentrate refolded β2m using Vivaspin system and a 5kDa membrane until a
volume of ~50mL (~1mg/mL)
 Purify monomer by size exclusion chromatography
 Sephadex 75 16/60 column (GE Healthcare) used, 5 ml β2m solution loaded
per run
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Interparticular eﬀects in SAXS: WT B2M pH=2










Figure 14.5: SAXS curve WT B2M at pH=2. The plateau at low S is characteristic
of repulsive interparticular eﬀects, linked to the acidic denatured state (unfolded and
charged) of WT B2M at pH=2.
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Mapping of the interaction between the folding inter-
mediate state I1 and ANS
Figure 14.6: Chemical shift changes upon interaction of I1 and ANS, obtained during
the folding of B2M. A binding appears in the 87-93 region of B2M, which corresponds
to the apical, opposite to P32, part of the protein.
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